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 ABSTRACT 
QUANTITATIVE EVALUATION OF REDOX PROCESSES IN  
INTACT RAT LUNGS AND ENDOTHELIAL  
CELLS AND THE EFFECT OF  
HYPEROXIA 
 
Zhuohui Gan, B.S., M.S. 
Marquette University, 2011 
 
A common initial treatment of hypoxemia in patients with lung failure secondary to acute 
lung injury (e.g., adult respiratory distress syndrome) is oxygen (O2) therapy (hyperoxia). 
However, prolonged O2 therapy causes lung O2 toxicity, which can further impair lung functions. 
The rat model of lung O2 toxicity replicates key features of human lung O2 toxicity. In addition, 
rats develop tolerance or susceptibility to 100% O2 by pre-exposing them to 85% O2 (hyper-85) or 
60% O2 (hyper-60) for 7 days, respectively. Therefore, the long-term objectives of this study are to 
elucidate mechanisms involved in rat tolerance of 100% O2, and to further understanding of the 
mechanisms involved in lung O2 toxicity. In this work, the effects of rat exposure to hyperoxia on 
targeted lung cytosolic/mitochondrial redox enzymes with pro- or anti-oxidant properties were 
evaluated using indicator dilution methods. The effect of hyperoxia on mitochondrial membrane 
potential (∆Ψm) in cultured endothelial cells was also evaluated using an approach developed in 
this study. Computational modeling was used for quantitative analysis data from intact lungs or 
cultured endothelial cells, and for estimation of parameters descriptive of the activities of targeted 
enzymes and ∆Ψm. The results revealed an increase in the lung activity of NAD(P)H:quinone 
oxidoreductase 1 (NQO1) in hyper-85 and hyper-60 rats, a decrease in the lung activity of 
NADH:ubiquinone reductase (complex I) in rats exposed to 85% O2 for >24 hours and an increase 
in the lung activity of Q-cytochrome c reductase (complex III) in hyper-85 rats. Exposure of 
endothelial cells to 95% O2 for 48 hours did not alter ∆Ψm but increased its sensitivity to 
mitochondrial uncouplers. These results suggest that the decrease in the activity of complex I 
might be an early manifestation of an adaptive response to 100% O2; and the increase in the 
activity of complex III might be important to this adaptive response. Thus, complexes I and III 
could serve as non-invasive indices of lung O2 toxicity or tolerance using clinical imaging 
methods, or as therapeutic targets for protecting against lung O2 toxicity.   
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CHAPTER 1. INTRODUCTION AND BACKGROUND 
1.1 Acute Lung Injury and O2 Toxicity 
 Acute lung injury (ALI) and its most severe form acute respiratory distress syndrome 
(ARDS) are characterized by inflammation of the lung parenchyma leading to impaired gas 
exchange function, hypoxemia (low blood PO2) and possibly resulting in multiple organ failure 
(Clark & Lambertsen, 1971; Fisher, Forman & Glass, 1984; Freeman & Crapo, 1981). ARDS is 
one of the most frequent causes of admission to intensive care units (ICU), with around 190,000 
cases per year in the USA and a 35% ~ 45% mortality rate (Phua et al., 2009; Ragaller & Richter, 
2010). Major causes for ARDS include sepsis, pneumonia, major trauma, toxins, shock, multiple 
transfusions, inhalation injury, lung transplant, severe burns, ionizing radiation, and 
chemotherapeutic agents (Cehovic, Hatton & Fahy, 2009). An important aspect of the 
pathogenesis of ARDS is compromise of the barrier properties of the pulmonary capillary 
endothelium and alveolar epithelium, which leads to pulmonary edema and hypoxemia (low blood 
PO2) (Clark & Lambertsen, 1971; Crapo, Barry & Foscue, 1980). Thus the most common initial 
treatment for ARDS is O2 therapy (normobaric hyperoxia) to restore blood PO2 to close to its 
normal level.  
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Figure 1. 1 O2 therapy increased arterial PO2 of  ARDS patients close to the normal level. 
Although high O2 therapy initially improves arterial blood PO2 (Figure 1.1), sustained 
exposure to high O2 is limited by its lung O2 toxicity, which can further impair lung functions. 
Currently, there is no effective way to mitigate the toxic effects of supplemental O2 therapy. 
The lung injury caused by normobaric hyperoxic therapy is progressive. Early clinical 
aspects of lung O2 toxicity include coughing, altering in mucociliary movement, and reflecting 
tracheobronchitis (Clark & Lambertsen, 1971). With time, these tracheal symptoms become more 
intense. Behnke et al. showed that after 4 hours of 100% O2 exposure, pulmonary symptoms such 
as substernal pain first appear (Behnke, Johnson & Poppen, 1935). Clark et al. showed that 
exposure to supraphysiological concentrations of O2 (> 50%) for prolonged periods (> 13 hours) 
impair pulmonary functions (Clark & Lambertsen, 1971). After 24-hour exposure to high O2 (> 
50%), functional changes such as a decrease in vital capacity, a decrease in pulmonary compliance, 
a decrease in the pulmonary diffusing capacity for carbon monoxide, and absorption atelectasis are 
observed (Welch, Morgan & Clamann, 1963; Clark & Lambertsen, 1967; Caldwell, Lee & 
Schildkraut, 1966; Carvalho, Depaula & Schettino, 1998). Hyperoxia-induced decreases in 
alveolar volume, capillary volume, and alveolar and capillary surface densities may be explained 
by the increase in alveolar tissue and particularly of the interstitium, alveolar capillary 
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proliferation, absorption atelectesis and rupture of some alveolar septa (Kapanci, Tosco & 
Eggermann, 1972; Hyde & Rawson, 1969; Carvalho, Depaula & Schettino, 1998). The decrease in 
carbon monoxide diffusing capacity may be due to an increase in air-blood barrier thickness which 
is caused by swelling of epithelial and endothelial cells, fibroblastic proliferation, fibrin deposition, 
and increased numbers of lining cells in the alveolar lumina (Kapanci et al., 1972; Hyde & 
Rawson, 1969). The above early pulmonary changes are reversible if the host is returned to 
normal PO2 before the symptoms become more serious (Clark & Lambertsen, 1971). However, for 
those subjects exposed to hyperoxia for prolonged periods such as ARDS patients, the above 
cellular and structural changes eventually result in the development of bronchopneumonia, 
pulmonary edema, and progressive hypoxemia. Time of onset of the above changes varies with the 
inspired PO2 and exposure period (Joffe 1969, Hyde & Rawson, 1969).  
1.2 Animal Models of O2 Toxicity 
To evaluate the time course, severity and pathogenesis of lung O2 toxicity, several animal 
models of hyperoxic lung injury including rats, mice, rabbits have been developed (Clark & 
Lambertsen, 1967, Crapo et al., 1980, Hayatdavoudi, O’Neil & Barry, 1981, Ho et al., 1996, 
Matute-Bello 2008). The rat model mimics several aspects of lung O2 toxicity observed clinically 
(Kapanci et al., 1972; Hyde & Rawson, 1969; Crapo et al., 1980). Hyperoxia-induced histological 
changes observed in man that have also been observed in rats include an increase in the thickness 
of air-blood barrier, an increase in the number of interstitial cells, a decrease in capillary surface 
area, a decrease in pulmonary capillary blood volume and alveolar volume, and the damage of 
endothelial cells (Crapo et al., 1980). 
 For rats, the severity of hyperoxic lung injury is dependent on PO2 level and exposure 
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period (Crapo et al., 1980). For instance, rats exposed to > 95% O2 die within 60 to 72 hours, but 
rats exposed to 85% O2 or 60% O2 can survive for a prolonged period of time. However, among 
animal models, rats are unique in that, after exposed to 85% O2 for 5-7 days, they develop 
tolerance or adaptation to the otherwise lethal effects of exposure to >95% O2 as evidenced by an 
increase in their survival in subsequent exposure to 100% O2 environment (Figure 1.2). This 
tolerance is not observed in other rodents, but a similar tolerance occurs in humans (Capellier, 
Maupoil & Boussat, 1999). Interestingly, rats exposed to 60% O2 for 5-7 days become more 
susceptible to 100% O2 as evidenced by a decrease in their survival in subsequent exposure to 
100% O2 (Figure 1.2). 
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Figure 1. 2 Cumulative mortality of rats exposed to 100% O2. ∆, control animals kept in air before 
exposed to 100% O2; ▲, animals exposed to 85% O2 for 7 days before being exposed to 100% O2;  ●, 
animals exposed to 60% O2 for 7 days before being exposed to 100% O2. (Reproduced from Figure 1 in 
Hayatdavoudi et al., 1981  which is available online  at  
http://jap.physiology.org/content/51/5/1220.full.pdf) 
 Studies by Crapo et al. (1980) and Hayatdavoudi et al. (1981) provide detailed 
descriptions of histological and morphometric changes in lungs of rats exposed to lethal (100% 
O2), adaptive (85% O2) and susceptible (60% O2) hyperoxia.  
 No significant structural changes are observed in lungs of rats exposed to 100% O2 for up 
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to 40 hours (Figure 1.3) compared with rats exposed to room air (normoxic rats) (Crapo, Freeman 
& Bary, 1983). However, by 60 hours there is a 30% loss in pulmonary capillary endothelial cells 
and cell surface, lung infiltration of phagocytic leukocytes and other cells, and an increase in the 
thickness of air-blood barrier. Rats that survive 60 hours of exposure to 100% O2 experience 
additional loss of pulmonary capillary endothelial cells and edema, which lead to further increase 
in the thickness of air-blood barrier, pleural effusion, severe hypoxemia, and death within 72 hours.  
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Figure 1. 3 Alterations in pulmonary capillary endothelial cell volume, surface area and number in 
response to rat exposure to 100% O2 for up to 72 hours. * indicates a significant difference from that of 
normoxic rats (P<0.05). D is the time of death of rats and occurred at a mean of 66 hours of exposure. 
(Reproduced from Figure 1 in Crapo et al., 1983 which is available online at  http://www.the-
aps.org/publications/tphys/legacy/1983/issue3/170.pdf.) 
 For rats exposed to 85% O2 for 72 hours, lung histological and/or morphometric changes 
are undetectable although the sequence of events leading to lung O2 toxicity has presumably 
begun (Crapo et al., 1980). However, by 5 days, histological and morphometric changes similar to 
those observed after 60 hours of exposure to 100% O2 are observed. By 7 days, the inflammation 
is still evident and the lungs have lost more endothelial cells, but pleural effusion and respiratory 
function impairment have substantially subsided and longer exposure lead to an adapted steady 
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state without further progression of toxic manifestation. Moreover, the rats start to gain body 
weight (Crapo et al., 1980; Hayatdavoudi et al., 1981). Figure 1.4 outlines the different stages of 
the development of lung O2 toxicity in rats exposed to 85% O2. During the initiation phase (0-2 
days), an increase in the formation of reactive oxygen species is observed and the expression of 
inflammatory factors is increased, while histological and morphometric changes are not detectable 
(Crapo et al., 1983). During inflammatory phase (3~5 days), the lung experiences significant 
structural, cellular  and functional changes, in addition to significant loss of body weight due to a 
decrease in food/water intake. The adaptation phase (>5 days) is characterized by no further loss 
of endothelial cells, reversal of pulmonary functional impairment, and an increase in body weight. 
 
Figure 1. 4 Rat lung biochemical and structural changes during the three phase of  O2 toxicity 
associated with exposed to 85% O2 (Crapo et al., 1980; Hayatdavoudi et al., 1981). 
 For rats exposed to 60% O2 for 7 days, there is a decrease in the volume of endothelial 
cells and the arithmetic mean thickness of endothelial cells (Crapo et al., 1980, Hayatdavoudi et 
al., 1981). No further morphologic changes are observed following rat exposure to 60% O2 for up 
to 64 days. Interestingly, rats exposed to 60% O2 for 7 days become more susceptible to 100% O2 
(Figure 1.2) (Crapo et al., 1980; Hayatdavoudi et al., 1981).  
 Based on the histological and functional changes, for all above O2 levels, the pulmonary 
capillary endothelium is a primary site of O2 toxicity. The loss of pulmonary endothelial cells is an 
important characteristic of lung O2 injury. Previous studies indicated that rats exposed to 85% O2 
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increased cyanide-resistant O2 consumption as a measure of the rate of reactive oxygen species 
(ROS) formation, primarily in endothelium (Crapo & Tierney, 1974). The production of ROS can 
be associated with direct endothelium injury, demonstrated by increased LDH release in O2 
challenged endothelial cells (Crapo & Tierney, 1974; Crapo et al., 1980; Hayatdavoudi et al., 
1981). Previous studies also reported some differences in ultra-structure among the rats exposed to 
100% O2, 85% O2 and 60% O2, especially the significant differences in the response of the 
pulmonary endothelium. For instance, rats exposed to 100% O2 exhibited lethal changes in the 
capillary endothelial cells manifested by pyknotic nuclei, swelling of the perinuclear cisternae, the 
rough endoplasmic reticulum and mitochondria, and the consequent rupture of plasma membrane. 
Necrosis of the capillary endothelial cells was a major event and was accompanied by an apparent 
stagnation of blood flow in capillary lumens. No adaptive changes were apparent. In marked 
contrast, rats exposed to 85% O2 for 7 days exhibited some adaptive changes such as hypertrophy 
of capillary endothelial cells instead of simple swelling, a significant decrease in capillary lumen 
and a significant increase in the thickness of endothelial cells and total tissue volume 
(Hayatdavoudi et al., 1981; Crapo et al., 1980). In rats exposed to 60% O2 for 7 days, there was no 
significant difference in the total tissue volume and the capillary lumen; however the thickness of 
endothelial cells was decreased significantly (Hayatdavoudi et al., 1981; Crapo et al., 1980). These 
results suggest that the pulmonary capillary endothelium is not only a primary target of O2 toxicity, 
but also a likely important site in which biochemical adaptation to O2 toxicity occurs (Crapo et al., 
1980). Elucidating the factors that contribute to O2 toxicity and tolerance has the potential to 
further understanding of the mechanisms involved in initiating lung O2 toxicity and for identifying 
potential targets/mechanisms for mitigating the toxic effects of O2 therapy on lung tissue. 
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CHAPTER 2. PRESENT STATUS OF PROBLEM, OBJECTIVES AND 
SPECIFIC AIMS 
2.1 Biochemical Mechanisms of Lung O2 Toxicity 
 Although the mechanisms resulting in pulmonary hyperoxic injury are not fully 
understood, there is ample evidence that the deleterious effects of high O2 are the results of 
increased formation of ROS such as O2
-
, H2O2  and hydroxyl radical (Freeman & Crapo, 1981; 
Sander et al., 1993). Studies have suggested that mitochondrial electron transport chain 
NADH:ubiquinone oxidoreductase (complex I) and coenzyme Q-cytochrome c reductase 
(complex III) are important sources of ROS under hyperoxic conditions (Crapo  & Tierney, 1974; 
Freeman & Crapo, 1981; Sander et al., 1993; Brueckl et al., 2006). At normal PO2 level, cells can 
scavenge ROS via enzymatic (e.g., superoxide dismutase, catalase, glutathione reductase) and 
non-enzymatic (e.g., vitamins C and E) anti-oxidants. The increase in the formation of ROS under 
hyperoxic conditions has been suggested to overwhelm the cellular anti-oxidant mechanisms and 
cause various cytotoxic effects, including lipid peroxidation, damage to protein structures, 
dysfunction of enzymes, DNA strand breakage, and ultimately cell death (Rourke, Cortassa & Aon, 
2005; Brueckl et al., 2006). This can compromise the barrier properties of the endothelial and 
epithelial cells and can result in lung edema, impaired gas exchange function, and hypoxemia. 
Moreover, the increase in ROS formation can initiate other cell responses that may be important to 
the pathogenesis of lung O2 toxicity such as the increase in the expression of vascular adhesion 
molecules (e.g., P-selectin) which can result in the recruitment of phagocytic cells into the lung 
tissue (Brueckl et al., 2006). 
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2.2 Biochemical Mechanisms of Rat Tolerance and Susceptibility to Lethal O2 Levels 
 Previous studies, predominantly in lung tissue homogenate, have suggested that classic 
antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase 
protect against lung O2 toxicity (Crapo et al., 1980; Hayatdavoudi et al., 1981; Wang, Manevich & 
Feinstein, 2004). For instance, an increase in overall activity of CuZn-SOD was reported in lung 
tissue homogenates of rats exposed to 85% O2 for 7 days, but not in lung tissue homogenates of 
rats exposed to 100% O2 for 60 hours (Ho, Dey & Crapo, 1996). Although the activities of these 
enzymes do increase in lung homogenates of rats adapted to the lethal effects of > 95% O2, they 
do not appear to account for all aspects of this adaptive response. For instance, Coursin et al. 
reported a significant increase in the activities of these classic anti-oxidant enzymes in lung 
homogenates of rats exposed to 65% O2 for six weeks (Coursin, Cihla & Will, 1987). However, 
these rats were more susceptible to the lethal effects of > 95% O2 than normoxic rats. 
 The anti-oxidant enzyme peroxiredoxin 6 (Prdx6) has also been suggested to play a role 
in protection from O2 toxicity (Manevich & Fisher, 2005; Fatma et al., 2009). Prdx6 catalyzes the 
reduction of H2O2 and hydroperoxides to H2O by utilizing glutathione. Studies have shown that 
over-expression of Prdx6 confers some protection against oxidative stress by prolonging the 
survival of mice in lethal hyperoxia, and genetic inactivation of this enzyme increases sensitivity 
of mice to O2 toxicity (Wang et al., 2004). 
 An important aspect of lung O2 toxicity is edema. Na
+
/K
+
-ATPase and Na
+
 channels play 
a key role in clearing edema via active transport of Na
+
. A study by Factor et al. (2000) suggests 
that over-expression of Na
+
/K
+
-ATPase in rats improves alveolar fluid clearance and protects rats 
against O2 toxicity as measured by the increase in the time these rats survive in a > 95% O2 
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environment. However, a study by Nici et al (1991) shows an increase in Na
+
/K
+
-ATPase 
expression in lung homogenate of rats exposed to 100% O2 for 60 hours, which die within 74 
hours of exposure to 100% O2. The results of this study suggest that the increase in the expression 
of Na
+
/K
+
-ATPase is not sufficient to protect against lung O2 toxicity or explain the adaptation 
induced by rat exposure to 85% O2 for 7 days. 
 The induction of phase II enzymes such as the cytosolic enzyme NAD(P)H:quinone 
oxidoreductase 1 (NQO1) has been suggested to play a role in rat tolerance of > 95% O2 (Cho et 
al., 2002). The induction occurs via the anti-oxidant response element (ARE) mediated by an 
increase in the rate of ROS formation (Cho et al., 2002). In addition to its role as a phase II 
enzyme, NQO1 has been suggested to provide additional protective effects including regeneration 
of endogenous and exogenous antioxidants, scavenging of superoxide (O2
-
), and competition with 
one-electron quinone reductases. The competition with one-electron quinone reductases mitigates 
the effects of semiquinone formation and subsequent redox cycling (Cadenas 1995; Siegel & Ross, 
2000; Siegel et al., 2004). 
 Several studies have evaluated the role of NQO1 in protection against pulmonary O2 
toxicity with mixed results (Whitney & Frank, 1993). Whitney et al. found that treatment with 
dicumarol (NQO1 inhibitor) or the induction of NQO1 did not significantly diminish or improve 
the survivability of adult rats exposed to lethal O2 levels. The results with dicumarol treatment 
may be in part because dicumarol has such a high affinity for plasma proteins that only a small 
fraction would be taken up by the lung in vivo (Audi et al., 2005). 
 Cho et al. (2002) showed that mice deficient in the transcription factor Nrf2, which is 
involved in the induction of NQO1, had significantly lower lung NQO1 mRNA expression and 
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were significantly more sensitive to hyperoxia (> 95% O2 for 72 hours) than wild type mice. 
Furthermore, they showed that exposure of wild type mice to hyperoxia increased their lung 
homogenate NQO1 activity. 
 Another important strategy that cells may follow to protect against lung hyperoxic injury 
is to mitigate the activities of ROS sources including mitochondrial complexes I, III and IV 
(Figure 2.1). Campian et al. (2007) found that HeLa cells exposed to 80% O2 for 3 days (HeLa-80) 
decreased by ~50% intracellular ROS production and increased the activity of cytochrome c 
oxidase (complex IV) by ~100%. These results suggested that the increase in complex IV might 
act to deplete upstream electron-rich intermediates responsible for ROS production, and hence 
induce a tolerance to hyperoxia (Campian, Qian & Gao, 2004; Campian, Gao & Qian, 2007). 
Campian’s studies indicated that it was possible to make cells tolerant to hyperoxia by 
manipulation of ROS sources instead of anti-oxidant defense (Campian et al., 2007). 
 Brueckl et al. (2006) evaluated the sources of ROS in isolated perfused rat lungs 
ventilated with hyperoxic gas (70% O2). They demonstrated a hyperoxia-induced increase in ROS 
production in pulmonary capillary endothelial cells that was rotenone inhibitable. Moreover, they 
demonstrated that this early hyperoxia-induced increase in endothelial complex I ROS production 
leads to an increase in intracellular calcium which stimulates calcium dependent activation and 
translocation of Rac1 in endothelial cells from the cytoplasm to the plasma membrane. This in 
turn leads to activation of endothelial NAD(P)H oxidase, which becomes the main source of 
hyperoxia-induced endothelial ROS production after 30 min of lung ventilation with 70% O2. 
These early hyperoxia-induced increases in endothelial ROS production and intracellular 
endothelial calcium may initiate various cellular responses including an increase in the expression 
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of vascular adhesion molecules (e.g., P-selectin). The increase in the expression of vascular 
adhesion molecules can result in the recruitment of inflammatory cells into the lung tissue as seen 
in lungs of rat exposure to hyperoxia (85% O2) for > 72 hours. These results suggest that the early 
hyperoxia-induced increase in endothelial ROS production via complex I may be important to the 
initiation of the gross lung structural and functional changes associated with rat exposure to 
hyperoxia (85% O2) for > 72 hours. 
 
Figure 2. 1 Possible strategies that cells may follow to protect against hyperoxic lung injury.  
2.3 Mitochondrial Membrane Potential and Hyperoxia 
 Mitochondria play an important role in cell physiology and pathology such as ATP 
synthesis, regulation of intracellular calcium, production of ROS, apoptosis, and other cellular 
functions (Nicolls & Budd, 2000; Duchen, Surin & Jacobson, 2003). Mitochondrial functions 
involve the maintenance of the proton electrochemical potential (∆p) which is made up of a 
mitochondrial membrane potential (∆Ψm) dominantly across inner mitochondrial membrane and a 
small pH gradient (Nicolls & Budd, 2000), pHp m ∆−∆Ψ=∆ 60 . A typical ∆p is comprised of 
a 150 mV ∆Ψm and a ∆pH of −0.5 (Nicolls & Budd, 2000).  Thus, ∆Ψm  is the dominant 
component of ∆p. 
∆Ψm is an important indicator of mitochondrial function and a measure of the energetic 
state of the cell, and oxidative stress has been show to alter ∆Ψm in cultured cells (Huang, Yappert 
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& Jumblatt, 2008). The collapse of ∆Ψm is an early signal of cell apoptosis or necrosis and a 
change in ∆Ψm represents cellular abnormity. Since the pulmonary capillary endothelium is a 
primary and early target of lung O2 toxicity and the loss of endothelial cells due to necrosis is one 
of the important changes after prolonged hyperoxic exposure, it would be useful to determine the 
effect of hyperoxia on endothelial ∆Ψm. As mentioned above, the mitochondrial electron transport 
chain is the main source of ROS under hyperoxic conditions. Previous studies have demonstrated 
that the rate of mitochondrial ROS production is inversely proportional to ∆Ψm (Huang et al., 
2008). For instance, human lens epithelial cells grown under hyperoxic conditions (80% O2) for 
24 to 36 hours showed a reduction in ∆Ψm as compared to cells grown under a normoxic 
environment for the same time period (Huang, Yappert & Jumblatt, 2008). This decrease in ∆Ψm 
was concomitant with an increase in mitochondrial ROS production. This hyperoxia-induced 
decrease in ∆Ψm is consistent with the decrease in ∆Ψm observed in cultured human lens epithelial 
cells treated with H2O2 (Huang et al., 2008). The effect of hyperoxia on the  ∆Ψm in pulmonary 
endothelial cells has not been evaluated. 
2.4 Objectives and Specific Aims 
 J. Lorrain Smith described pulmonary O2 toxicity for the first time in 1889. Since then, a 
large number of studies on mechanisms of lung O2 toxicity and tolerance have been carried out 
(Clark & Lambertsen, 1967; Welch et al., 1963; Crapo et al., 1980; Hayatdavoudi et al., 1981; Ho 
et al., 1996; Gomi & Matsuo, 2002). These studies have predominantly focused on evaluating the 
effect of hyperoxia on the activities of anti-oxidant enzymes in lung tissue homogenates. 
Hyperoxia-induced changes in the activities of redox enzymes, predominantly in lung tissue 
homogenates, have been demonstrated (Crapo et al., 1980; Hayatdavoudi et al., 1981; Wang et al., 
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2004). However, the factors that contribute to rat tolerance of 100% O2 following exposure to 85% 
O2 for 5-7 days are still not fully understood. 
 Previous studies, predominantly in lung tissue homogenates, have suggested that redox 
enzymes, among other factors, play a role in rat tolerance and susceptibility to 100% O2 (Crapo et 
al., 1980; Audi et al., 2005; Campian et al., 2007). However, the results of these in vitro studies do 
not necessarily predict hyperoxic-induced changes in the activities of redox enzymes in an intact 
lung. This is because potential changes in key aspects of the enzyme environment in an intact lung 
(e.g., availability of electron donors, competing redox enzymes, tissue permeation of electron 
acceptors, tissue perfusion) that may influence redox enzyme kinetics are not preserved. Studies 
evaluating the activities of redox enzymes in intact lungs have lagged behind studies in lung tissue 
homogenates, in part because of the complexity of the intact lung. Recent studies have 
demonstrated the utility of the multiple indicator dilution method (MID) and redox active probes 
for evaluating the activities of cell surface, cytoplasmic, and mitochondrial redox enzymes in the 
intact lungs (Audi et al., 2005, 2008). 
MID usually involves the bolus injection or finite pulse infusion of indicators or probes 
into the organ’s arterial inlet, followed by measurements of their concentrations in the venous 
effluent as a function of time. The indicators usually include a vascular indicator and a test 
indicator, which is a substrate for the targeted metabolic function(s) of interest (e.g. redox 
enzyme). The interactions of the test indicator with these metabolic function(s) on passage through 
the organ result in characteristic differences between test indicator concentration in venous 
effluent-time curve and vascular indicator concentration in venous effluent-time curve. The 
information content of data resulting from MID can be complex because, in addition to the 
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targeted metabolic function(s), several other factors can influence the amount of indicator that is 
removed and/or modified on passage through the lung. These include organ perfusion (e.g., 
perfused capillary surface area, capillary transit time distribution), and reactions taking place in 
the blood (e.g., plasma protein binding). With appropriate experimental design and indicators, the 
indicator dilution data contain information about all these processes. Interpretation of this data 
necessitates the use of mathematical models based on hypotheses regarding the processes 
responsible for all mechanisms of indicator disposition on passage through the organ. The 
resulting kinetic model parameters include measures of the activities of the metabolic function(s) 
of interest. 
MID can provide information about the activities of redox enzymes in cells accessible to 
redox active probes from the vascular space, presumably dominated by capillary endothelial cells 
since these cells are in direct contact with the blood and account for a large fraction (up to 50% in 
normoxic lungs) of total lung cells. This is important since the pulmonary endothelial cell is the 
primary target of O2 toxicity and a potential site where biochemical adaptation to O2 toxicity 
occurs (Crapo et al., 1980). 
 The work described in this dissertation utilizes MID as well as mathematical modeling to 
quantitatively evaluate the effect of rat exposure to 85% O2 on the activities of cytosolic (NQO1) 
and mitochondrial (complexes I and III) redox enzymes, as well as the rate of lung H2O2 release 
during the initiation phase (12-24 hours) and adaptation phase (5-7 days) of rat exposure to 85% 
O2. 
 Due to the importance of ∆Ψm to cellular bioenergetics, several approaches have been 
developed to probe ∆Ψm in intact cells (Ward, Rego & Frenguelli, 2000; Duchen et al., 2003; 
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Huang et al., 2007). Generally speaking, these approaches make use of fluorescent cationic dyes 
such as Rhodamine 123 (R123), tetramethylrhodamine methyl ester (TMRM) which have been 
shown to accumulate in mitochondria driven in part by ∆Ψm (Ward et al., 2000; Huang et al., 
2007).  These approaches, which are based on the Nernst equation, do not account for other factors 
that determine the cellular disposition of these dyes, including multi-drug efflux pump P-
glycoprotein (Pgp) for which these dyes are known substrates, and plasma membrane potential 
(∆Ψp). In addition, these approachs measure intracellular dye fluorescence, and hence are 
confounded by the fact that these dyes tend to undergo self-quenching at the high concentrations 
attained in mitochondria due to aggregation. Therefore, one of the objectives of this work is to 
develop a quantitative approach for evaluating ∆Ψm in intact cells that overcomes the limitations 
of existing methods. 
2.4.1 Targets 
a.  NAD(P)H : Quinone Oxidoreductase 1 (NQO1) 
 Using MID and mathematical modeling, Audi et al. (2003) demonstrated that the redox 
active quinone compound duroquinone (DQ) is reduced to durohydroquinone (DQH2) on passage 
through the pulmonary circulation of the isolated perfused rat lung, wherein DQH2 appears in the 
venous effluent. Inhibitor studies reveal that NQO1 is the dominant reductase involved in the 
reduction of DQ, and the capacity of the lung to reduce DQ to DQH2 was shown to be a measure 
of lung NQO1 activity (Audi et al., 2005; Audi et al., 2008; Lindemer, Bongard & Hoffmann, 
2011). Rat exposure to 85% O2 for 21 days, as a model of pulmonary oxidative stress, increases 
the capacity to reduce DQ to DQH2 in the pulmonary circulation, as well as lung tissue NQO1 
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activity and protein level (Audi et al., 2005). On the other hand, rat exposure to 85% O2 for 48 
hours, which is not long enough to make rats tolerance to the lethal effects of 100% O2, has no 
effect on the capacity of the lung to reduce DQ, or on tissue homogenate NQO1 activity and 
protein level (Audi et al., 2008).  
 Therefore, one of the questions addressed in this study is whether the measured increase 
in NQO1 activity after rat exposure to 85% O2 for 21 days is detectable after rat exposure to 85% 
O2 for 7 days as measured by the capacity of a lung to reduce DQ. An affirmative result would be 
consistent with a role of NQO1 in protection against O2 toxicity. 
b. Mitochondrial Complexes I and III 
Mitochondria is the most important site of ATP synthesis via the electron transport chain. 
Electrons are delivered through the mitochondrial electron transport chain during energy 
transduction, while a small fraction (2-5%) of electrons leak to O2 prematurely, forming the O2 
free radical superoxide and further dismutating into H2O2 or other radicals (Muller 2000; 
Andreyev, Kushnareva & Starkov, 2005). The electron transport chain components complexes I 
and III are reported as the important sites where ROS are formed (Chen, Vazquez & Moghaddas, 
2003; Muller, Liu & Remmen, 2004; Campian et al., 2004). The proposed site of ROS formation 
at complex I is its NADH dehydrogenase located on the matrix side of inner membrane (Chen et 
al., 2003; Muller et al., 2004).  There are two possible sites of ROS formation at complex III : the 
quinol-oxidizing (Qo) center which orients the intermembrane space and the quinone-reducing (Qi) 
center which is located in the inner membrane facing mitochondrial matrix. Compared with 
complex I, the inhibition of complex III results in more ROS generation (Chen et al., 2003; Muller 
et al., 2004). Limiting electron flow into complex III can mitigate mitochondrial ROS production. 
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On the other hand, the inhibition of complex IV, which is the downstream component of complex 
III, enhances electron leak and ROS generation at complexes I and III (Chen et al., 2003). 
Few studies have evaluated the effect of hyperoxia on the activities of mitochondrial 
complexes I, III and IV. Brueckl et al. (2006) exposed rats to 70% O2 and measured the formation 
of H2O2 in pulmonary endothelium in situ using the membrane-permeable probe 2,7-
dichlorofluorescein (DCF). Paradies et al. (2004) showed that increased formation of ROS under 
hyperoxic conditions decreased complex I activity in bovine heart submitochondrial particles due 
to the oxidation of the inner mitochondrial membrane phospholipid cardiolipin. Cardiolipin is 
required for electron transfer in complex I and to prevent the proton leakage at complex I. Thus 
the oxidation of cardiolipin might result in an increase in ROS production at complex I due to an 
increase in electron leakage. The study by Campian et al. (2004, 2007) showed a ~2-fold increase 
in the activity of complex IV in wild-type Hela cells after exposure to 80% O2 for 3 days.  
Recently, Audi et al. (2008) demonstrated the capacity of the rat lung to reduce the redox 
active quinone compound coenzyme Q1 (CoQ1) to its hydroquinone (CoQ1H2) form, and to oxidize 
CoQ1H2 to CoQ1 on passage through the pulmonary circulation. Inhibitor studies revealed that 
mitochondrial complex I and NQO1 are the dominant sites of CoQ1 reduction on passage through 
the lung, and that mitochondrial complex III is the dominant site of CoQ1H2 oxidation. Hyperoxic 
studies show that rat exposure to 85% O2 for 48 hours decreases the overall lung capacity to reduce 
CoQ1 to CoQ1H2 predominately due to a ~ 50% decrease in the capacity of complex I mediated 
CoQ1 reduction with no effect on lung complex III activity as measured by the capacity of the lung 
to oxidize CoQ1H2 to CoQ1 (Audi et al., 2008). Therefore, an important objective of this study is to 
determine whether a change in the activity of complex III could occur after rat exposure to 85% O2 
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for 7 days as measured by the capacity of a lung to oxidize DQH2 or CoQ1H2. Another important 
objective is to determine how early the decrease in the activity of complex I, as measured by the 
capacity of a lung to reduce CoQ1, after rat exposure to 85% O2 occurs, and whether the decrease in 
lung  complex I activity detected after 48 hours of rat exposure to 85% O2 is maintained following 
rat exposure to 85% O2 for 7 days. 
 
Figure 2. 2 Metabolism of quinone compounds and the inhibitors. 
c. Mitochondrial Membrane Potential 
 Rhodamine dyes such as rhodamine 123 (R123), tetramethyrhodamine ethyl ester (TMRE) 
are one of the earliest and most widely used probes for monitoring ∆Ψm in isolated mitochondria 
and intact cells because of their availability and relatively high fluorescence quantum yield 
(Nicolls & Budd, 2000). The most common approach for evaluating ∆Ψm in intact cells using 
rhodamine has involved fluorescence detection using fluorescence microscopy or laser confocal 
microscopy (Nicolls & Budd, 2000; Duchen et al., 2003). This general approach has been 
confounded by the tendency of rhodamine to undergo quenching due to aggregation at 
concentrations > 5 µM, which may be attained in mitochondria, and by the potential for photo 
bleaching and/or photo-induced cell injury (Nicolls & Budd, 2000; Solaini, Sgarbi & Lenaz, 2007;  
Zhang, Huang & Carson, 2001). Moreover, this general approach provides indices of ∆Ψm, such as 
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probe total cellular fluorescence or mitochondrial fluorescence, rather than an estimate of ∆Ψm in 
mV. Because of the logarithmic form of the Nernst equation, a change in ∆Ψm results in a much 
larger change in the measured probe cellular or mitochondrial fluorescence (Nicolls & Budd, 
2000). Furthermore, this approach is sensitive to the binding of rhodamine to mitochondria, which 
can lead to overestimation of ∆Ψm (Solaini et al., 2007). In addition, most of the previous 
approaches for evaluating ∆Ψm in cells do not account for the fact that rhodamine dyes are 
substrates of the multi-drug efflux transporter P-glycoprotein (Nicolls & Budd, 2000; Huang et al., 
2007). Thus, one of the objectives of this work is to develop a quantitative approach for evaluating 
∆Ψm in cultured BPAEC. This approach could be utilized in future studies for evaluating the effect 
of hyperoxia on ∆Ψm in intact lungs. 
d. Hydrogen Peroxide (H2O2) 
 Since an increase in the formation of ROS plays a key role on lung O2 toxicity, the 
measurement of ROS generation could be important. In a previous study, a decrease in the activity 
of complex I is demonstrated in lungs of rats exposed to 85% O2 for 48 hours (Audi et al., 2008). 
This might be important since Brueckl et al. (2006) suggested that an increase in ROS production 
by complex I may be important to the initiation of the gross lung structural and functional changes 
associated with rat exposure to hyperoxia (85% O2) for > 72 hours.  Thus studies are needed to 
evaluate the effect of the depression in complex I activity observed in hyperoxic lungs on ROS 
production. 
 The primary ROS formed in mitochondria is superoxide (O2
-
) which can not cross the 
mitochondrial membrane due to its charge. The formation of O2
-
 is measured in purified 
submitochondrial particles or mitochondria (Chen et al., 2003; Campian et al., 2004). Intracellular 
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O2
-
 can convert to H2O2 quickly due to the existence of intracellular SOD such as mitochondrial 
MnSOD, cytosolic CuZn-SOD (Suzy & Serpil, 2001; Brand 2010). H2O2 can permeate cellular 
membranes rapidly (Bienert, Schjoerring and Jahn, 2006; Wilhelm, Vankova & Maxova, 2003) 
and has a much longer half-life (Bienert et al., 2006). Thus, for intact cells, H2O2 usually is 
measured as an index of O2
-
 formation (Campian et al., 2004; Brueckl et al., 2006). 
 Though H2O2 can be produced by pyruvate dehydrogenase (PDH), 2-oxoglutarate 
dehydrogenase (OGDH) directly (Brand 2010), in most cases, the initial ROS product is O2
-
 which 
can be scavenged and converted into H2O2 (Suzy & Serpil, 2001; Brand 2010). Thus, the 
production of H2O2 is usually associated with the production of O2
-
. The mitochondrial electron 
transfer chain is the major source of O2
-
 where mitochondrial complex I and complex III are two 
primary sites of O2
-
 formation (Muller 2000; Chen et al., 2003). Other sites of O2
-
 production 
include complex II, complex IV, PDH, OGDH, glycerol 2-phosphate dehydrogenase (GPDH), 
NADPH oxidase, and monoamine oxidases (Muller 2000; Chen et al., 2003;  Andreyev et al., 
2005; Brueckl et al., 2006; Brand 2010). The production of  H2O2/O2
-
 can be stimulated by 
hyperoxia, hypoxia, and inhibitors such as antimycin A, endotoxin (Brueckl et al., 2006; 
Minamiya 1995; Song, Al-Medhi & Fisher, 2001; Wilhelm et al., 2003). The produced H2O2 can 
be scavenged by antioxidant enzymes such as glutathione peroxidase and catalase (Barja  2002; 
Brand 2010). 
 Fluorescent probes such as amplex red (AR), ortho-phenylenediamine dihydrochloride (o-
PD),  2,7-dichlorofluorescein (DCF), and homovanillic acid are widely used to estimate the 
formation of H2O2 (Kinnula, Everitt & Whorton, 1991; Zhou, Diwu & Panchuk, 1997; Wilhelm et 
al., 2003; Chen et al., 2003; Campian et al., 2007). Several studies have measured the production 
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or release rate of H2O2 in submitochondrial particles, mitochondria or cells using homovallic acid, 
AR, DCF or o-PD (Kinnula et al., 1991; Zhou et al., 1997; Chen et al., 2003; Campian et al., 2004; 
Heumüller, Wind & Barbosa, 2007). Few studies have been carried out to estimate the rate of 
H2O2 release or production in isolated perfused lungs (Al-mehdi, Shuman & Fisher, 1997a; Song, 
Al-mehdi & Fisher, 2001, Brueckl et al., 2006). Al-mehdi et al. (1997a) developed a method to 
estimate intracellular release of H2O2 from perfused lung using o-PD, but the effect of hyperoxia 
was not evaluated. Brueckl et al. (2006) used DCF and fluorescent microscopy to measure the 
formation of H2O2 in rat pulmonary endothelial cells in situ. Labinskyy et al. (2006) applied the 
same method to measure the formation of H2O2 but in rat carotid arteries. Song et al. (2001) 
measured H2O2 in the endothelial cells of perfused rat lung under ischemia conditions using AR 
by microscope. Though these methods were able to detect lung H2O2 formation or release, Al-
mehdi’s method (1997) had a relatively low sensitivity and Brueckl’s method (2006) did not 
provide the rate of H2O2 formation. 
 Therefore, one of addressed aims of this study is to develop an apporach to evaluate the 
rate of H2O2 release from perfused rat lungs. Compared with DCF and o-PD, amplex red (AR) is 
reported as a more specific and sensitive probe of H2O2 (Zhou et al., 1997; Chen et al., 2003; 
Brand 2010). Therefore, in this study, AR is selected as the probe of H2O2 to estimate the lung rate 
of H2O2 release utilizing MID. 
2.4.2 Specific Aims 
The long-term objectives of this work are to elucidate the underlying mechanisms of rat 
tolerance to 100% O2, and to further understanding of the mechanisms involved in lung O2 toxicity.  
The specific aims are: 
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Specific Aim # 1:  
Determine the effect of rat exposure to 85% O2 for 7 days (Hyper-85) on the activities of 
cytosolic (NQO1) and mitochondrial (complexes I and III) redox enzymes in intact lungs. 
Hypothesis:Exposure of rats to 85% O2  for 7 days will increase the activity of NQO1, decrease 
the activity of complex I, and increase the activity of complex III in the intact lung, and that 
measurements of the activities of these redox enzyme in hyper-85 lungs can provide critical 
insights into their potential roles in conferring tolerance to 100% O2. 
Specific Aim # 2: 
Determine how early following rat exposure to 85% O2 does mitochondrial complex I activity 
decrease in the intact lung and determine the effect of rat exposure to 85% O2 on lung rate of 
H2O2 release.  
Hypothesis:Lung mitochondrial pro-oxidant enzyme complex I is highly sensitive to rat exposure 
to 85% O2, and that a decrease in lung complex I activity is an early index of the initiation phase 
of lung O2 injury. 
Specific Aim # 3: 
Develop an approach for quantitative assessment of mitochondrial membrane potential (∆Ψm) 
in intact cultured endothelial cells by measuring the disposition of Rhodamine dyes in the 
extracellular medium. 
Hypothesis: ∆Ψm plays a dominant role in the disposition of rhodamine dyes in the intact cultured 
endothelial cells, and that measurements of rhodamine concentrations in the extracellular medium 
provide sufficient information to estimate ∆Ψm in intact cells. 
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CHAPTER 3. EXPERIMENTAL METHODS 
3.1 Probes and Inhibitors  
3.1.1 Redox Active Quinone Compounds: Probe to Estimate the Activity of NQO1, Complex I 
and III  
Quinone compound 2,3,5,6-tetramethyl-1,4-benzoquinone (duroquinone, subsequently 
referred to as DQ) and coenzyme Q1 (CoQ1), the homology of coenzyme Q10, are selected as the 
probes for enzyme NQO1, complex I and III.  
DQ and CoQ1 are redox active compounds that have been used to probe pulmonary 
endothelial surface and the activity of intracellular redox enzymes due to their high water and lipid 
solubility, as well as their flow-limited character, availability and ability to be substrates of one or 
more of the targeted enzymes (Merker, Audi & Lindemer, 2007; Audi et al., 2008). NQO1 plays a 
dominant role in DQ reduction to its two-electron reduction product durohydroquinone (DQH2) on 
a single passage through the rat pulmonary circulation (Audi et al., 2003; Lindemer et al., 2011) 
and complex III is the dominant enzyme mediating the oxidation of DQH2. A NQO1 contribution 
to CoQ1 reduction has been identified and the protective effect of CoQ1 in complex I dysfunction 
has been attributed to non NQO1-mediated CoQ1 reduction followed by CoQ1H2 oxidation at 
complex III (Merker et al., 2007; Audi et al., 2008). Thus, CoQ1 and its reduced form CoQ1H2, 
DQ and its reduced form DQH2 are useful for probing the activities of NQO1, complex I and 
complex III in intact lungs using MID. 
3.1.2 Amplex Red: Probe to Estimate the Amount of H2O2 
10-acetyl-3,7-dihydroxyphenoxazine (Amplex red, subsequently referred to as AR) is a 
colorless membrane-impermeable probe of H2O2. In the presence of peroxidase such as 
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horseradish peroxidase (HRP) or myeloperoxidase (MPO), AR can react with H2O2 quickly, 
resulting in H2O and high-intensity fluorescent resorufin as described below (Zhou et al., 1997). 
OHresorufinOHAR
Peroxidase
222 + →+  
AR is highly selective for H2O2 compared with other probes such as DCF which can react 
with other ROS. The oxidized product of AR, resorufin which can be measured fluorometrically or 
spectrophotometrically, has a high quantum yield (54,000 M
-1
 cm
-1
). Thus, the sensitivity of AR to 
detect H2O2 could be as low as nM using its fluorescence. (Zhou 1997, Song 2001). However, 
measuring resorufin using a fluorometric assay is limited by the fact that resorufin undergoes self-
quenching when its concentration is greater than 5 uM. This self-quenching property of resorufin 
does not affect its absorbance spectrum and hence measuring resorufin spectrophotometrically is 
not limited by its concentration (Zhou et al., 1997). Compared with other dyes such as 
dihydrorhodamine and dihydrofluorescein, AR has a relatively slow auto-oxidation rate and is 
resistant to photobleaching (Zhou et al., 1997). For these reasons, AR has been widely used as an 
extracellular probe of H2O2 in cultured cells and in isolated lungs (Song et al., 2001; Chen et al., 
2003; Zhou et al., 1997; Heumüller et al., 2008). In this study, AR was used to estimate the rate of 
H2O2 released from lung tissue into perfusate by the measurement of the absorbance of produced 
resorufin. 
3.1.3 FAPGG: Probe to Estimate Perfused Surface Area 
N-[3-(2-Furyl) acryloyl]-Phe-Gly-Gly (FAPGG) is used to evaluate the rate constant of 
ACE-mediated FAPGG hydrolysis as an index of perfused capillary surface area. 
FAPGG is a membrane-impermeable substrate of angiotensin converting enzyme (ACE). 
When the perfusate containing FAPGG passes through the lung, ACE located on the cellular 
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surface hydrolyzes FAPGG into FAP and GG. Since the activity of ACE on a unit surface area is 
stable, the measurement of FAPGG in the venous efflux can be used to evaluate the rate constant 
of ACE-mediated FAPGG hydrolysis. 
The linear steady state rate of ACE-mediated FAPGG hydrolysis passage through a 
perfused lung is represented as a permeability-surface area product (PS, ml/min) defined by the 
following equation: 
 )1ln( EFPS −−=  
where 
1
21
2
3
abs
absabs
ratioextractionstatesteadyE
−
=−= ; abs1 is the absorbance value of  
FAPGG sample before the hydrolysis reaction, abs2 is the absorbance value of FAPGG sample 
after the hydrolysis reaction, and F is the perfusate flow (Audi et al., 2005).  In the present study, 
PS is considered to be an index of perfused capillary endothelial surface area in intact rat lungs 
(Audi et al., 2003, 2005, 2008).  
3.1.4 Rhodamine Dyes: Probe to Monitor Mitochondrial Membrane Potential in Cultured Cells 
Rhodamine 123 (R123) is one of several monovalent cationic fluorescent dyes widely 
used as the probe for monitoring ∆Ψm in isolated mitochondria and intact cells. R123 is widely 
used because of its relatively high fluorescence quantum yield. However, R123 tends to undergo 
self-quenching at concentrations > 5 µM which results in a nonlinear relationship between the 
fluorescence and its concentration. Because of the relatively large ∆Ψm, and the tendance of R123 
to aggregate in mitochondria, the concentration of R123 in mitochondria is ususally thousands of 
times that in the extracellular medium. Therefore, even the addition of a low concentration to the 
extracellular medium could result in mitochondrial concentrations > 5 µM. At this high 
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concentration, R123 tends to undergo self-quenching. To avoid the effect of the self-quenching, 
R123 fluorescence in extracellular medium, which is low enough, instead of R123 fluorescence in 
mitochondria was measured and used for the model fitting in this study. Tetramethylrhodamine 
ethyl ester (TMRE) is an analogue of R123, but with a higher membrane permeability and lower 
cell toxicity (Farkas, Wei & Febbroriello, 1989; Ward, Rego & Frenguelli, 2010). In this study, 
TMRE was used to validate ∆Ψm estimated using R123. 
3.1.5 Inhibitors of the Targeted Enzymes – NQO1, Complex I, III and IV 
 Rotenone (Rot) is a lipophilic chemical which can cross cellular membranes easily. It 
inhibits the transfer of electrons from the iron-sulfur center in complex I to ubiquinone and thus 
can be used as an inhibitor of complex I (Li, Ragheb & Lawler, 2003). Antimycin A (AA) binds to 
the Qi site of complex III in the cytochrome b subunit and blocks the flow of electrons from 
semiquinone to ubiquinone in the Q-cycle of complex III in oxidative phosphorylation. So AA 
inhibits the electron transport pathway, thus prevents the consumption of O2 and disrupts the 
proton gradient across the inner membrane (Huang, Cobessia & Tung, 2005; Park, Han & Kim, 
2007). Potassium cyanide (KCN) is a potent inhibitor of the cellular respiration, acting on 
mitochondrial cytochrome c oxidase (complex IV) and blocking the production of ATP (Seddon  
& Mcvitte, 1974). Dicumarol is a coumarin-derived natural compound which is used clinically 
due to its anticoagulant properties. The best defined action of dicumarol is the inhibition of NQO1 
by competing with NAD(P)H at the pyridine nucleotide binding site (González, Ariza & Villalba, 
2007). But it can also exert its effects through mechanisms unrelated to NQO1 such as inhibiting 
glutathione peroxidase II (Mays & Benson, 1992), affecting stability of microtubules (Madari 
2003) or impairing the electron transport chain (González et al., 2007). 
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   These inhibitors were utilized in this study to differentiate the contributions of their 
corresponding targeted enzymes on the metabolism of quinone probes.  
3.1.6 Inhibitors for the Factors Affecting the Cellular Disposition of Rhodamine Dyes 
 Carbonyl cyanide m-chlorophenylhydrazone (CCCP) is a potent mitochondrial uncoupler 
which inhibits oxidative phosphorylation by dissipating the proton gradient across the inner 
mitochondrial membrane and thus dissipating ∆Ψm (Kim 2004; Park, Jo & Pak, 2002). 9,10-
dihydro-5-methoxy-9-oxo-4-acridine-Carboxamide (GF120918) is a specific inhibitory modulator 
of P-glycoprotein (Pgp) which is a multi-drug efflux pump for many chemicals including 
rhodamine dyes (Seral, Michot & Chanteux, 2003; Krishna & Mayer, 2000). A buffer containing a 
high concentration of potassium (138 mM) is used to dissipate ∆Ψp by inhibiting potassium 
channels across the plasma membrane (He & Curry, 1995). 
 These inhibitors were utilized in this study to differentiate the contributions of their 
corresponding targets to the cellular disposition of rhodamine probes. 
3.2 Multiple Indicator Dilution Method (MID) and Lung Infusion 
 MID has been used to assess the kinetics of transport and metabolism of substrates in 
intact organs such as liver, brain, heart and lung. The indicators are introduced into the organ 
inflow as a rapid bolus or a pulse of finite duration, and then their concentrations are measured in 
the organ’s venous effluent as a function of time. The information content of data resulting from 
MID can be complex because, in addition to the metabolic processes of interest occurring within 
the tissue, other factors such as organ kinematics. The binding to protein can also influence the 
amount of indicator that is removed and/or modified on passage. Therefore, an interpretation of 
                                                                                                                                                              29                                                             
  
these data necessitates the use of mathematical models based on the hypotheses regarding the 
processes responsible for all mechanisms of indicator disposition on passage through the organ. 
The resulting kinetic model parameters include measures of the activities of metabolic processes 
of interest. 
 Generally speaking, MID data do not provide information about the specific types of cells 
affecting the reduction of a redox active probe such as DQ on passage through the lung. However, 
resulting DQ MID data would be expected to provide information about the activities of NQO1 in 
cells accessible to DQ from the vascular space, presumably dominated by the pulmonary capillary 
endothelium with its large surface area and direct contact with the blood. In this study, MID is 
used to measure the lung capacity to reduce the redox active probes such as duroquinone (DQ) and 
coenzyme Q1 (CoQ1), and the lung capacity to oxidize their reduced forms (DQH2 and CoQ1H2) 
on passage through the pulmonary circulation. For each probe, the general approach is to measure 
the rate of appearance in the venous effluent of the probe’s reduced form (DQH2 or CoQ1H2) 
during the arterial infusion of the probe’s oxidized form (DQ or CoQ1), and the oxidized form 
during the arterial infusion of the reduced form. This approach is carried out in the absence or 
presence of one or more inhibitors of the targeted redox enzymes. The resulting data provide 
information about the activities of the targeted redox enzymes in the intact rat lungs. Figure 3.1 
shows schematic diagram of lung ventilation-perfusion system for single pass MID studies. 
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Figure 3. 1 Schematic diagram of lung ventilation-perfusion system with MID application. 
3.3 Mathematical Models 
 In this study, either MID infusion experiment or the measurement of the fluorescence of 
extracellular rhodamine includes multiple processes which affect the distribution or metabolism of 
probes. Thus, the acquired data can not be used to estimate the activities of targeted enzymes 
directly. To interpret the data quantitatively and estimate parameters of interest such as the activity 
of targeted enzyme, mathematical models which describe the related biological system are 
required. In the following section, a kinetic model to describe the processes affecting the 
distribution or metabolism of quinone probes during passage through an intact lung is introduced 
as an example.  
3.3.1 Example: Kinetic Model for Redox Metabolism of Quinone during Passage Through 
Lung 
 Quinone(s) are substrates for redox enzymes NQO1, complex I and complex III. Utilizing 
MID, we are able to evaluate the redox metabolism of quinone compounds in an intact lung. For 
quantitative interpretation of the resulting data, a kinetic model that not only accounts for quinone 
tissue and vascular interactions but also the distribution of capillary transit times is needed (Audi 
et al., 2004, 2005, 2008). 
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Figure 3. 2 Time course of DQ/DQH2 concentration in the venous effluent during 100 µM DQ infusion 
experiment passage through an intact rat lung.  
Figure 3.2 shows the time course of DQ/DQH2 concentration in the venous effluent 
during 100 µM DQ arterial infusion passage through an intact rat lung using the MID method 
described in 3.2. The efflux of DQ/DQH2 are the net results of  multiple factors, including i) 
quinone and hydroquinone interactions with competing nonlinear tissue redox processes, ii) 
quinone and hydroquinone interactions with protein (i.e., BSA) in the vascular and tissue spaces, 
and iii) capillary perfusion kinematics (i.e.,  a heterogeneous distribution of capillary transit times, 
hc(t)).  
 A previously developed whole lung kinetic model for the pulmonary disposition of 
quinones and hydroquinones could be utilized to quantitatively interpret this data (Audi et al., 
2004, 2005, 2008). The model consists of a capillary region that accounts for quinone (Q) and 
hydroquinone (QH2) tissue and vascular interactions, and conducting arteries and veins. The 
capillary region has a distribution of capillary transit times, hc(t) (Ramakrishna et al., 2010). The 
capillary region is modeled as parallel non-interacting capillary elements with transit times 
distributed according to hc(t) (Figure 3.3). 
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 A              B 
 A single capillary element consisting of a vascular region and its surrounding lung tissue 
region with volumes Vc (ml) and Ve (ml), respectively (Figure 3.4). Within the vascular region, 
quinone (Q) and hydroquinone (QH2) participate in nonspecific and rapidly equilibrating 
interactions with the perfusate albumin (BSA). The free (i.e., not BSA bound) vascular 
concentrations of Q and QH2 can freely permeate into the tissue region from the vascular region. 
Within the tissue region, Q is reduced via NQO1, complex I, and an other reductase(s), and QH2 is 
oxidized via mitochondrial complex III. These reduction and oxidation processes are assumed to 
follow Michaelis-Menten kinetics, where Vmax and Km represent the maximum reduction or 
oxidation rate and Michaelis-Menten constant, respectively. For a given redox process, Vmax is 
then a measure of the activity of that process in the intact lung. All nonspecific Q and QH2 
interactions in the vascular and tissue spaces are assumed to follow the law of mass action (Audi 
et al., 2005, 2008).  
Figure 3. 3 Parallel pathways corresponding to capillaries with different transit time. Cin(t) is an input 
function of infused probe and tci(s) are the times for the perfusate passage through given length 
capillaries. B: Approximation of the function form of the capillary transit time distribution hc(t) for 
normoxic lungs. 
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Figure 3. 4 Schematic representation of quinone redox metabolism passage through single capillary. 
Vmax1, Vmax2, Vmax3 and Vmax4 are the respective maximum rates for quinone reduction via NQO1, 
hydroquinone oxidation via complex III, quinine reduction via complex I and quinine reduction via 
other reductases. Km1a, Km2a, Km3a and Km4a are the apparent Michaelis-Menten constants for NQO1, 
complex III, complex I and other reductases.  Q, Q-Pe, and Q-Pc represented free, albumin-bound and 
tissue protein-bound quinone respectively. QH2, QH2-Pe, and QH2-Pc represented free, albumin-bound 
and tissue protein-bound hydroquinone respectively. k1, k2, k3 and k4 were bound rate constants for the 
interactions of Q-BSA, Q-tissue protein, QH2-BSA and QH2-tissue protein. k-1, k-2, k-3 and k-4 were 
bound rate constants for the interactions of Q-BSA, Q-tissue protein, QH2-BSA and QH2-tissue protein. 
Based on the single capillary element model depicted in Figure 3.4, the species balance 
equations descriptive of spatial and temporal variations in the concentrations of Q and QH2 in the 
vascular volume (Vc) and tissue volume (Ve) are 
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where W = convective transport velocity = L/ t c; x = 0 and x = L are the capillary inlet and outlet, 
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respectively; t c is the capillary mean transit time; Q(x,t), and QH2(x,t) are vascular concentrations 
of free quinone (Q) and hydroquinone (QH2) forms, respectively, at distance x from the capillary 
inlet at time t;  Q = α1 Q and 2QH = α3 QH2 are the total (free + BSA bound) vascular 
concentrations of Q and QH2, respectively; α1 = 1 + (Q bound fraction/ Q free fraction) and α3 = 1 
+ (QH2 bound fraction/ QH2 free fraction) are constants which account for the rapidly 
equilibrating interactions of Q and QH2 with the 5% BSA perfusate calculated from the fractions 
of Q and QH2 bound to BSA obtained by ultrafiltration (Audi et al., 2003). Vmax1, Vmax2, Vmax3 and 
Vmax4 are the respective maximum rates of quinone reduction via NQO1, hydroquinone oxidation 
via complex III, quinone reduction via complex I and quinone reduction via other reductase(s). 
Km1a, Km2a, Km3a and Km4a are the respective apparent Michaelis-Menten constants for quinone 
reduction via NQO1, hydroquinone oxidation via complex III, quinone reduction via complex I 
and quinone reduction via other reductase(s).  VF1 = (α2 /α1) Ve and VF2  = (α4 /α3) Ve are the 
respective virtual volumes of the distributions for Q and QH2, where α2 and α4 are the constants 
which account for the rapidly equilibrating interactions of Q and QH2 with lung tissue sites (Pe) of 
association, respectively. For DQ and DQH2, α1 =25 and α3=4. For CoQ1 and CoQ1H2,  α1 =14.6, 
and α3=16.5 (Audi et al., 2005, 2008).  These values were determined by centrifugal ultrafiltration. 
Equations E3.1 - 3.2 are for a single capillary element. For the lung model, the effect of the 
distribution of capillary transit time (hc(t)) on the plasma concentrations and the redox status of Q 
and QH2 on passage through the pulmonary circulation was taken into consideration (Audi et al., 
2003, 2008). Most of the dispersion within the lung vascular region is due to the capillary bed 
(Ramakrishna et al., 2010). Thus, Q and QH2 transit through the arteries and veins are represented 
by a shifted impulse function, where the shift was the plasma mean transit time through the arteries 
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and veins determined as previously described (Ramakrishna et al., 2010). To provide the whole 
organ output Q and QH2, the outputs for all transit times were summed, weighted by hc(t) as 
previous described (Audi et al., 2003, 2005, 2008; Dawson et al., 2003). The activities of targeted 
enzymes could be quantitatively estimated by fitting the above model to the experiment data such as 
data in Figure 3.2.  
3.3.2 MATLAB 
  To implement the kinetic model in 3.3.1, a mathematical programming software is 
required to numerically integrate the model’s system of coupled non-linear partial differential 
equations. MATLAB (“MATrix LABoratory”) is a tool for numerical computation, especially 
array-based data. The programming efficiency of MATLAB is quite high compared to other 
language such as FORTRAN or C. MATLAB has its own function library which contains 
hundreds of functions and thus makes it easier for the users to solve numerical problems. However, 
as an interpreted language, the computation efficiency of MATLAB is relatively low compared to 
FORTRAN or C. To overcome this shortcoming when a large number of  computations is needed, 
MATLAB supplies a gateway function to support C or Fortran functions, so that the user can use 
Fortran or C functions in MATLAB easily. In this study, the mathematical models were solved in 
MATLAB due to its portability, usability, extendibility and abundant functions. When a large 
number of computations were required, C functions were embedded through an MATLB-C 
gateway function in order to improve computation efficiency.  
3.4 Statistics 
  The number of animals used in each condition was determined using power analysis (a 
                                                                                                                                                              36                                                             
  
power >85), which determines the minimum number of lungs needed to obtain valid and 
meaningful results. t-test was used to compare two groups of data statistically. For multiple groups 
of data, one-way ANOVA was used for statistical comparison. For the comparison of single 
parameter in 2 groups such as Vmax of complex I for normoxic lungs and hyper-85 lungs, ∆Ψm 
estimated by R123 data and TMRE data, a modified one side t-test is utilized. Briefly, the 
normalized variances of distribution for 2 groups are calculated and scaled with weights from their 
corresponding inverse information matrices. The difference of parameters from 2 groups is then 
divided by the square root of the sum of variances of disturbance and the resulting t value is 
showed below, 
2
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t
×
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−
=  
where P1, P2 are the values of same parameters from different groups. VD1 and VD2 are the 
variances of distribution which are the sum of squared variances. DF1 and DF2 are their degrees of 
freedom. E1 and E2 are the scalar weights from corresponding inverse information matrices. 
P<0.05 is considered the criterion for statistical significance. 
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CHAPTER 4. LUNG ACTIVITIES OF NQO1, MITOCHONDRIAL 
COMPLEXES I AND III AFTER EXPOSURE OF RATS TO 85% O2 FOR 7 
DAYS 
4.1 Introduction 
 It is known that rats exposed to 85% O2 for 7 days, but not rats exposed to 85% O2 for 2 
days develop a tolerance of 100% O2 (Crapo et al., 1978, 1980). Previously, Audi et al. 
demonstrated that rat exposure to 85% O2 for 48 hours, decreased lung complex I activity by 
~50% with no effect on lung activities of complex III or NQO1 (Audi et al., 2008). These results 
stimulated the following question. Are the activities of these enzymes changed in rats exposed to 
85% O2 for 7 days? Thus, This work was to evaluate the effect of rat exposure to 85% O2 for 7 
days (hyper-85) on lung tissue activities of cytosolic NQO1 and mitochondrial complexes I and III 
in the isolated perfused lung. The activities of  NQO1, complex I, and/or complex III in the intact 
lung can be measured using indicator dilution methods with the redox-active quinone compounds 
duroquinone (DQ), coenzyme Q1 (CoQ1) and their hydroquinones as test indicators. The general 
approach involved pulse infusion of each quinone (DQ or CoQ1) or its hydroquinone (DQH2 or 
CoQ1H2) into the arterial inflow of isolated perfused lungs from rats exposed to room air 
(normoxic) or 85% O2 for 7 days, and then the venous efflux rate of hydroquinone during quinone 
infusion and vice versa was measured. This protocol was carried out over a range of 
quinone/hydroquinone concentrations, and in the absence or presence of one or more inhibitors of 
NQO1, complex I, and complex III. A previously developed kinetic model for the pulmonary 
disposition of these quinones and their hydroquinones (Audi et al., 2008) was used for estimating 
parameters descriptive of the activities of the targeted redox enzymes in normoxic and hyper-85 
lungs. 
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4.2 Materials and Methods 
Materials 
Duroquinone (DQ) and Coenzyme Q1 (CoQ1) were purchased from Sigma Chemical 
Company (St. Louis, MO). Durohydroquinone (DQH2) and CoQ1 hydroquinone (CoQ1H2) were 
prepared by reduction of DQ or CoQ1 with potassium borohydride (KBH4).  Bovine serum 
albumin (Standard Powder, BSA) was purchased from Serologicals Corp (Gaithersburg, MD). 
Standard NQO1 and NQO1 antibody were purchased from Santa Cruz Biotechnology Co (Santa 
Cruz, CA). Beta actin antibody was purchased from Abcom (Cambridge, MA). Pierce* ECL 
Western Blotting Substrate was purchased from Thermo Scientific (Rockford, IL).  Rabbit-anti-
mouse IgG1 antibody and other reagent grade chemicals not mentioned above were purchased 
from Sigma Chemical Company. 
4.2.1 Hyperoxic Exposure 
For normoxic lung studies, male Sprague-Dawley rats (275 to 325 g; Charles River) were 
exposed to room air. For the hyperoxic lung studies, age matched rats were housed in a Plexiglas 
chamber (13W x 23L x 12H inches) maintained at ~ 85% O2 (hyper-85), balance N2, for 7 days 
with free access to food and water (Audi et al., 2008). The total gas flow was 3.5 liters/min, and 
the chamber CO2 was maintained at < 0.5 %. The temperature within the chamber was maintained 
at 20-22
o
C using a custom built cooling system. The chamber was opened every other day for 15 
min to weigh the animals, place them in a clean cage, and replace food, water, and CO2 absorbent. 
The protocol was approved by the Institutional Animal Care and Use Committees of the Zablocki 
Veterans Affairs Medical Center and Marquette University (Milwaukee, WI).  
                                                                                                                                                              39                                                             
  
4.2.2. Isolated Perfused Lung Preparation 
 
Rats were anesthetized with pentobarbital sodium (40 mg/kg body wt. i.p.), the trachea 
was then clamped, the chest was opened and heparin (0.7 IU/g body wt.) was injected into the 
right ventricle (Audi et al., 2008). A 1 ml blood sample was collected for measurement of aortic 
blood hematocrit. The pulmonary artery and the trachea were then cannulated, and the pulmonary 
venous outflow was accessed via a cannula in the left atrium. The lung was then removed from the 
chest and attached to a ventilation and perfusion system (Figure 4.1). The control perfusate 
contained 4.7 mM KCl, 2.51 mM CaCl2, 1.19 mM MgSO4, 2.5 mM KH2PO4, 118 mM NaCl, 25 
mM NaHCO3, 5.5 mM glucose, and 5% fatty-acid free bovine serum albumin (BSA) (Audi et al., 
2003). The single pass perfusion system (Figure 4.1) was primed (Masterflex roller pump) with 
the control perfusate maintained at 37
o
C and equilibrated with 15% O2, 6% CO2, balance N2 
Figure 4. 1 Lung perfusion-ventilation system. 
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resulting in perfusate PO2, PCO2 and pH of ~105 Torr, 40 Torr, and 7.4, respectively. Initially, 
control perfusate was pumped through the lung until the lung was evenly balanced and venous 
effluent was free of blood. The lung was ventilated (40 breaths/min) with end-inspiratory and end-
expiratory pressures of ~ 6 and 3 mmHg, respectively, with the above gas mixture. The pulmonary 
arterial pressure was referenced to atmospheric pressure at the level of the left atrium and 
monitored continuously during the course of the experiments.  The venous effluent pressure was 
atmospheric pressure. 
For the quinone/hydroquinone pulse infusion experiments described below, the lung was 
removed at the end of the experiment and weighed to obtain lung wet weight. The lung was then 
dried and weighed again to obtain dry weight and wet/dry weight ratio. 
4.2.3 Lung Experimental Protocols   
To determine the DQ reduction capacity of the lung, four 135-second long sequential 
arterial pulse infusions at DQ concentrations of 50, 100, 200, and 400 µM were carried out with a 
perfusate flow of 10 ml/min. For each pulse infusion, a venous effluent sample (1 ml) was 
collected between 130 ~ 135 seconds after the initiation of the pulse infusion. An infusion for 130 
seconds is long enough for the venous effluent concentrations of DQ and DQH2 to reach the 
steady state (Audi et al., 2005; Audi et al., 2003).  Between pulse infusions, the lung was perfused 
with 30 ml of fresh perfusate to wash the lung and perfusion system of any remaining traces of 
DQ and/or DQH2 (Audi et al., 2005). For some of the lungs, the 400 µM DQ pulse infusion was 
repeated after lung treatment with the NQO1 inhibitor dicumarol (400 µM).  
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To determine the capacity of NQO1-mediated DQ reduction on passage through the 
pulmonary circulation, each lung was perfused for 5 min with perfusate containing antimycin A 
(AA, 10 µM, complex III inhibitor) or potassium cyanide (KCN, 2 mM, complex IV inhibitor) to 
inhibit complex III mediated DQH2 oxidation (Boveris, Oshino & Erecinska, 1971). This was 
followed by four successive DQ pulse infusions, as above DQ infusion, with the inhibitor present 
throughout the infusion protocol. 
 To evaluate the capacity of complex III mediated DQH2 oxidation on passage through the 
pulmonary circulation, each lung was perfused for 5 min with perfusate containing dicumarol or 
dicumarol plus rotenone (complex I inhibitor, 20 µM) (Audi et al., 2003; Audi et al., 2005; Audi 
et al., 2008). This was followed by four 135-second sequential arterial pulse infusions at DQH2 
concentrations of 50, 100, 200, and 400 µM at a flow of 10 ml/min, with the inhibitors present 
throughout the infusion protocol. A 1 ml venous effluent sample was collected between 130 and 
135 seconds after initiation of each pulse infusion. For some of the lungs, the 400 µM DQH2 
infusion was repeated after lung perfusion with AA to inhibit complex III mediated DQH2 
oxidation. The flow rate was determined in previous studies by the maximum of the dynamic 
range when the activities of targeted enzymes were decreased by the application of inhibitors. 
 To determine the CoQ1 reducing capacity of the lung, four 45-second long sequential 
arterial pulse infusions at CoQ1 concentrations of 25, 50, 100, 200, and 400 µM were carried out 
with a perfusate flow of 30 ml/min. This flow was chosen to optimize the sensitivity of this assay 
for an increase/decrease in complex I activity. For each pulse infusion, a venous effluent sample 
(1 ml) was collected between 43 and 45 seconds after initiation of the pulse infusion. At this flow, 
infusion for 42 seconds is long enough for the venous effluent concentrations of CoQ1 and 
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CoQ1H2 to reach the steady state (Audi et al., 2008).  Between pulse infusions, the lung was 
perfused with 30 ml of fresh perfusate to wash the lung and perfusion system of any remaining 
traces of CoQ1 and/or CoQ1H2 (Audi et al., 2008). 
 The CoQ1 reducing capacity of the lung is the net result of lung CoQ1 reduction capacity 
and CoQ1H2 oxidation capacity. To determine CoQ1 total lung reduction capacity, the lung was 
perfused for 5 min with perfusate containing AA or KCN to inhibit complex III mediated CoQ1H2 
oxidation (Boveris et al., 1971). This was followed by five 45-second sequential arterial pulse 
infusions at CoQ1 concentrations of 25, 50, 100, 200, and 400 µM at a flow of 30 ml/min, with the 
inhibitor(s) present throughout the infusion protocol.  The same protocol but using rotenone as the 
inhibitor of complex I was applied to determine complex I mediated reduction capacity. The CoQ1 
pulse infusions in the presence of dicumarol, which is the inhibitor of NQO1, was applied to 
determine the lung NQO1 mediated reduction capacity, and the CoQ1 pulse infusions in the 
presence of dicumarol and rotenone was applied to determine the reduction capacity of other 
reductase(s).  
 To evaluate the capacity of complex III mediated CoQ1H2 oxidation on passage through 
the pulmonary circulation, each lung was perfused for 5 min with perfusate containing dicumarol 
plus rotenone to minimize CoQ1 reduction (Audi et al., 2003, 2005, 2008). This was followed by 
five 45-second sequential arterial pulse infusions at CoQ1H2 concentrations of 25, 50, 100, 200, 
and 400 µM at a flow of 30 ml/min, with the inhibitors present throughout the infusion protocol. A 
1 ml venous effluent sample was collected between 42 and 45 seconds after initiation of each 
pulse infusion. For some of the lungs, the 400 µM CoQ1H2 infusion was repeated after lung 
perfusion with AA to inhibit complex III mediated CoQ1H2 oxidation. 
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 To determine perfused lung surface area, a 150 µM 20-second pulse infusion of the 
angiotensin converting enzyme (ACE) substrate N-[3-(2-Furyl) acryloyl]-Phe-Gly-Gly (FAPGG) 
was carried out at a perfusate flow of 30 ml/min (Audi et al., 2005). Two 1 ml venous effluent 
samples were collected between 16 and 20 seconds after the start of the FAPGG infusion (Audi et 
al., 2005, 2008).  
4.2.4 Determination of Quinone (DQ, CoQ1) and Hydroquinone (DQH2, CoQ1H2) 
Concentrations in Venous Effluent Samples 
 For a given quinone compound, the concentrations of its oxidized and reduced forms in 
each venous effluent sample were determined as previously described using the extinction 
coefficients of 0.0143 µM
-1
 cm
-1
 for CoQ1, 0.00229 µM
-1
 cm
-1
 for CoQ1H2, 0.02164 µM
-1
 cm
-1
 for 
DQ and 0.0017 µM
-1
 cm
-1
 for DQH2 (Audi 2005, Audi 2008). Briefly, venous effluent samples 
were centrifuged (13,500 g) for 1 min. For each sample, 100 µl of the resulting supernatant was 
added into a micro tube containing 0.8 ml ice-cold ethanol and 10 µl potassium ferricyanide  (12.1 
mM in water) which oxidized hydroduroquinone to quinone or 10 µ1 EDTA (1 mM in water) to 
minimize auto-oxidation of hydroquinone.  The tubes were mixed on a vortex mixer followed by 
centrifugation at 13,500 g for 7 min. A perfusate sample that had passed through the lungs but 
contained no probe was treated in the same way to be used as the blank for absorbance 
measurements. The absorbance values were measured at 275 nm for CoQ1 or CoQ1H2 and 265 nm 
for DQ or DQH2 using a Beckman DU 7400 spectrophotometer. Sample concentrations of probes 
(in µM) were calculated from the absorbance values of the fully oxidized (abs1) and EDTA-treated 
supernatant (abs2).  
For DQ or DQH2 infusion,  
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At steady state, 92 ± 3 (SD) % and 95 ± 4 (SD) % of the infused DQ and DQH2, 
respectively, were recovered in the total venous effluent as DQ + DQH2, with the loss attributable 
primarily to binding of both forms to the tubing (data not shown). 93 ± 6 (SD) % and 92 ± 6 (SD) 
% of the infused CoQ1 and CoQ1H2 were recovered in the total venous effluent as CoQ1 + CoQ1H2, 
respectively. 
The steady state efflux rates of hydroquinone (or quinone) from the lung during quinone 
(or hydroquinone) arterial infusion was calculated as the product of the perfusate flow and the 
steady state venous effluent hydroquinone (or quinone) concentrations.  
4.2.5 Determination of Perfused Capillary Surface Area 
A permeability-surface area product (PS, ml/min) is considered to be an index of perfused 
capillary endothelial surface area in intact rat lungs (Audi et al., 2003, 2005, 2008). PS represented 
by the linear steady state rate of ACE-mediated FAPGG hydrolysis passage through a perfused 
lung during FAPGG perfusion is defined by the equation described in chapter 3.1.3.  
4.2.6 Determination of Activities of Targeted Redox Enzymes in Lung Homogenate 
i. Lung homogenate NQO1 activity and Protein Expressions 
 Lungs were isolated and connected to the ventilation-perfusion system as described above, 
after which they were washed free of blood by Hank’s Balanced Salted Solution (HBSS) 
containing 2.5% ficoll, PH 7.4. The blood-free lung was weighted, minced and homogenized 
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using a Ploytron tissue homogenizer on ice in a beaker containing the homogenization buffer 
which contained 10 mM HEPES, 3.8mM EDTA and 1% protease inhibitor cocktail, PH7.4. The 
volume of the homogenaiztion buffer in the beaker was 5-fold (vol/mass) of the lung wet weight. 
NQO1 activity 
A fraction of the above lung homogenate was centrifuged (13,500g) at 4 
o
C for 30 min. 
The supernatant was collected and stored on ice. The protein concentration was determined using 
Bio-Rad protein assay (Bio-Rad laboratories, Hercules, CA) using BSA as the standard. The 
NQO1 activity was then measured using a modified procedure of Lind et al (Lind, Cadenas & 
Hochstein, 1990). Briefly, the collected supernatant was diluted by 1:100 using the buffer 
containing 25 mM Tris·HCl. Then 50 µl diluted supernatant was added into a semimicro 
spectrophotometric cuvette containing 1 ml assay buffer which contained 25 mM Tris·HCl, 0.23 
mg/ml BSA, 0.01% (vol/vol) tween-20, 50 µM 2,6-dichlorophenolindophenol (DCPIP), 5 
µΜ flavin adenine dinucleotide (FAD) with or without 20 µΜ dicumarol, PH 7.4. The reaction 
was initiated by the addition of NADPH (final concentration 200 µΜ). The absorbance of reduced 
DCPIP was measured spectrophotometrically at 600 nm every 15 seconds for 10 min. The 
concentration of reduced DCPIP is calculated from the recorded absorbance values using an 
extinction coefficient of 0.021 µM-1 cm-1. NQO1 activity (nmol DCPIP reduction min-1 mg 
protein
-1
) was determined as the difference between the rate of DCPIP reduction in the presence 
and absence of dicumarol over the linear portion of the reaction progress curve (Audi et al., 2005, 
2008).  
 NQO1 Protein Expression 
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 A fraction of the above lung homogenate was centrifuged (13,500 g) at 4 
o
C for 30 min. A 
portion of the resulting homogenate supernatant was then centrifuged at 10,000 g for 15 min. The 
protein concentration of the resulting supernatant was determined using the BCA protein assay. 
Supernatant containing 25 µg protein was then subjected to sodium dodecyl sulphate-
polyacrylaminde gel electrophoresis (SDS-PAGE) using MES-SDS running buffer. The proteins 
were then transferred to a polyvinylidene fluoride (PVDF) membrane and washed several times 
using a Tris buffered saline with tween-20 solution (TBST). The resulting membrane was 
incubated in TBST containing 5% non-fat milk at room temperature for 1 hours and then 
incubated in TBST containing 1:4000 dilution of NQO1 antibody (A180, Santa Cruz 
Biotechnology Co.) and 1:6000 beta actin antibody (AC-15, Abcam) at 4 
o
C overnight. The 
membrane was washed for several times using TBST and then incubated in TBST containing 
1:12000 dilution of rabbit-anti-mouse IgG1 antibody at room temperature for 2 hours. Before 
imaging, the membrane was washed and then incubated in Pierce* ECL Western Blotting 
Substrate (Thermo Scientific, MA) for 5 min. The intensity of protein band was captured and 
analyzed using an Image Station 4000MM (Kodak, NY). 
ii. Mitochondrial activities of complex I and complex IV 
Lungs were isolated and washed free of blood with perfusate containing 2.5% Ficoll. The 
lungs were then weighed, minced, and homogenized as above with buffer (pH 7.2) containing 225 
mM mannitol, 75 mM sucrose, 5 mM 3-[N-morpholino]propanesulfonic acid, 20 mM ethylene 
glycol-bis(B-aminoethyl ether)-N,N,N’,N’-tetraacetic acid,  2% fatty-acid free BSA,  and 0.02 ml 
per ml protease inhibitor cocktail set III (Calbiochem, La Jolla, CA). Lung homogenates were 
centrifuged at 1,500 g for 5 min at 4 °C, and the resulting supernatants were centrifuged again at 
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13,000 g for 30 min at 4°C to obtain a crude mitochondrial fraction (P2). The P2 fractions were 
washed twice by resuspension in 8 ml ice-cold homogenization buffer without BSA and then 
centrifuged (13,000 g for 20 min at 4°C). The final P2 fractions were resuspended in 1-ml BSA-
free homogenization buffer. The protein concentrations were determined using BCA Protein Assay 
Kit (Thermo Scientific, MA) using BSA as the standard. 
Mitochondrial complex I activity 
Complex I activity was measured using a modified procedure of Lenaz et al (2004). 
Briefly, 20 µl thawed P2 fraction was added into a semi spectrophotometric cuvette containing 1 
ml assay buffer which contains 13 mM Tris,  1.3 mM EDTA, 50 mM KCl, 2 mM KCN, 2 µM 
Antimycin A, 100 µM CoQ1 and 100 µM NADH with or without 2 µM rotenone. NADH 
oxidation was monitored as the decrease in absorbance at 340 nm every 20 seconds for 20 min. 
The concentration of NADH was calculated from the recorded absorbance values using an 
extinction coefficient of 6.22 mM
-1
 cm
-1
. Complex I activity (nmol NADH oxidation min
-1
 mg 
protein
-1
) was determined as the difference between the rate of NADH oxidation in the presence 
and absence of rotenone over the linear portion of the reaction progress curve (Audi et al., 2008). 
Mitochondrial complex IV activity 
Complex IV activity was measured using a modified procedure of Storrie et al (Storrie & 
Madden, 1990; Audi et al., 2008). The thawed P2 fraction was diluted by 1:10 using phosphate 
buffer which contains 40 mM KH2PO4, 40 mM K2HPO4, 0.1% Triton X-100,  PH6.2. Then 50 µl 
diluted mitochondrial fraction was added into 1 ml cytochrome c buffer which contains 40 mM 
KH2PO4, 40 mM K2HPO4, 0.1% Triton X-100 and 0.22 mM 70%-reduced cytochrome C. The 
reduction percentage of cytochrome c is adjusted by NaHS solution. The oxidation of reduced 
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cytochrome c was monitored as the decrease in absorbance at 550 nm every 20 seconds for 10 min. 
The concentration of reduced cytochrome c was calculated from the recorded absorbance values 
using an extinction coefficient of 0.0191 µM-1 cm-1. Complex IV activity was expressed using the 
oxidation rate of reduced cytochrome c (nmol min
-1
 mg protein
-1
). 
4.2.7. Lung Histology 
 Lungs were isolated and washed free of blood using KRB pefusate containing 5% BSA. 
The lungs were then perfused with 10% buffered formalin, and the airways were also filled with 
the buffered formalin (~5 ml) via the trachea. The pulmonary artery and trachea were then 
clamped and the lungs were removed and placed in buffered formalin. The lungs were then 
shipped to Research Animal Diagnostic Laboratory (Columbia, MO) for the preparation of lung 
slices. To prepare the lung slices, the fixed lungs were subjected to dehydration and infiltration 
with paraffin wax, and then embedded into wax-filled block molds. The largest lobe of blocked 
lungs was sliced into 5 µm sections at 3 mm intervals using an automated microtome, and then 
were mounted onto glass slides. The sections were then stained with hematoxylin and eosin (H&E) 
and sealed with mounting medium and a coverslip. The prepared lung slices were then observed 
with a microscope at 200× magnification. 
4.3 Results 
4.3.1 Rat Body Weight, Lung Dry Weight, Aortic Blood Hematocrit and Perfused Capillary 
Surface Area 
Rats lost ~14% of their pre-exposure body weight over the 7-day 85% O2 exposure period 
(Figure 4.1) consistent with results from previous studies (Crapo et al., 1980). Most of this weight 
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loss occurred between days 2 and 6. Age-matched normoxic rats gained body weight steadily over 
the 7-day exposure period (Figure 4.2). 
Figure 4.2 Rats body weights (as a 
percent of pre-exposure body weight) over 
7-day exposure period to room air 
(normoxic) or 85% O2 (hyper-85). Values 
are mean ± SE. Normalized weights at a 
given time are significantly different from 
normalized weights at the previous time 
point for * normoxic and & hyper-85, 
respectively (P<0.05).  
Rat exposure to 85% O2 for 7 
days increased lung wet weights by ~80% (Table 4.1). There was no significant difference 
between wet-to-dry weight ratio compared to normoxic lungs. These results are consistent with 
results from previous studies (Audi et al., 2008; Crapo et al., 1980) and suggest that 85% O2 
induced increase in lung wet weight and dry weight are mostly due to increased tissue mass rather 
than edema. 
Rat exposure to 85% O2 increased aortic blood hematocrit by 17% as compared to 
normoxic lungs in agreement with that reported in previous studies (Crapo et al., 1980, 1983). 
Those studies suggested that this increase could be due to dehydration, consistent with the 
measured body weight loss in hyper-85 rats (Table 4.1). Another possible explanation is an 
increase in erythropoiesis. Hyper-85 rats show signs of cyanosis even in a hyperoxic environment 
due to an increase in the thickness of lung air-blood barrier (Crapo et al., 1978, 1980), which 
suggests a tendency for hyperoxemia. Hyperoxemia requires an increase in erythropoiesis to 
recover the capacity for systemic O2 delivery (Semenza, 1994, 2007) which can be induced 
through an increase in expression of the erythropoietin gene (Ratcliffe, Ebert & Firth, 1997; 
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Chandel 2010).  
Exposure to 85% O2 for 7 days decreased lung PS (ml/min), an index of perfused 
capillary endothelial surface area, by 56% as compared to normoxic lungs (Table 4.1). This is 
consistent with the 50% decrease in capillary volume and endothelial surface area measured 
morphometrically (Crapo et al., 1980).  
 B. W. (g) W. W.  (g) W/D Hct (%) PS (ml/min) 
Normoxic 320±3 1.20±0.02 5.53±0.05 43.5±0.3 23.8±0.3 
Hyper-85 269±2* 2.27±0.05* 5.70±0.04 50.4±0.4* 10.3±0.3* 
Table 4. 1 Body weight (B.W.), lung wet weight (W.W.), lung wet weight/lung dry weight ratio (W/D), 
hematocrit (Hct), and PS of normoxic rats and rats exposed to 85% O2 for 7 days  (Mean ± SE), n=94 
and 96 for normoxic and hyper-85 rats respectively.  
4.3.2 Lung Histology 
 Figure 4.3 shows histological sections of a normoxic lung and a hyper-85 lung. The 
sections of hyper-85 lung indicate a significant increase in lung tissue content  (44.9±1.5, n=6) 
compared with the sections of  normoxic lung (25.3±1.6, n=6). An increase in the thickness of 
air-blood barrier and an increase in the matter found in septa in hyper-85 lung are also observed, 
consistent with the results of a study by Crapo et al. (Crapo et al., 1980).  
4.3.3 Quinone/Hydroquinone Pulse Infusion Results   
Figure 4.4 shows that rat exposure to 85% O2 for 7 days has a differential effect on the 
redox metabolism of DQ and CoQ1 on passage through the pulmonary circulation. In hyper-85 
lungs, the hydroquinone efflux rates increased by 32% during DQ infusion and decreased by 25% 
during CoQ1 infusion as compared to that in normoxic lungs. For each quinone, the rate of 
hydroquinone efflux during quinone infusion is the net result of quinone reduction to 
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hydroquinone and hydroquinone oxidation to quinone. Thus, the differential effect of rat exposure 
to 85% O2 on DQ or CoQ1 reduction could be due to hyperoxia-induced change in quinone 
reduction and/or hydroquinone oxidation. To determine the underlying mechanisms of this 
differential response, the effects of lung treatment with one or more inhibitors of the dominant 
quinone reductases or hydroquinone oxidases on the redox metabolism of DQ, CoQ1, and their 
hydroquinones on passage through the pulmonary circulations of normoxic and hyper-85 lungs 
were evaluated. 
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Figure 4.3 Images of histological sections of a normoxic and a hyper-85 rat lung. The magnification is 
x200. 
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Figure 4.4 The differential effect of rat exposure to 85% O2 for 7 days on DQ redox metabolism and 
CoQ1 redox metabolism. A: the relationship between the steady state rate of DQH2 efflux and the 
infused DQ concentrations during DQ arterial infusion, for normoxic lungs (n = 4), hyper-85 lungs (n = 
5). B: The relationship between the steady state rate of CoQ1H2 efflux and the infused CoQ1 
concentrations during CoQ1 arterial infusion, for normoxic lungs (n = 7), hyper-85 lungs (n = 11). 
Values are mean ± SE. * Hyper-85 rates significantly different from the normoxic rates at the same 
infused concentrations 
Lungs treatment with dicumarol decreased the rate of DQH2 efflux during DQ infusion by 
>95% during DQ infusion in both normoxic and hyper-85 lungs. This is consistent with NQO1 
being the dominant reductase of DQ on passage through the pulmonary circulation (Audi et al., 
2005).  
The steady state rate of DQH2 efflux during DQ infusion in the presence of AA was 
measured to evaluate the capacity of NOQ1-mediated DQ reduction (Figure 4.5). For both 
normoxic and hyper-85 lungs, the rates of DQH2 efflux during DQ infusion were higher than those 
in the absence of AA (Figure 4.4 A), consistent with the inhibition of DQH2 oxidation. Lungs 
treatment with AA also increased the difference in the steady state efflux rate of DQH2 between 
normxoic and hyper-85 lungs at the two highest infusion concentrations (Figure 4.5) as compared 
to the difference in the absence of AA (Figure 4.4 A). This suggests a higher rate of DQH2 
oxidation in hyper-85 lungs as compared to normoxic lungs. 
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Figure 4.5 The relationship between the steady state rate of DQH2 efflux and the infused DQ 
concentrations during DQ arterial infusion in the presence of AA (10 µM), for normoxic lungs (n = 5), 
hyper-85 lungs (n = 5). Values are mean ± SE. * Hyper-85 rates significantly different from the 
normoxic rates at the same infused concentrations 
The steady state rate of DQ efflux during DQH2 infusion in the presence of dicumarol 
was measured to evaluate the capacity of lungs to oxidize DQH2 (Figure 4.6 A). In hyper-85 lungs, 
the steady state efflux rate of DQ was ~40% higher than that of normoxic lungs at the two highest 
infused concentrations. In the presence of AA, the efflux rate of DQ during DQH2 infusion was 
nearly zero. This is consistent with complex III being the dominant DQH2 oxidase on passage 
through the pulmonary circulation (Audi et al., 2005). 
The rate of DQ efflux during DQH2 infusion was measured in the presence of dicumarol 
and rotenone to evaluate the effect of rat exposure to 85% O2 on mitochondrial complex III 
mediated DQH2 oxidation. The complex I inhibitor rotenone was added to minimize competition 
between DQH2 and reduced endogenous coenzyme Q9 hydroquinone (CoQ9H2) for oxidation via 
complex III. For both normoxic and hyperoxic lungs, the rates of DQ efflux during DQH2 infusion 
were higher in the presence of dicumarol plus rotenone than in the presence of dicumarol alone 
(Figure 4.6). Futhermore, for hyper-85 lungs, the steady state rates of DQ efflux during DQH2 
                                                                                                                                                              55                                                             
  
infusion at the two highest concentrations in the presence of dicumarol plus rotenone were about 
30% higher than those in normoxic lungs. For both normoxic and hyper-85 lungs, the rate of DQ 
efflux during DQH2 infusion at the highest concentration in the presence of AA along with 
dicumarol and rotenone was virtually zero (data not shown). This further supports that complex III 
is the dominant site for DQH2 oxidation on passage through the pulmonary circulation of both 
normoxic and hyper-85 lungs.  
As stated above, the steady state efflux rate of CoQ1H2 during CoQ1 infusion was on 
average ~25% lower in hyper-85 lungs than in normoxic lungs over the range of infused 
concentrations.  To evaluate the contributions of  complex I and NQO1 mediated CoQ1 reduction 
to this decrease, the steady state efflux rate of CoQ1H2 during CoQ1 infusion were measured in the 
presence of rotenone, dicumarol, or rotenone plus dicumarol. 
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Figure 4.6 A: The relationship between the steady state rate of DQ efflux and the infused DQH2 
concentrations during DQH2 arterial infusion in the presence of Dic (400 µΜ), for normoxic lungs (n = 
6), hyper-85 lungs (n = 6). B: The relationship between the steady state rate of DQ efflux and the 
infused DQH2 concentrations during DQH2 arterial infusion in the presence of Dic (400 µΜ) and Rot 
(20 µΜ), for normoxic lungs (n = 4), hyper-85 lungs (n = 4). Values are mean ± SE. * Hyper-85 rates 
significantly different from the normoxic rates at the same infused DQH2 concentrations. 
Lungs treatment with rotenone decreased the efflux rate of CoQ1H2 by ~67% in normoxic 
lungs and ~46% in hyper-85 lungs, as compared to the rates in the absence of rotenone (Figure 4.7 
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B), consistent with complex I being a dominant site of CoQ1 reduction (Audi et al., 2008). 
Moreover, lungs treatment with rotenone eliminated the difference in CoQ1H2 efflux rates between 
normoxic and hyper-85 lungs measured in the absence of inhibitors, consistent with a decrease in 
the capacity of complex I mediated CoQ1 reduction in hyper-85 lungs as compared to normoxic 
lungs. 
Lungs treatment with dicumarol decreased the efflux rate of CoQ1H2 in both normoxic 
and hyper-85 lungs, and the decrease was larger in hyper-85 lungs (~60%) than in normoxic lungs 
(~25%) (Figure 4.7 C). As a result, treatment of lungs with dicumarol increased the difference in 
CoQ1H2 efflux rates between normoxoic and hyper-85 lungs compared with that measured in the 
absence of inhibitors. This increase was consistent with an increase in the capacity of NQO1 
mediated CoQ1 reduction in hyper-85 lungs as compared to normoxic lungs. This result is also 
consistent with the hyperoxia-induced increase in the capacity of NQO1-mediated DQ reduction 
(Figure 4.5). 
Figure 4.7 D shows that the steady state CoQ1H2 efflux rates decreased by ~85% and 
>95% in the presence of rotenone and dicumarol in normoxic and hyper-85 lungs, respectively. 
These results are consistent with the dominant role of complex I and NQO1 in CoQ1 reduction on 
passage through these lungs. 
To evaluate the capacity of lungs to oxidize CoQ1H2, the steady state rate of CoQ1 efflux 
during CoQ1H2 infusion was measured in the presence of rotenone and dicumarol to minimize 
CoQ1 reduction. Figure 4.7 F shows that the steady state efflux rate of CoQ1 during CoQ1H2 
infusion in the presence of rotenone and dicumarol in hyper-85 lungs was on average ~28% higher 
than that in normoxic lungs at the two highest infused concentrations. This result suggests an 
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increase in the capacity of complex III mediated CoQ1H2 oxidation in hyper-85 lungs as compared 
to normoxic lungs. Additional lung treatment with AA decreased the efflux rate of CoQ1 to nearly 
zero (data not shown). This is consistent with complex III being the dominant CoQ1H2 oxidase on 
passage through pulmonary circulation (Audi 2008). 
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Figure 4.7 A: The relationship between the steady state rate of CoQ1H2 efflux and the infused CoQ1 
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concentrations during CoQ1 arterial infusion for normoxic lungs (n = 7), hyper-85 lungs (n = 11). B: 
The relationship between the steady state rate of CoQ1H2 efflux and the infused CoQ1 concentrations 
during CoQ1 arterial infusion in the presence of rotenone (Rot, 20 µM), for normoxic lungs (n = 5), 
hyper-85 lungs (n = 8). C: The relationship between the steady state rate of CoQ1H2 efflux and the 
infused CoQ1 concentrations during CoQ1 arterial infusion in the presence of dicumarol (Dic, 400 µM), 
for normoxic lungs (n = 4), hyper-85 lungs (n = 4). D: The relationship between the steady state rate of 
CoQ1H2 efflux and the infused CoQ1 concentrations during CoQ1 arterial infusion in the presence of 
dicumarol (Dic, 400 µM) and rotenone (Rot, 20 µM), for normoxic lungs (n = 4), hyper-85 lungs (n = 
3). E: The relationship between the steady state rate CoQ1H2 efflux and the infused CoQ1 
concentrations during CoQ1 arterial infusion in the presence of antimycin A (AA, 10 µM) , for 
normoxic lungs (n = 4), hyper-85 lungs (n = 3).  F: The relationship between the steady state rate of 
CoQ1 efflux and the infused CoQ1H2 concentrations during CoQ1H2 arterial infusion in the presence of 
dicumarol (Dic, 400 µM) and rotenone (Rot, 20 µM), for normoxic lungs (n = 6), hyper-85 lungs (n = 
4).  Values are mean ± SE. * Hyper-85 rates significantly different from the normoxic rates at the same 
infused CoQ1 concentrations.  
Treatment of lungs with AA is one approach to inhibit complex III mediated CoQ1H2 or 
DQH2 oxidation. Another approach is to treat the lungs with the complex IV inhibitor KCN which 
reduces the respiratory chain and closes complex III for hydroquinone oxidation (Audi 2005, Audi 
2008).  Figure 4.8 shows that the efflux rate of DQH2 was not different during DQ infusion in the 
presence of AA or KCN in normoxic lungs. For hyper-85 lungs, the efflux rate of DQH2 during 
DQ infusion in the presence of KCN was slightly higher than that in the presence of AA at the 
highest infused concentration. However, for normoxic lungs, but not for hyper-85 lungs, the 
steady state CoQ1H2 efflux rates during CoQ1 infusion in the presence of KCN were ~30% higher 
than that in the presence of AA (Figure 4.9). These results suggests that a different effect of KCN 
on CoQ1 redox metabolism compared with AA in normoxic lungs. 
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Figure 4.8 The relationship between the steady state rate of DQH2 efflux and the infused DQ 
concentrations during DQ arterial infusion  in the presence of  AA (10 µM) or KCN (2 mM) A: 
normoxic lungs, antimycin A (n = 5), KCN (n = 5). B: hyper-85 lungs, AA (n = 5), KCN (n = 3). Values 
are mean ± SE. * rates in the presence of KCN significantly different from rates in the presence of 
antimycin A at the same infused DQ concentrations.  
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Figure 4.9 The relationship between the steady state rate of CoQ1H2 efflux and the infused CoQ1 
concentrations during CoQ1 arterial infusion  in the presence of  AA (10 µM) or KCN (2 mM) A: 
normoxic lungs, AA (n = 4), KCN (n = 4). B: hyper-85 lungs, AA (n = 3), KCN (n = 4). Values are 
mean ± SE. * rates in the presence of KCN significantly different from rates in the presence of 
antimycin A at the same infused CoQ1 concentrations.  
4.3.4 Activities of NQO1, Complex I and Complex IV in Lung Homogenates 
Rat exposure to 85% O2 for 7 days increased total lung NQO1 activity by 72% (Table 4.2). 
This increase was eliminated when NQO1 activity was normalized to total lung protein which 
increased by 114% in hyper-85 lungs as compared to normoxic lungs.  
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 Homogenate NQO1 Activity 
(µmol/min/lung) 
Homogenate NQO1 Activity 
(nmol/min/mg protein) 
Normoxic 26.5 ± 1.7 670 ± 80 
Hyper-85  45.6 ± 4.7
*
 538 ± 43 
Table 4.2 Lung homogenate NQO1 activity Values are mean ± SE. n = 7 and 7 for normoxic and 
hyper-85 lungs, respectively.  
* 
Indicate value significantly different from the corresponding normoxic. 
Table 4.3 shows that mitochondrial complex I activity per mg protein was ~50% lower in 
mitochondrial fractions derived from hyper-85 lungs than from normoxic lungs. On the other hand, 
complex IV activity per mg protein increased in hyper-85 lung homogenates by ~90% as 
compared to normoxic lungs (Table 4.3).  
 Complex I activity 
(nmol/min/mg protein)  
Complex IV activity 
(nmol/min/mg protein) 
Normoxic 13.2 ± 2.3 232 ± 16 
Hyper-85    6.8 ± 1.2
*
    439 ± 51 
*
 
Table 4.3 Mitochondrial complexes I and IV activities. For complexes I and IV activities, n = 5 and 7 
for normoxic and hyper-85 lungs, respectively. Values are mean ± SE. 
*
 Indicates value significantly 
different from the corresponding normoxic value. 
4.3.5 Immunoblots of  NQO1 in Lung Homogenate 
 Figure 4.10 shows examples of NQO1 immunoblots for normoxic and hyper-85 lung 
homogenates. Band intensities for hyper-85 lungs were on average ~ 3-fold that of normoxic lungs 
(Table 4.4).  
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Figure 4.10 Western blots of NQO1. 1
st
 column: normoxic rats, n=10; 2
nd
 column: rats exposed to 85% 
O2 for 7 days, n=12. 
 
 Normoxic Hyper-85 
Band intensity 100 298±85 * 
Table 4.4 NQO1 band intensities for normoxic and hyper-85 lungs. Values are mean ± SE. Normoxic 
lungs, n = 10; hyper-85 lungs, n = 12 respectively. 
* 
P<0.05. Note that for each run, the band intensity 
for normoxic lung was assigned an arbitrary value of 100.  
4.4 Kinetic Analysis of Quinone and Hydroquinone Pulse Infusion Data 
The data in Figures 4.4, 4.5, 4.6, 4.7 are the net results of  multiple factors, for 
quantitative interpretation of these data, the whole lung kinetic model for the pulmonary 
disposition of quinones and hydroquinones described in chapter 3.3 was required.  
 The model consists of conducting arteries, veins and a capillary region that accounts for 
quinone (Q) and hydroquinone (QH2) tissue and vascular interactions (Audi et al., 2005, 2008). 
The capillary region has a distribution of capillary transit times, hc(t) (Ramakrishna et al., 2010). 
For a single capillary element, the species balance equations descriptive of spatial and temporal 
variations in the concentrations of Q and QH2 in the vascular volume (Vc) and tissue volume (Ve) 
are described in chapter 3.3.2. For the lung model, the effect of the distribution of capillary transit 
time (hc(t)) on the plasma concentrations and the redox status of Q and QH2 on passage through 
the pulmonary circulation was taken into consideration (Audi et al., 2003, 2008). To provide the 
whole lung output, the outputs for all transit times were summed, each weighted according to hc(t). 
Previously, Ramakrishna et al. determined hc(t) for normoxic rat lungs and hyper-85 lungs, and 
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demonstrated that rat exposure to 85% O2 for 7 days decreased capillary mean transit time by 42% 
and increased the relative dispersion of hc(t) by 40% ( Ramakrishna et al., 2010). These values 
were used in the kinetic analysis of the normoxic and hyper-85 quinone and hydroquinone pulse 
infusion data.  
4.4.1. Kinetic Analysis of DQ/DQH2 Data 
For DQ/DQH2, the relevant redox reactions are NQO1 mediated DQ reduction and 
complex III mediated DQH2 oxidation. Thus, equations E3.1-E3.2 reduce to E4.3 - E4.4. 
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 In the absence of rotenone (complex I inhibitor), DQH2 competes with endogenous 
CoQ9H2 for oxidation via complex III. The steady state DQ efflux rates during DQH2 infusion in 
the presence of dicumarol alone appear to follow linear kinetics for the range of infused DQH2 
concentrations studied (Figure 4.5 A). Thus, in the absence of rotenone, Vmax2 and Km2a in 
Equations (E4.3-E4.4) are substituted for with a tissue mediated DQH2 oxidation rate kox (ml/min), 
resulting in the equations E4.5-E4.6.  
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Since the venous effluent data are measured at the steady state, the steady-state forms of 
equations E4.3-E4.6 are shown below  
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 For DQ or DQH2 infusion, the unknown model parameters under steady-state conditions 
are Vmax1 ( µmol/min) and Vmax2 ( µmol/min), the respective maximum rates for DQ reduction via 
NQO1 and DQH2 oxidation via complex III; Km1a (µM) and Km2a (µM), the apparent Michaelis-
Menten constants for NQO1 mediated DQ reduction and complex III mediated DQH2 oxidation, 
respectively; and kox (ml/min), the tissue mediated DQH2 oxidation rate on passage through the 
pulmonary circulation in the absence of rotenone. 
 The values of these parameters for normoxic and hyperoxic lungs were estimated using 
the following approach. First, the values of Vmax1 and Km1a, parameters descriptive of NQO1-
mediated DQ reduction, were determined. This was done by fitting the steady-state solution of the 
lung model to the steady state rates of DQH2 efflux during DQ infusion in the presence of 
antimycin A (Figure 4.5), which corresponded to setting Vmax2 to zero in Equations E4.3-E4.4. 
The estimated values of these model parameters are given in Table 4.5. Rat exposure to 85% O2 
for 7 days increased Vmax1 by ~200%. The estimated value of Km1a was 1 µM, which was the 
lower bound setting for this parameter in the least squares fitting procedure (see Figure 4.5 for 
model fit). 
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Table 4.5 Values of model parameters descriptive of NQO1-mediated DQ reduction in normoxic and 
hyper-85 lungs estimated from the steady-state DQH2 efflux rates during DQ infusion in the presence 
of AA. Values are mean ± SE. n = 5 for both groups. Vmax1 is the maximum DQ reduction rate; Km1a is 
the apparent Michaelis-Menten constant.  
*
 Significantly different from normoxic. 
 For a given lung, the parameters descriptive of complex III-mediated DQH2 oxidation 
(Vmax2 and Km2a) were estimated by fitting the steady state solution of the organ model to the 
steady state rates of DQ efflux during DQH2 infusion in the presence of dicumarol and rotenone, 
with Vmax1 was set to zero in Equations (E4.3-E4.4) to account for the presence of dicumarol. The 
results in Table 4.6 show that rat exposure to 85% O2 increased Vmax2 by ~180%, with no 
significant effect on Km2a. 
 
 
 
 
 
 
Table 4.6 Values of model parameters descriptive of complex III mediated DQH2 oxidation in 
normoxic and hyper-85 lungs estimated from the steady-state DQ efflux rates during DQH2 infusion in 
the presence of dicumarol plus rotenone. Values are mean ± SE. n = 4 for both groups. Vmax2 is the 
maximum DQH2 oxidation rate; Km2a is the apparent Michaelis-Menten constant.  
*
 Significantly 
different from normoxic values.  
The value of Kox was estimated by fitting the solution of the steady state organ model, 
with Vmax1 set to zero in Equations (E4.5-E4.6), to the steady state rates of DQ efflux during 
DQH2 infusion in the presence of dicumarol (Figure 4.6 A). Table 4.6 shows that rat exposure to 
85% O2 for 7 days increased the estimated value of Kox by  ~140% as compared to normoxic lungs. 
 Vmax1 
(µmol/min) 
Vmax1 
(µmol/min/g dry wt) 
Km1a 
(µM) 
Normoxic  1.38± 0.07              6.4 ± 0.3     1.0 
Hyper-85 4.11 ± 0.39
 *
            10.8 ± 0.7
*
     1.0 
 Vmax2 
(µmol/min) 
Vmax2 
(µmol/min/g dry wt) 
Km2a 
(µM) 
Normoxi
c  
1.67 ± 0.10     8.7 ± 0.7     42  ± 2 
Hyper-85 4.65 ± 0.36
* 
   13.6 ± 1.8
* 
     36  ± 11 
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Table 4.7 Value of model parameter descriptive of the DQH2 oxidation capacity in normoxic and 
hyper-85 lungs estimated from the steady-state DQ efflux rates during DQH2 infusion in the presence 
of dicumarol. Values are mean ± SE. n = 6 for both groups. Kox is total rate of DQH2 oxidation on 
passage through the pulmonary circulation. 
*
 Significantly different from normoxic values. 
 A second estimate of the values of Vmax1 and Km1a for normoxic and hyper-85 lungs was 
obtained by fitting the steady state lung model solution to the steady state rates of DOH2 efflux 
during DQ infusion in the absence of inhibitors (Figure 4.4 A), with Kox in Equations (E4.5-E4.6) 
set to the mean values in Table 4.7. The estimated values of Vmax1 for hyper-85 lungs were ~140% 
higher than that estimated for normoxic lungs (Table 4.8).  
 
 
 
 
 
Table 4.8 Values of model parameters descriptive of NQO1-mediated DQ reduction in normoxic and 
hyper-85 lungs estimated from the steady-state DQH2 efflux rates during DQ infusion. Values are mean 
± SE. n = 6 for both groups, respectively. Km1a is Michaelis-Menten constant of DQ reduction via 
NQO1. 
*
 Significantly different from normoxic values.   
 For normoxic and hyper-85 lungs, the values of Vmax1 in Table 4.8 vs. Table 4.5, i.e. 
estimated from the steady state rates of DQH2 efflux during DQ infusion in the absence or 
presence of AA, respectively, were not significantly different. This is consistent with the dominant 
inhibition effect of AA being on complex III- mediated DQH2 oxidation. 
4.4.2. Kinetic Analysis of CoQ1/CoQ1H2 Data 
All the redox processes in Figure 3.4 contribute to the pulmonary disposition of CoQ1 and 
 Kox 
(ml/min) 
Kox 
 (ml/min/g dry wt) 
Normoxic 6.38  ±  0.60 27.6  ± 2.9 
Hyper-85 15.2 ± 1.58
*
  35.0  ±  8.4 
 Vmax1 
(µmol/min) 
Vmax1 
(µmol/min/g dry wt) 
Km1a 
(µM) 
Normoxic  1.46 ± 0.10             7.2 ± 0.8     4.4 ± 1.4 
Hyper-85 3.52 ± 0.12
* 
           10.1 ± 0.6
*
     6.4 ± 1.6 
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CoQ1H2 (Audi et al., 2008). Thus for CoQ1 and CoQ1H2 pulse infusion data, the governing 
differential equations are E3.1-E3.2. The steady state forms of these equations are equations 
E4.11-4.12.   
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where Q and QH2 stand for CoQ1 and CoQ1H2 respectively.  
For CoQ1 or CoQ1H2 infusion, the unknown model parameters under steady-state 
conditions are Vmax1 (µmol/min), Vmax2 (µmol/min), Vmax3 (µmol/min) and Vmax4 (µmol/min), the 
respective maximum rates for CoQ1 reduction via NQO1, CoQ1H2 oxidation via complex III, 
CoQ1 reduction via complex I and CoQ1 reduction via other reductase(s) respectively;  Km1a (µΜ), 
Km2a(µM), Km3a (uM) and Km4a (uM), the apparent Michaelis-Menten constants for NQO1 
mediated CoQ1 reduction, complex III mediated CoQ1H2 oxidation, complex I mediated CoQ1 
reduction and other reductase(s) mediated CoQ1 reduction, respectively.   
 The values of these parameters were estimated by simultaneously fitting the steady-state 
solutions of the lung model equations to the mean values of the normoxic and hyper-85 data in 
Figures 4.7 A, B, C, E and F. For this fitting procedure, the Michaelis-Menten constants (intensive 
parameters) for the various redox enzymes were assumed to be the same for normoxic and hyper-
85 lungs. On the other hand, the Vmax values (extensive parameters) for the various redox enzymes 
were allowed to be different for normoxic and hyper-85 lungs. Thus, for the above fitting 
procedure, the number of model parameters was 12. The effect of an inhibitor was simulated by 
the setting the value(s) of Vmax of the inhibitor’s targeted redox enzyme to zero. Thus, in the 
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presence of rotenone, dicumarol, or antimycin A, Vmax3, Vmax1, or Vmax2 was set to zero, 
respectively. The estimated values of the parameters for normoxic and hyper-85 lungs along with 
95% confidence intervals are given in Table 4.9. A modified one-sided t-test (chapter 3.3.3) was 
used to determine whether the estimated Vmax values for normoxic and hyper-85 lungs were 
different. The results revealed that hyper-85 lungs increased the capacity of NQO1 mediated CoQ1 
reduction by 250%, increased the capacity of complex III mediated CoQ1H2 oxidation by 25%, 
and decreased the capacity of complex I mediated CoQ1 reduction by 35%.  
The confidence intervals for the Michaelis-Menten constants for CoQ1/CoQ1H2 redox 
processes are relatively large (as compared to the estimated parameter values). One possible 
reason is that the actual values of these parameters are low relative to the range of CoQ1 
concentrations achieved in this study. 
To evaluate the model, the estimated values of model parameters for normoxic and hyper-
85 lungs (Table 4.9) were used to predict the steady-state efflux rates of CoQ1H2 during CoQ1 
infusion in the presence of dicumarol and rotenone which were not used for the estimation of the 
model parameters. Figure 4.7 D showed that the model was able to predict these data reasonably 
well.   
Vmax (µmol/min) Km (µM) 
Targets 
Normoxic Hyper-85  
NQO1  0.50±0.37 1.76±0.56* 30.8 ± 42.3 
Complex III 4.09±0.49 5.07±0.60*    31.3 ± 7.2 
Complex I 2.73±0.59 1.88±0.54* 49.6 ± 33.5 
Other Reductase (s) 1.37±0.61 1.13±0.63 13.7 ± 19.2 
Table 4.9 Value of model parameters in normoxic and hyper-85 lungs estimated from CoQ1/ CoQ1H2 
infusions. Values are mean ± 95% CI.  
*
 Significantly different from normoxic. 
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 To account for the increase in lung dry weight of hyper-85 lungs as compared to 
normoxic lungs, the estimated values of Vmax(s) in Table 4.9 were normalized to lung dry weight. 
This normalization assumes that all lung cells are accessible to CoQ1 and CoQ1H2 on passage 
through the pulmonary circulation (Audi et al., 2008). The normalized values are given in Table 
4.10. The normalized values of Vmax1 (NQO1) for hyper-85 lungs are ~100% higher than for 
normoxic lungs. The normalized values of Vmax3 (complex I) for hyper-85 lungs are now ~59% 
lower than that for normoxic lungs. These results suggest that, even if taking the increase in the 
number of lung tissue cells into consideration, the increase in NQO1 activity and the decrease in 
complex I activity are still significant. For complex III, the normalized values of Vmax2 (complex 
III) for hyper-85 lungs are now ~26% lower than that for normoxic lungs. Compared with the 
~25% increase in the overall lung Vmax2 for hyper-85 lungs, this significant decrease might suggest 
a more complex change in complex III in hyper-85 lungs compared with complex I and NQO1. 
For other reductase(s), there are no significant differences between the values for normoxic and 
hyper-85 lungs either in overall Vmax4 or Vmax4 per gram dry lung. This suggests that either other 
reductase(s) in hyper-85 lungs did not change or the contribution of other reductase(s) on Q-QH2 
metabolism was minor. 
Vmax (µmol/min/g) 
Targets 
Normoxic Hyper-85 
NQO1 2.27±1.68 4.77±1.51* 
Complex III 18.6±2.23 13.7±1.63* 
Complex I 12.4±2.68 5.08±1.46* 
Other Reductase (s) 6.25±2.77 3.05±1.71 
Table 4.10 Values of normalized maximum reaction rates in normoxic and hyper-85 lungs estimated 
from CoQ1/ CoQ1H2 infusions. Values are mean ± 95% CI.  *: Significantly different from normoxic. 
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4.5 Discussion and Conclusions  
 Rat exposure to 85% O2 for 7 days had a differential effect on the redox metabolism of 
DQ and CoQ1, with the lung DQ reduction capacity increasing by 37% and the lung CoQ1 
reduction capacity decreasing by 25%. Inhibitor studies and kinetic analysis revealed that the 
increase in DQ reduction capacity in hyper-85 lungs could be accounted for by a 140% increase in 
the maximum rate of NQO1 mediated DQ reduction (Vmax1) and a 180% increase in maximum 
rate of complex III mediated DQH2 oxidation (Vmax2). The decrease in CoQ1 reduction capacity in 
hyper-85 lungs could be accounted for by a 250% increase in the maximum rate of NQO1 
mediated CoQ1 reduction (Vmax1), a 25% increase in maximum rate of complex III mediated 
CoQ1H2 oxidation (Vmax2) and a 35% decrease in maximum rate of complex I mediated CoQ1 
reduction (Vmax3). These results suggest a hyperoxia-induced increase in the activities of NQO1 
and complex III, and a decrease in the activity of complex I in isolated perfused lungs. 
The effect of hyperoxic exposure on NQO1 
Rat exposure to 85% O2 for 7 days increased the lung NQO1 activity as measured by the 
increase in the capacity (Vmax1) of NQO1 mediated DQ reduction (~140%) or CoQ1 reduction 
(~250%). Since the lung dry weight increased ~68% in rats exposed to 85% O2 for 7 day as 
compared to normoxic lungs, presumably due to an increase in the number of interstitial cells, this 
brought into question whether the increase in NQO1 activity was simply the result of the increase 
in the number of lung tissue cells. Table 4.11 shows that the increase in lung dry weight is not 
sufficient to account for the increase in lung NQO1 activity. Both DQ and CoQ1 data suggest an 
increase in NQO1 activity per gram of dry lung, by ~40% and ~110% respectively.  
 Western blots indicated that The expression of NQO1 in per mg lung protein of hyper-85 
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lungs is ~298% of that of normoxic lungs. Taking the amount of lung protein into consideration, 
the amount of NQO1 expression in hyper-85 lungs is about 5-fold of normoxic lungs. The increase 
in NQO1 expression in hyper-85 lungs might explain the increase in NQO1-mediated quinone 
reduction. 
 Although the activity of NQO1 in lung tissue homogenate increased by ~70% in hyper-85 
lungs as compared to normoxic lungs, this increase disappeared when the activity was expressed 
by per mg of lung protein (Table 4.11). One possible reason may be that other dicumarol-
inhibitable reductase(s) besides NQO1 contribute to the reduction of DCPIP which is used as the 
probe of NQO1 activity in tissue assay. This could be evaluated by using a different NQO1 
inhibitor, such as 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indol-4,7-dione (ES936), 
which inhibits NQO1 by an alternative mechanism (Bongard et al., 2009).  
 Both DQ and CoQ1 are substrates for NQO1. Hence, a hyperoxia-induced change in lung 
NQO1 activity would be expected to have a proportionate change in the model parameter (Vmax1) 
descriptive of the capacity of NQO1 mediated DQ and CoQ1 reduction. Both DQ and CoQ1 pulse 
infusion data suggest a hyperoxia-induced increase in lung NQO1 activity per gram of dry lung 
weight as compared to normoxic lungs, but DQ suggests a smaller increase (~40%) than CoQ1 
(~110%). This difference could be due to the effect of dicumarol on reductase(s) other than NQO1 
(e.g. complex I) for which CoQ1 is also a substrate (Audi et al., 2008).  
NQO1 Normoxic Hyper-85 
Vmax1 (µmol/min) from DQ data # 1.38± 0.07 4.11 ± 0.39* 
Vmax1 (µmol/min/ g dry weight) from DQ data # 6.4 ± 0.3 10.8 ± 0.7* 
Vmax1 (µmol/min) from CoQ1 data # 0.50±0.37 1.76±0.56* 
Vmax1 (µmol/min/ g dry weight) from CoQ1 data # 2.27±1.01 4.77±1.51* 
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Activity in lung homogenate (µmol/min/lung) & 26.5 ± 1.67 45.6 ± 4.74* 
Activity in lung homogenate (nmol/min/mg protein) 
&
 670 ± 80 538 ± 43 
NQO1 protein expression (%) 
&
 100 298±85* 
Table 4. 11 Values of NQO1 activity estimated by different methods. #: Values are mean ± 95% CI.  &: 
values are mean± SE.  *: P<0.05. Significantly different from normoxic. 
The effect of hyperoxic exposure on Complex I 
 The results of the CoQ1 pulse infusion data suggest that rat exposure to 85% O2 for 7 days 
decreased the activity of complex I (Vmax3) by ~35%. This decrease is even larger (~60%) when 
Vmax3 is normalized to lung dry weight (Table 4.12). This result is consistent with the ~50% 
decrease in complex I activity (per mg protein) in lung homogenate (Table 4.12). Thus the ~50% 
depression in complex I activity measured by Audi et al. in lungs of rats exposed to 85% O2 for 48 
hours is maintained after 7-day exposure to 85% O2. This suggests that the hyperoxia-induced 
depression in complex I activity may be an early manifestation of an adaptive response to the 
hyperoxic environment.  
 Previous studies have suggested that hyperoxia-induced decrease in complex I activity 
could be due to the fact that 7 out of the 45 complex I subunits are encoded by mitochondrial 
DNA (mDNA), which is known to be highly sensitive to ROS (Chicco & Sparagna, 2007). The 
decrease in complex I activity could also be through the oxidation of cardiolipin, which is 
important for the electron transport function of complex I.  
 Ratner et al. (Ratner, Starkov & Matsiukevich, 2009) demonstrated that exposure of 
neonatal mice to hyperoxia (75% O2) for 72 hours decreased complex I activity by ~70%.  This 
decrease compromises mitochondrial oxidative phosphorylation, contributes to an alveolar 
development arrest, and also contributes to the development of bronchopulmonary dysplasia 
(Ratner et al., 2009). The importance of the depression in complex I activity to O2 toxicity was 
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demonstrated by treating mice with a complex I inhibitor, which resulted in an alveolar 
development arrest under normoxic conditions. Based on these results, Ratner et al. (2009) 
concluded that hyperoxia-induced decrease in complex I activity might play a key role in lung O2 
toxicity.  Additional studies would be needed to evaluate the effect of this decrease in complex I 
activity on mitochondrial bioenergetics.  
Complex I  Normoxic Hyper-85 
Vmax3 (mol/min) from CoQ1 data 
#
 
2.73±0.59 1.88±0.54* 
Vmax3 (mol/min/g dry weight) from CoQ1 data 
#
 
12.4±1.60 5.08±1.46 * 
Activity in lung homogenate (nmol/min/mg protein)
&
 
13.2 ± 2.31 6.78 ± 1.24* 
Table 4. 12 Values of complex I activity estimated by different methods. #: Values are mean ± 95% CI. 
&: values are mean± SE.  *: P<0.05. Significantly different from normoxic. 
Effect on complex III 
 Although rat exposure to 85% O2 for 7 days increased the lung capacity (Vmax2) of 
complex III mediated DQH2 and CoQ1H2 oxidation as compared to normoxic lungs, the increase 
was much larger for DQH2 (~180%) than for CoQ1H2 (~25%). Furthermore, the increase in Vmax2 
for CoQ1H2 dissipated when Vmax2 was normalized to lung dry weight (Table 4.13). It is not clear 
what could account for this difference since both DQH2 and CoQ1H2 are substrates for complex III 
and hence a change in complex III activity would be expected to have a proportionate change in 
the capacity of complex III to oxidize DQH2 or CoQ1H2 on passage through the pulmonary 
circulation. One possible reason could be the competition between endogenous CoQ9H2 and 
CoQ1H2 or DQH2 for oxidation via complex III. The advantage of DQH2 in the competition with 
CoQ9H2 for the oxidation at complex III is that the reduction of DQ is independent of complex I, 
which makes the competition between DQH2 and CoQ9H2 not as complex as the competition 
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between CoQ1H2 and CoQ9H2. The decrease in complex I activity reduces the competition from 
CoQ9H2 and hence increases the oxidation of DQH2 via complex III. Since the formation of 
CoQ1H2 is dependent on complex I, then for CoQ1H2, the competition from CoQ9H2 changes less.  
Complex III Normoxic Hyper-85 
Vmax2 (µmol/min) from DQ data 1.67 ± 0.10 4.65 ± 0.36* 
Vmax2 (µmol/min/ g dry weight) from DQ data 8.7 ± 0.7 13.6 ± 1.8* 
Vmax2 (µmol/min) from CoQ1 data 4.09±0.49 5.07±0.60* 
Vmax2 (µmol/min/ g dry weight) from CoQ1 data 18.6±1.32 13.7±1.63 
Table 4. 13 Values of complex III activity estimated by different methods. Values are mean ± 95% CI.   
In addition to its effects on lung activities of NQO1 and complex I and III, rat exposure to 
85% O2 for 7 days increased the activity of complex IV in lung tissue homogenates by ~90% 
compared to normoxic lung homogenates. Previous studies indicated that the electron transport 
chain complexes I and III have a tight relationship and act as a supercomplex (Genova, Bianchi & 
Lenaz, 2005). In addition, part of complex IV is bound to and functionally associated with 
complex III (van Raam et al., 2008). Thus, complexes I, III and IV might consistitute a 
mitochondrial supercomplex (van Raam et al., 2008). In the present study, mitochondrial electron 
transport chain complexes are differentially altered by rat exposure to 85% O2 for 7 days, with the 
increases in the activities of complexes III and IV and the decrease in the activity of complex I. 
Regarding the specific relationship between mitochondrial electron transport chain components 
(Genova et al. 2005; Van Raam et al., 2008), the above results raise the following questions. Do 
these hyperoxia-induced changes in the activities of complexes I, III and IV occur simultaneously 
or sequentially? Do these changes occur independently or dependently? Are these changes toxic or 
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protective? Addressing these questions would further understanding of how the mitochondrial 
electron transport chain adjusts the activities of its complexes and hence its overall function in 
response to an oxidative stress stimulus such as hyperoxia.  
 Previous studies have suggested that the hyperoxia-induced increase in ROS formation 
plays a key role in lung O2 toxicity. Thus, at least two potential strategies that lung cells might 
follow to counter this increase, either improving defenses against the increased ROS generation or 
improving metabolic mechansims that might suppress ROS generation in the first place (Campian 
et al., 2004). Of these two possibilities, preemptive suppression of ROS production would be the 
most effective and economical solution (Campian et al., 2004). This study indicated that rats 
exposed to 85% O2 for 7 days not only increased the activities of antioxidant enzymes such as 
NQO1 but also changed the activities of mitochondrial ROS sources such as mitochondrial 
complexes I and III. Since the intracellular production of ROS by mitochondria under hyperoxia 
might be the most important mechanism of hyperoxic damage, manipulation of ROS generation 
from mitochondria could be an efficient way to counter hyperoxia-induced lung injury. The 
decrease in complex I activity could be a means of decreasing the production of electron-rich 
intermediates such as ubisemiquinone. The increases in the activities ofcomplex III and complex 
IV could be a means of enhancing the capacity to utilize electron-rich intermediates and hence 
decreasing ROS production at complex III. Future studies are needed to evaluate the effect of this 
increase in complexes III and IV on mitochondrial ROS production. 
 Lungs treatment with AA (an inhibitor of complex III) or KCN (an inhibitor of complex 
IV) would be expected to inhibit complex III-mediated hydroquinol oxidation completely (Seddon 
& Mcvitte, 1974, Lenaz 2001). Thus, one would expect no difference in the steady-state rates of 
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hydroquinol (DQH2 or CoQ1H2) efflux during quinone (DQ or CoQ1) infusion from lungs treated 
with either AA or KCN. The results show that for normoxic and hyperoxic lungs, the efflux rates 
of DQH2 during DQ infusion in the presence of AA or KCN were virtually the same expect for a 
small but significant difference at the highest DQ infused concentration in hyper-85 lungs (Figure 
4.8). The efflux rate of CoQ1H2 during CoQ1 infusion in the presence of AA or KCN was also not 
different in hyper-85 lungs. However, for normoxic lungs, the efflux rates of CoQ1H2 during CoQ1 
infusion in the presence of KCN were ~30% higher than in the presence of AA (Figure 4.9). One 
possible reason for this difference is that KC, but not AA (Dickman & Mandel, 1990), can 
stimulate glycolysis (Belinsky, Kauffman & Thurman, 1989) and hence increase pyruvate 
availability, which in turn increases NADH supply for complex I and finally increases the rate of 
complex I mediated CoQ1 reduction. The effect of such an increase in NADH availability may not 
be as important for complex I mediated CoQ1 reduction in hyper-85 lungs as in normoxic lungs 
due to the ~50% depression in complex I activity in hyper-85 lungs. This explanation would also 
be consistent with the lack of difference in DQH2 efflux during DQ infusion in the presence of AA 
or KCN because DQ is not a substrate for complex I which requires NADH. One possible reason 
for the differential effects of KCN and AA on glycolysis could be the fact that KCN but not AA is 
known to inhibit GSH peroxidase (Kraus & Ganther, 1980). The inhibition of GSH peroxidase 
would divert glucose-6-phosphate from the pentose phosphate pathway to glycolysis. Additionally, 
it is known that AA does not completely inhibit the electron flow from ubiquinone to cytochrome 
c (Lenaz 2001) and hence has a relatively weak inhibition effect on ATP production compared to 
KCN. Both factors suggest that KCN could stimulate more glycolysis rather than AA. 
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 In summary, rat exposure to 85% O2 for 7 days decreased lung complex I  activity by 
~50%, increased lung complex III activity by ~25%,  and increased lung NQO1 activity by ~40% 
and ~110% for DQ and CoQ1 respectively. The depression in lung complex I activity following rat 
exposure to 85% O2 for 48 hours is maintained in rats exposed to 85% O2 for 7 days which have 
developed a tolerance to 100% O2. This suggests that the decrease in lung complex I activity 
might be an early manifestation of an adaptive response to hyperoxic exposure, though the 
decrease in lung complex I activity alone was not sufficient to induce rat tolerance to 100% O2 in 
rats exposed to 85% O2 for 48 hours. The increase in lung NQO1 activity measured after exposure 
to 85% O2 for 21 days is detectable in rats exposed to 85% O2 for 7 days. Thus, we suspect that 
the increase in lung NQO1 activity might be a secondary anti-oxidant response under hyperoxic 
exposure.  
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CHAPTER 5. LUNG MITOCHONDRIAL COMPLEX I ACTIVITY AND H2O2 
RELEASE DURING THE INITIATION PHASE OF O2 TOXICITY 
5.1 Introduction 
Previously, Audi et al. demonstrated that rat exposure to 85% O2 for 48 hours decreased 
the overall capacity of the lung to reduce CoQ1 to CoQ1H2, predominately due to a 50% 
depression in the capacity of complex I-mediated CoQ1 reduction, but with no effect on the 
capacity of NQO1-mediated CoQ1 reduction and the capacity of complex III-mediated CoQ1H2 
oxidation, or lung capillary perfusion kinematics (Audi et al., 2008). The results presented in 
chapter 4 of this dissertation demonstrated that this decrease persists after 7 days of rats exposed 
to 85% O2, which is long enough for rats to develop a tolerance of 100% O2. Ratner et al. (2009) 
suggested that the depression in complex I activity is an important aspect of the initiation phase of 
O2 toxicity due to its effect on cellular ATP production via oxidative phosphorylation. These 
results raised the following questions. How early following rat exposure to 85% O2 does complex 
I activity decrease? What is the effect of this decrease in complex I activity on lung ROS 
production? The work described in this chapter attempts to address these questions.  
To address the first question, the effects of rat exposure to 85% O2 for 12 or 24 hours on 
complex I activity in lung homogenate and on complex I mediated CoQ1 reduction on passage 
through the pulmonary circulation of isolated perfused lungs were evaluated. Audi et al. 
demonstrated that rat exposure to 85% O2 for 48 hours had no effect on NQO1 mediated CoQ1 
reduction, complex III mediated CoQ1H2 oxidation or lung perfusion kinematics (Audi et al., 
2008). Thus any change in CoQ1 reduction in lungs of rats exposed to 85% O2 for 12 hours or 24 
hours was attributed to a change in complex I mediated CoQ1 reduction and hence in complex I 
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activity in the intact lung.  
To address the second question, a spectrophotometric method for measuring the rate of 
H2O2 release from isolated perfused rat lung using Amplex Red (AR) was developed. The general 
approach of the developed assay involves the recirculation of perfusate containing AR and HRP 
through the pulmonary circulation and the measurement of resorufin concentration in reservoir 
samples collected periodically during a 30-min recirculation period.  
5.2 Materials and Methods 
Coenzyme Q1 (CoQ1) was purchased from Sigma Chemical Company (St. Louis, MO). 
Bovine serum albumin (Standard Powder, BSA) was purchased from Serologicals Corp. 
(Gaithersburg, MD). Reduced CoQ1 (CoQ1H2) was prepared by reduction of CoQ1 with potassium 
borohydride (KBH4) as previously described (Cadenas, Boveris & Ragan, 1977).  Amplex Red 
(AR), horseradish peroxidase (HRP) and other reagent grade chemicals were purchased from 
Sigma Chemical Company.  
5.2.1 Hyperoxic Exposure  
 Rats were exposed to 85% O2 for 12 hours, 24 hours or 48 hours as described in chapter 
4.2.1.   
5.2.2 Lung Preparation 
The isolated perfused rat lung preparation and the ventilation-perfusion system are 
described in chapter 4.2.2.  
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5.2.3 Lung Infusion Protocols 
 CoQ1 Pulse Infusion 
To determine the rate of CoQ1 reduction on passage through the pulmonary circulation, 
two 45-second long sequential arterial pulse infusions at CoQ1 concentrations of 50 and 200 µM 
were carried out with a perfusate flow rate of 30 ml/min. For each pulse infusion, a venous 
effluent sample (1 ml) was collected between 43 and 45 seconds after the initiation of the pulse 
infusion. Between pulse infusions, the lung was perfused with 30 ml of fresh perfusate to wash the 
lung and perfusion system of any remaining probes of CoQ1 and/or CoQ1H2.   
Perfused Capillary Surface Area 
The perfused capillary surface area was determined using the ACE substrate FAPGG as 
described in chapter 4.2.5. 
5.2.4 Characterization of AR-H2O2 Assay and Determination of Optimal Perfusion Conditions 
 To make sure that H2O2 or HRP does not interfere with the absorbance spectrum of 
resorufin, the spectra of AR, resorufin, H2O2, and HRP were determined  in HBSS containing 10 
mM HEPES. Figure 5.1 shows the absorbance spectra for amplex red (AR), resorufin, horseradish 
peroxidase (HRP) and H2O2. As expected, the absorbance peak of resorufin is at 571 nm. The 
absorbances of AR, HRP and H2O2 at 571 nm are close to zero and hence do not interfere with the 
resorufin absorbance. 
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Figure 5.1 Spectra of resorufin, horseradish peroxidase, amplex red and H2O2 A: spectrum of resorufin. 
B: spectrum of horseradish peroxidase. C: spectrum of amplex red   D: spectrum of H2O2 
 To check the extinction coefficient of resorufin and the linearity of AR-H2O2 reaction, a 
standard curve that represents the relationship between H2O2 concentration and the resulting 
resorufin absorbance was obtained. 1, 5, 10 or 25 nmol H2O2 was added into 1 ml HBSS-HEPES 
containing 25 nmol AR and 5U HRP, and the resulting absorbance at 571 nm was measured. The 
extinction coefficient was then estimated using a linear regression.  To select a proper perfusate for 
the lung experiments, AR-H2O2 standard curves were obtained using the above approach in 
HBSS-HEPES, KRB containing 5% (mass/vol) dextran (~66 kDa) or 5% (mass/vol) BSA, the 
linear range and the extinction coefficient were then determined as above. 
Figure 5.2 A and B are  typical standard curves which show a linear relationship between 
the absorbance of formed resorufin at 571 nm and H2O2 concentration in the range 0.5-25 µM. 
The resulting extinction coefficient was 0.054 µM
-1
 cm
-1
 in HBSS-HEPES (Figure 5.2 A) which is 
consistent with previous report (Haughland, 2002), and 0.044 µM
-1
 cm
-1
 in KRB-Dex (Figure 5.2 
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B). In both HBSS-HEPES and KRB-Dex, the absorbance at 571 nm increased linearly with the 
increase in the concentration of H2O2. But much less absorbance at 571 nm was detected using 
KRB containing 5% BSA (Figure 5.2 C). This suggests that BSA itself may have H2O2-
scanvenging property and hence interferes with the AR-H2O2 assay. Therefore, for lung 
experiments, KRB-Dex was selected as the perfusate for AR-H2O2 assay. 
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Figure 5.2 The relationship between absorbance and concentrations of H2O2 in different buffers. H2O2 
was added into the cuvette with buffer containing 50 µM AR and 5U HRP. The concentration of H2O2 
was 1 µM, 5 µM, 10 µM, 25 µM respectively.  The absorbance was measured at 571 nm. A: HBSS-
HEPES buffer B. KRB buffer containing 5% Dextran C: KRB buffer containing 5% BSA. 
  To evaluate the utility of this AR-H2O2 assay for determining the rate of H2O2 release, 
glucose-glucose oxidase reaction was used to produce H2O2 in cell-free KRB (KRB-GO) which 
contained 5.5 mM glucose, 0.02 U glucose oxidase, 50 µM AR, 5U HRP and 5% dextran. The 
resulting absorbance was measured every 20 seconds for 10 min. The rate of H2O2 production was 
estimated using linear regression based on an appropriate standard curve. Figure 5.3 A shows the 
time-dependent increase in the absorbance at 571 nm in cell-free KRB-GO perfusate. The 
estimated rate of H2O2 production from this glucose-glucose oxidase H2O2 system using AR-H2O2 
assay was around ~2 nmol/min for 1 ml solution (2 µM/min).  
To determine the sensitivity of the AR-H2O2 assay to metabolic inhibitors of known ROS 
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sources, the rate of H2O2 production by the glucose-glucose oxidase system was estimated in the 
absence and presence of 20 µM rotenone (complex I inhibitor), 10 µM antimycin A (complex III 
inhibitor), 1 mM apocynin (NADPH oxidase inhibitor) or 6 mM DEM (glutathione scavenger). 
The absorbance of a semimicro fluorescent cuvette containing KRB-GO buffer with or without an 
inhibitor was measured every 20 seconds in a 10-min period. 
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Figure 5.3 The effect of inhibitors on the formation of resorufin. KRB buffer containing 5% dextran, 
25 µM AR, 5U HRP, 5.5 mM glucose, glucose oxidase with specific inhibitor was mixed well in a 
semi-fluorescent cuvette. A sample with the same buffer but without inhibitor was used as control and 
measured simultaneously. The absorbance at 571 nm was measured every 15 sec for 8 min. A: 0.02U 
glucose oxidase in the absence or presence of 20 µM rotenone; B: 0.015U glucose oxidase in the 
absence or presence of 10 M antimycin A; C: 0.02U glucose oxidase in the absence or presence of 1 
mM apocynin; D: 0.02U glucose oxidase in the absence or presence of 6 mM DEM. 
Figure 5.3 shows that the assay is insensitive to the presence of rotenone, antimycin A or 
DeM. However, apocynin decreased the detected rate of H2O2 production as measured by the 
absorbance of resorufin in the medium by ~80% (Figure 5.3 C). This decrease could be due to the 
effect of apocynin on glucose-glucose oxidase H2O2 production or on the formation of resorufin. 
To address this question, an AR- H2O2 standard curve in the buffer containing 1 mM apocynin was 
obtained. Figure 5.4 showed that in the presence of 1 mM apocynin, the absorbance at 571 nm of 
mixed AR–H2O2 sample was 10~20% of that of mixed samples in the absence of apocynin. This 
result suggests that apocynin might have an antioxidant property and hence competes with AR for 
H2O2. This result is consistent with the results of a study by Heumüller et al. in which they 
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evaluated the rate of resorufin formation in buffer with or without apocynin using different H2O2 
production systems and different H2O2 probe including AR (Heumüller 2008). In summary, 
rotenone, antimycin A and DEM do not interfere with the AR-H2O2 assay, whereas apocynin does, 
presumably due to its H2O2 scavenging property.  
 
Figure 5.4 Standard curve of amplex red- H2O2 reaction 
in the presence of apocynin. The relationship between 
absorbance and concentrations of H2O2 added into the 
cuvette with the perfusate containing 50 µM AR, 5U 
horseradish peroxidase and 1 mM apocynin. The 
concentration of H2O2 was 1 µM, 5 µM, 10 µM, 25 µM 
respectively.  The absorbance was measured at 571 nm. 
 
5.2.5 Estimation of Lung Rate of H2O2 Release 
 Based on the results of the above bench top experiments (see the results below), KRB 
buffer containing 5% (mass/vol) dextran (KRB-Dex) was chosen as the perfusate for the isolated 
perfused lung experiments. 
The following protocol was used to determine the rate of H2O2 release from the rat lung. 
Isolated lungs were washed free of blood using KRB-Dex. A 1 ml perfusate sample that had 
passed through the lungs but contained no AR was collected and used as the blank, after which the 
reservoir content was emptied and replaced with 20 ml KRB-Dex perfusate containing 50 µM AR 
with or without 5U of HRP. A 1 ml sample of the AR-containing KRB-Dex perfusate was removed 
from the reservoir prior to the start of the recirculation period. This sample was used to determine 
the background H2O2 production, and is referred below as the background sample. The remaining 
AR containing perfusate in the reservoir was then recirculated through the lung for a period of 30 
min with the pump flow set at 10 ml/min. During the recirculation period, a 1 ml reservoir sample 
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was removed every 5 min. This sample was centrifuged at 13,500 g for 1 min and the absorbance 
of resulting supernatant was measured at 571 nm (Beckman DU7400). The sample was then added 
back to the reservoir to minimize the change in the total volume of perfusate in the recirculation 
system. To maximize the reaction rate between AR and H2O2, the above recirculation protocol was 
repeated with the addition of 5U of HRP to the perfusate. At the end of experiment, the volume of 
perfusate in the reservoir was measured. 
Following the AR recirculation experiments, the lung was washed free of AR or resorufin 
and an index of perfused capillary surface area was contained as described in chapter 4.2.5. 
 The absorbance of resorufin in each collected sample during the recirculation period was 
converted to H2O2 concentration using an AR-H2O2 standard curve. The amount of H2O2 in the 
reservoir at a specific sampling time was determined as the product of H2O2 concentration in the 
reservoir sample and the corresponding reservoir volume. The lung rate of H2O2 release was then 
estimated as the slope of the relationship between sampling time and the amount of H2O2 in the 
reservoir. The absorbance values of the background sample measured at the sampling times were 
used to determine the background (lung independent) rate of H2O2 release. Thus, the lung rate of 
H2O2 release (nmol/min) was the difference between the rate determined from the reservoir 
samples and the background sample. 
 To estimate the effect of the activity of complex I on lung H2O2 release, the above 
protocol was repeated following lungs treatment with rotenone (20 µM). To estimate the 
sensitivity of this assay to H2O2 from mitochondria, the above protocol was repeated following 
lungs treatment with antimycin A (10 µM). The protocol was repeated in lungs ventilated with 5% 
CO2 balanced O2 to determine the dependence of the rate of H2O2 release on O2 level. 
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5.2.6 Determination of the Activities of Complex I/IV in Lung Homogenate 
 The activities of complex I and complex IV in lung homogenate were measured as 
described in chapter 4.2.6. 
5.3 Experimental Results 
5.3.1 Effects of Rats Exposeure to 85% O2 for 12, 24 or 48 hours on Body Weight, Lung Weight 
and Lung Perfused Capillary Surface Area 
 Rat exposed to 85% O2 for 12, 24 or 48 hours had no significant difference in rat body 
weight, lung wet weight, lung dry weight, or perfused capillary surface area as compared to 
normoxic rats (Table 5.1). These results are consistent with those of Crapo et al. in which they 
reported that rats exposed to 85% O2 for up to 72 hours had no detectable lung histological or 
morphometric changes (Crapo et al., 1980). Additionally, Block and Fisher showed that rat 
exposure to 100% O2 for 48 hours had no effect on lung vascular flow distribution (Block & 
Fisher, 1977).  
Table 5. 1 Body weight (B.W.), lung wet weight (W.W.), lung dry weight (D.W.), lung wet weight/lung 
dry weight ratio (W/D) and PS of normoxic rats and rats exposed to 85% O2 for 0, 12, 24 and 48 hours  
(Mean ± SE), n=94, 4, 7 and 13 respectively. 
5.3.2 Effect of Rat Exposure to 85% O2 for 12, 24, or 48 Hours on the Redox Metabolism of 
CoQ1 as a Measure of Complex I Activity in the Intact Lung 
 Rat exposure to 85% O2 for 24 hours or 48 hours, but not 12 hours decreased by ~20% 
the rate of CoQ1 reduction on passage through pulmonary circulation at 50 µM or 200 µM CoQ1 
 B.W.  (g) W.W. (g) D.W. (g) W/D  PS (ml/min) 
Normoxic 320±3.3 1.20±0.02 0.22±0.01 5.53±0.05 23.3±1.1 
12 h (n=4) 313±5.1 1.28±0.13 0.23±0.01 5.59±0.22 23.0±1.3 
24 h (n=7) 307±8.9 1.14±0.02 0.21±0.01 5.34±0.06 23.1±1.4 
48 h (n=13) 303±4.0 1.20±0.04 0.22±0.01 5.67±0.10 26.7±3.0 
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infusion (Figure 5.1). A previous study (Audi et al., 2008) as well as the results in chapter 4 
demonstrated that the dominant oxidoreductases that determine the redox metabolism of CoQ1 on 
passage through rat lungs are complex I, complex III and NQO1. Audi et al. showed that rat 
exposure to 85% O2 for up to 48 hours had no effect on complex III-mediated CoQ1H2 oxidation, 
NQO1-mediated CoQ1 reduction or capillary perfusion kinematics (Audi et al., 2005, 2008). 
Thuse, a change in the steady state rate of CoQ1H2 efflux during CoQ1 infusion in lungs of rats 
exposed to 85% O2 for 48 hours or less would be attributed to a change in complex I mediated 
CoQ1 reduction and hence in complex I activity in intact lung. The results in Figure 5.1 suggest 
that rat exposure to 85% O2 for 24 hours and 48 hours, but not 12 hours decreased complex I 
activity in intact lungs.  
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Figure 5. 5 The efflux rate of CoQ1H2 during 50 or 200 µM CoQ1 infusion of rat lungs exposed to 
room air (n=12), 85% O2 for 12 hours (n=4), 85% O2 for 24 hours (n=5) and 85% O2 for 48 hours (n=7, 
data from Audi et al., 2008) respectively. A: 50 µM CoQ1 infusion B: 200 µM CoQ1 infusion Values are 
mean ± SE.  * Rates significantly different from the normoxic rates at the same infused CoQ1 
concentrations using one-way ANOVA (P<0.05). 
 To determine the capacity of complex I-mediated CoQ1 reduction in lungs of rats exposed 
to 85% O2 for 12, 24 or 48 hours, the lung kinetic model described in chapter 4.4 was fit to the 
steady state rates of CoQ1H2 efflux during CoQ1 infusion at 50 and 200 µM. For this model fitting 
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step, the only unknown parameter was the capacity (Vmax3) of complex I-mediated CoQ1 reduction. 
Other model parameters including Michaelis-Menten constant for complex I mediated CoQ1 
reduction, Michaelis-Menten parameters for other dominant redox processes that determine the 
fate of CoQ1 metabolism on passage the lung, and lung capillary transit time distribution were set 
at the mean values estimated for normoxic lungs (Table 4.9). Table 5.2 shows the estimated values 
of Vmax3 for the four groups of rats. Exposure to 85% O2 for 24 or 48 hours decreased Vmax3, 
which is a measure of complex I activity, by ~27% and ~34%, respectively.  
 
 
 
 
 
 
 
Table 5.2  Estimated parameter descriptives of capacity of complex I mediated CoQ1 reduction in 
normoxic rat (n=11), 12-hour 85% O2 exposed rats (n=4), 24-hour 85% O2 exposed rat (n=5), and 48-
hour 85% O2 exposed rats (n=7). Values are mean ± SE.  
*
 Significantly different from normoxic values 
using one-way ANOVA (P<0.05). 
5.3.3 Effect of Rat Exposure to 85% O2 for 12, 24, or 48 Hours on Complex I and Complex IV 
Activities in Lung Tissue Homogenate 
 Figure 5.6 shows that rat exposure to 85% O2 for 12, 24 or 48 hours decreased complex I 
activity (rotenone-sensitive NADH oxidation) in lung tissue homogenate by ~50%. This 
depression in complex I activity persisted after 7 days of rat exposure to 85% O2 as demonstrated 
in chapter 4.   
 Exposure to 85% O2 for 24 or 48 hours had no significant effect on complex IV activity in 
lung tissue homogenate as compared to normoxic lungs (Figure 5.7, Table 5.3). For 12-hour 
exposure group, the results were not conclusive. For one batch of rats exposed to 85% O2 for 12 
hours (n=3), the activity of complex IV in lung homogenate decreased by ~50% (50.4±0.94 
Vmax3 (Activity of Complex I) 
Rats 
(µmol/min) (µmol/min/g) 
Normoxic  3.20±0.14 14.6±0.7 
12-hour 3.12±0.07 13.6±0.3 
24-hour  2.33±0.14* 11.1±0.7* 
         48-hour  2.10±0.18* 9.5±0.8* 
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nmol/min/mg) as compared to normoxic lungs. However, for another two batches of rats exposed 
to O2 for 12 hours (n=6), there was no difference in the activity of complex IV in lung tissue 
homogenates compared to normoxic lungs. 
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Figure 5.6 Rotenone-sensitive NADH oxidation rates in lung homogenate from rats exposed to room 
air (n=12), 85% O2 for 12 hours (n=10), 85% O2 for 24 hours (n=4), 85% O2 for 48 hours (n=6) and 7 
days (n=7) respectively. Values are mean ± SE.  * Rates significantly different from the normoxic rate. 
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Figure 5.7 Cytochrome C oxidation rates in lung homogenate from rats exposed to room air (n=12), 
85% O2 for 12 hours (n=9), 85% O2 for 24 hours (n=4), 85% O2 for 48 hours (n=6) and 7 days (n=7) 
respectively. Values are mean ± SE.  * Rates significantly different from the normoxic rate. 
 
 
 
 
 
 
 
 
 
 Complex I 
(nmol/min/mg protein) 
 
Complex IV 
(nmol/min/mg protein) 
 
Normoxic (n=12) 13.18±0.78 121±22 
12 h (n=10) 6.39±0.25
*
 106±16 
24 h (n=4) 6.42±0.76
*
 112±23 
48 h (n=6) 6.92±1.12
*
 135±25 
7 days (n=7) 6.78±1.24
*
 231±27
*
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Table 5.3 The activities of complex I and IV in lung homogenates of rats exposed to 85% O2 for 0 hour 
(n=12), 12 hours (n=10), 24 hours (n=4), 48 hours (n=6) and 7 days (n=7), respectively. Values are 
mean ± SE.  * Values significantly different from the normoxic value. 
5.3.4 Effect of Rat Exposure to 85% O2 on Lung Rate of H2O2 Release 
Figure 5.8 A shows that, in the presence of HRP, the absorbance at 571 nm of reservoir 
samples collected at different sampling time over a 30-min lung recirculation period through a 
normoxic rat lung increased linearly. Thus, the corresponding resorufin concentrations and hence 
H2O2 concentrations increased linearly with time at a rate ~ 0.8 µM/min (or 16 nmol/min for the 
whole lung H2O2 release). Since the perfusate can produce H2O2 via spontaneous reaction, a 
fraction of this rate is lung independent. Figure 5.8 B shows that, in the presence of HRP, H2O2 
concentration in background sample increased linearly with time at a rate ~0.1 µM/min (2 
nmol/min for the whole lung H2O2 release). Thus, the lung-dependent H2O2 production rate is ~ 
0.7 µM /min (14 nmol/min for the whole lung H2O2 release). 
The above experiments were repeated without the addition of HRP in the perfusate. 
Figure 5.8 C shows that, in the absence of HRP, H2O2 concentration in the reservoir also increases 
linearly at a rate ~0.5 µM/min (10 nmol/min for the whole lung H2O2 release). This suggests that 
rat lungs have endogenous peroxidase activity on the luminal surface of the pulmonary 
endothelium. Figure 5.8 D shows that, in the absence of HRP in the perfusate, the rate of resorufin 
formation in the background sample (i.e. not recirculated through the lung) is virtually zero. 
 Figure 5.9 shows the effect of redox enzyme inhibitors on normoxic lung rate of H2O2 
release. Rotenone slightly decreased the detectable rate of H2O2 release (Figure 5.9 A) and 
antimycin A had no effect on the release rate of H2O2 (Figure 5.9 B). Figure 5.9 C shows that 
apocynin decreased the detected rate of H2O2 release by ~90%  which is consistent with the results 
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of the benchtop experiments, presumably due to apocynin’s H2O2 scavenging property. Figure 5.9 
D shows that DEM decreased the rate of H2O2 release by ~87%, though the expected result of 
DEM was that depleting glutathione (GSH) by DEM would increase the rate of H2O2 released into 
the vascular space since GSH is the main cytosolic H2O2 scavenger. 
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Figure 5.8 H2O2 release time course and spectra of reservoir or background samples during lung 
recirculation. The perfusate is KRB buffer containing 5% dextran, 50 µM AR. A: The H2O2 
concentration and its corresponding spectra of reservoir samples during lung recirculation in the 
presence of 5U HRP. 1 ml reservoir sample was taken every 5 min. B: The H2O2 concentration and its 
corresponding spectra of background sample in the presence of 5U horseradish peroxidase. The 
background sample was incubated at 37
o
C and measured every 5 min.  C: The H2O2 concentration and 
its corresponding spectra of reservoir samples during lung recirculation in the absence of 5U HRP. 1 ml 
reservoir sample was taken every 5 min. D: The H2O2 concentration and its corresponding spectra of 
background sample in the absence of 5U HRP. The background sample was incubated at 37
o
C and 
measured every 5 min. 
Figure 5.10 shows that hyperoxic ventilation (95% O2, 5% CO2) increased the detectable 
rate of H2O2 release by ~20% as compared to lungs ventilated with normoxic gas mixture (15% O2, 
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5% CO2, and balance N2). 
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Figure 5.9 H2O2 release rate during amplex red recirculation with inhibitors passage through normoxic 
lungs for control, in the presence of 20 µM rotenone, 10 µM antimycin A, 1 mM apocynin and 6 mM 
DEM respectively.  
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Figure 5.10 H2O2 release rate during amplex red recirculation with 95% O2 and 5% CO2 ventilation. 
Effect of Rat Exposure to 85% O2 on the Lung Rate of H2O2 Release 
 To investigate the effect of rat exposure to 85% O2 on the lung rate of H2O2 release, AR 
recirculation experiments were repeated for lungs from rats exposed to 85% O2 for 48 hours 
(initiation phase) or 7 days (adaptation phase). 
 Figure 5.11 shows that lung rates of H2O2 release from rats exposed to room air, 85% O2 
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for 48 hours or 7 days using the above AR-H2O2 assay with HRP. The activity of endogenous 
peroxidase in lungs exposed to room air, 85% O2 were estimated by AR-H2O2 recirculation assay 
without HRP (Figure 5.12). The results show that exposure to 85% O2 for 48 hours had no 
significant effect on the rate of H2O2 release in the absence or presence of HRP as compared to 
normoxic lungs, while exposure to 85% O2 for  7 days  decreased lung rate of H2O2 release by 35~ 
40% in the presence or absence of HRP (Table 5.4). Table 5.4 shows that the lung rates of H2O2 
release (nmol/min) normalized to lung dry weight (nmol/min/g) or perfused capillary surface area 
(nmol/min). Normalizing the rates to lung dry weight assumes that all the lung cells are 
contributing equally to the H2O2 released into the perfusate. On the other hand, normalizing the 
rates to perfused surface area assumes that the capillary endothelial cells are the main source of 
H2O2 released into the perfusate. For lungs of rats exposed to 85% O2 for 7 days, the rate of H2O2 
release per gram of dry lung weight was ~60% smaller than that for normoxic lungs, whereas the 
rates normalized to perfused capillary surface were not significantly different from that for 
normoxic lungs. 
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Figure 5.11 Lung H2O2 release rates from rat lungs during AR recirculation with HRP. A: Lung H2O2 
release rate during 50 µM AR recirculation in the presence of 5U HRP from rat exposed to room air 
(n=9), 85% O2 for 48 hours (n=6) and 7 days (n=4) respectively.  B: Lung H2O2 release rate in Figure A 
normalized to lung perfused surface area. Values are mean ± SE.  * Rates significantly different from 
the normoxic rate. 
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5.4 Discussion and Conclusions 
 In this study, the measurement of the efflux rate of CoQ1H2 during CoQ1 arterial infusion 
was used to determine how early following rat exposure to 85% O2 this decrease in complex I 
activity occurred. The results of this study reveal that rat exposure to 85% O2 for 24 hours, but not 
12 hours, decreased CoQ1H2 efflux rate during CoQ1 infusion. Quantitative analysis based on the 
mathematical model described in chapter 4 indicated a ~30% decrease in the capacity of complex I 
A
H
2
O
2
 e
ff
lu
x
 r
a
te
 (
n
m
o
l/
m
in
)
0
4
8
12
16
  normoxic                  48 h                  7d 
*
 
H
2
O
2
 e
ff
lu
x
 r
a
te
 (
n
m
o
l/
m
l)
0.0
0.2
0.4
0.6
0.8
B
   normoxic                 48 h                 7d  
Figure 5.12 H2O2 release rates from rat lungs during AR recirculation. A: Lung H2O2 release rate 
during 50 µM AR recirculation from rat exposed to room air (n=5), 85% O2 for 48 hours (n=4) and 7 
days (n=4) respectively.  B: Lung H2O2 release rate in Figure A normalized to lung perfused surface 
area. Values are mean ± SE.  * Rates significantly different from the normoxic rate. 
 
Table 5.4 H2O2 release rates from isolate rat lung during AR recirculation with or without HRP. The 
concentration of AR was 50 µM and the concentration of HRP was 5U. For AR+HRP recirculation, 
normoxic rats n=9; 85% 48 h rats n=6; 85% 7 days rats n=4. For AR recirculation, normoxic rats n=5; 
85% 48 h rats n=5; 85% 7 days rats n=4. Values are mean ± SE.  
*
 Significantly different from 
normoxic values. 
mediated CoQ1 reduction, and hence in complex I activity, in lungs from rats exposed to 85% O2 
for 24 hours as compared to normoxic lungs. Complex I activity in lung homogenates was also 
Rats AR+HRP recirculation AR recirculation 
 
 nmol/min nmol/ml nmol/min/g Nmol/min nmol/ml nmol/min/g 
Normoxic 13.2±0.9 0.56±0.03 59.8±3.9 10.9±0.93 0.48±0.04 49.5±4.1 
48 h 13.6±1.5 0.48±0.09 64.8±7.1 12.8±1.61 0.54±0.07 61.0±7.6 
7 d (n=7) 8.5±1.6* 0.68±0.10 23.0±4.3* 6.4±0.71* 0.53±0.07 17.3±1.9* 
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lower for lungs of rats exposed to 85% O2 for 24 hours. Previously, Bassett et al. showed that rats 
exposed to 100% O2 for 24 hours resulted in a NAD-linked but not FAD-linked decrease in ADP-
stimulated rate of respiration in lung homogenate (Bassett, Bowen & Reichenbaugh, 1992). Since 
NAD (NADH/NAD
+
) is the substrate for complex I while FAD (FADH2/FAD
+
) is the substrate for 
complex II, this result suggested a decrease in complex I activity, consistent with the results of this 
study. In summary, the decrease in lung complex I activity is detectable after 24-hour exposure to 
85% O2 and hence is a relatively early metabolic consequence of hyperoxic exposure. It occurs 
prior to the gross cellular and hemodynamic changes which are not detectable for at least 72 hours 
of hyperoxic exposure. Therefore, complex I could be an early index of the initiation phase of 
hyperoxic lung injury, and a target for imaging residue detection biomarkers such as 
125
I-
iodorotenone (VanBrocklin, Hanrahan & Enas, 2007). 
 Although rats exposed to 85% O2 for 12 hours had no significant effect on lung efflux rate 
of CoQ1H2 during CoQ1 infusion, it did result in a ~50% decrease in complex I activity in lung 
tissue homogenates as compared to normoxic lungs. One possible explanation for this apparent 
inconsistency could be due to the assumption that the lung activities of complex III and NQO1 
were not affected by exposure to 85% O2 for <48 hours. Cai et al. measured mRNA expression of 
complex III of lungs from premature newborn rats exposed to 85% O2 and found that the 
expression of complex III increased after 1 and 4 days exposure to 85% O2 but not for 2 or 3 days 
compared to the expression in lungs of normoxic rats (Cai, Chang & Li, 2008). This result 
suggested that the assumption that complex III activity was not affected by exposure to 85% O2 
for 12 hours because it was not affected by exposure to 85% O2 for 48 hours may not be true, and 
hence would need to be evaluated in the future. The activity of complex III could be evaluated 
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using lung infusion with DQH2 or CoQ1H2 which are the substrates of complex III. 
 In the present study, it is clear that there were no differences in complex IV activity of 
lung homogenates from rat exposure to 85% O2 for 24, or 48 hours compared to normoxic rats. 
However, the results regarding the effect of rat exposure to 85% O2 for 12 hours on complex IV 
activity in lung homogenates show a big variance, with 4 rats of  9 rats suggesting a ~50% 
decrease and other 5 rats suggesting no change as compared to normoxic lungs. Arab et al. (2010) 
demonstrated that a  ~40% decrease in complex IV activity occurred in cultured human 
cardiomyocytes after 3-hour exposure to hypoxia (95% N2/5% CO2) (Arab, Wang & Bausch, 
2010). This decrease in complex IV activity was reversible (Arab et al., 2010). Arab’s study 
suggests that complex IV could respond to a change in oxygen supply quickly and the adjustment 
of complex IV activity could be a way to adjust O2 consumption and further ATP synthesis. Raam 
et al. demonstrated that both complex III and complex IV were part of mitochondrial 
supercomplex and hence functionally associated (Van Raam et al., 2008). Thus, a decrease in 
complex IV activity in lungs of rats exposed to 85% O2 for 12 hours could slow down the flow of 
electron through complex III and hence decrease the capacity of complex III mediated CoQ1H2 
oxidation; or reversely, the decrease in complex IV activity could be a subsequential response of a 
decrease in complex III activity. This could explain why the decrease in complex I measured in 
lung homogenate of rats exposed to 85% O2 for 12 hours did not change the rate of CoQ1H2 efflux 
during CoQ1 infusion.  
 An important aspect of this study is the development of an assay for detecting the rate of 
H2O2 release from an isolated perfused rat lung. Using the developed AR assay, the rate of H2O2 
release from normoxic rat lungs in the absence or presence of HRP was 10 or 14 nmol/min, 
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respectively. This rate is relatively close to ~17 nmol/min/lung which is the sum of estimated 
H2O2 release rate from lung endothelium, epithelium and macrophages (Kinnula et al., 1991). 
Using ortho-phenylenediamine dihydrochloride (o-PD) as a probe of H2O2, Al-Medhi et al. 
estimated the rate of H2O2 release from an isolated perfused rat lungs was 3.8 nmol/min in the 
presence of 5U HRP (Al-Mehdi et al., 1997). This lower rate could be in part due to the difference 
in the experimental rats (300 g SD rats in this study V.S. 150 g SD rats in Al-Medhi’s study) and 
the difference in the efficiencies of the two H2O2 probes (AR V.S. o-PD).  
The AR-H2O2 assay requires the presence of a peroxidase. However, the results of the 
present study shows ~10 nmol/min H2O2 release during the recirculation of AR-containing 
perfusate in the absence of exogenous peroxidase (HRP). This result suggested the existence of 
endogenous peroxidase on the surface of the pulmonary capillary endothelium. This is consistent 
with the results of previous studies which demonstrated the presence of myeloperoxidase (MPO) 
on the endothelial surface which transmigrated from neutrophil cells to endothelial cells when 
intracellular adhesion molecule 1 (ICAM-1) were expressed on the endothelial surface (Hamada, 
Ikata & Katoh, 1996; Schuschke, Percival & Lominadze, 2002; Rhian, 2008; Heumüller et al., 
2008). This might explain the decrease in detectable rate of lung H2O2 release in the presence of 
DEM in the perfusate since Nathens et al. had demonstrated that DEM could inhibit the expression 
of ICAM-1 of endothelial cells (Nathens, Marshall & Watson, 1996) and hence inhibit the 
expression of MPO on the endothelial surface, which in turn would inhibit MPO-mediated AR-
H2O2 reaction. However previous studies on ICAM-1 expression were based on endothelial cells 
pre-exposure to DEM for 6 hours. A study whether 15-min pre-exposure to DEM on lung 
endothelial ICAM-1 expression has the similar effect is needed. 
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There are several cellular sources of H2O2, including NADPH oxidase, and mitochondrial 
complexes I and III. One way to evaluate the contribution of each of these sources to the measured 
rate of lung H2O2 release would be by manipulating the activities of these enzymes using 
metabolic inhibitors. Previous studies in isolated mitochondria, submitochondrial particles or cells 
demonstrated a 10- to 20-fold increase in the rate of ROS formation in the presence of AA as 
compared to that in the absence of AA (Ksenzenko, Konstantinov & Khomutov, 1983; Turrens & 
Boveris, 1997; Hansford, Hogue & Mildaziene, 1997; Starkov & Fiskum, 2001; Budinger, Tso & 
McClintock, 2002; Turrens, 2003; Chen et al., 2003; Li et al., 2003; Drechsel & Patel, 2009). On 
the other hand, the effect of rotenone on ROS generation is somewhat complicated. In 
submitochondrial particles, a rotenone-induced ROS production is observed (Turrens & Boveris, 
1980; Krishnamcorthy & Hinkle, 1988; Hansford et al., 1997; Kwong & Sohal, 1998). In intact 
mitochondria, rotenone-induced ROS production requires a very high degree of reduction of redox 
carrier’s upstream of the rotenone binding site (Kushnareva, Murphy & Andreyev, 2002; Li et al., 
2003; Andreyev et al., 2005). A few studies observed a decrease in ROS formation with rotenone 
treatment in sheep pulmonary microvascular endothelial cell suspensions (Sander et al., 1993). 
However, the results of the present study show that inhibiting complex I by rotenone or complex 
III by antimycin A had no effect on the lung rate of H2O2 release. This result suggests that the 
detected H2O2 release might not originate in mitochondria. The decrease in the rate of H2O2 
release by the GSH depleter DEM is opposite to the expected results and may be due to its effect 
on cellular surface adhesive molecules. Apocynin, a NADPH oxidase inhibitor, decreased the rate 
of H2O2 release by ~90%, but presumably due to its H2O2 scavenging property instead of its effect 
on NADPH oxidase. Hence, the effect of apocynin is not able to define the role of NADPH 
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oxidase on lung H2O2 release. The insensitivity of the lung rate of H2O2 release measured using 
the AR assay to inhibit complex I or III could be due to the insensitivity of this assay to 
intracellular sources of H2O2. Tan et al. pointed out that the cell impermeable AR was not a 
sensitive probe for intracellular H2O2 (Tan & Berridge, 2010). The insensitivity of AR to 
intracellular H2O2 might be due to transmembrane disequilibrium of H2O2 or to the magnitude and 
kinetics of H2O2 cellular gradients that limits its diffusion in and out of cells (Tan & Berridge, 
2010). Alternatively, there are multiple cellular antioxidant mechanisms (e. g. catalase, glutathione 
peroxidase) and other peroxide sinks that could scavenge intracellular generated H2O2 and hence 
prevent it from reaching AR in the vascular space (Tan & Berridge, 2010). Therefore, AR 
recirculation assay may be a sensitive method to detect lung H2O2 release but not a sensitive 
method to estimate intracellular H2O2 formation.  
The results of this study show that rat exposure to 85% O2 for 48 hours had no effect on 
the lung rate of H2O2 release, though lung complex I activity decreased by ~50% compared to 
normoxic rats. On the other hand, rat exposure to 85% O2 for 7 days (hyper-85) decreased the lung 
rate of H2O2 release by ~50%. As stated in chapter 4, hyper-85 lungs decreased perfused lung 
capillary surface area by ~50% and increased lung dry weight by ~70% as compared to normoxic 
lungs. If the source of H2O2 detected using this AR recirculation assay is the capillary endothelial 
cells, then the rate of H2O2 release would need to be normalized to the capillary surface area. If all 
lung tissue cells contribute to lung rate of H2O2 release, then normalizing the rate to lung dry 
weight would be appropriate. Table 5.4 shows that normalizing to perfused capillary surface area 
dissipates the difference between normoxic and hyper-85 lungs, while normalizing to lung dry 
weight augments the difference in the rate of H2O2 release between hyper-85 and normoxic lungs. 
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Additionally, the decrease in detectable lung rate of H2O2 release caused by DEM also suggests 
that endothelial surface played a role in the detectable H2O2 release.  
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CHAPTER 6. DIFFERENTIAL RESPONSES OF TARGETED LUNG REDOX 
ENZYMES TO RATS EXPOSURE TO 60% OR 85% O2 
6.1 Introduction 
As stated in chapter 1.2, the rat model of lung O2 toxicity is unique in that when adult rats 
are exposed to an adaptive 85% O2 environment for 5-7 days, they acquire tolerance to the 
otherwise lethal effects of 100% O2, in that if transferred to a 100% O2 environment they survive 
for prolonged period (Crapo et al., 1980; Sjostorm & Crapo, 1983; Frank, Iqbal & Hass, 1989; 
Coursin, Cihla & Will, 1987; Audi et al., 2005). Conversely, rats exposed to 60% O2 for 7 days 
become more susceptible to 100% O2 as evidenced by a decrease in their subsequent survival time 
in 100% O2 environment (Coursin et al., 1987; Hayatdavoudi et al., 1981). Elucidating the factors 
that contribute to this rat tolerance of or susceptibility to 100% O2 could further our understanding 
of the pathogenesis of lung O2 toxicity, and may lead to the identification of potential therapeutic 
targets for protecting lung tissue from the toxic effects of high O2 (Audi et al., 2005; Crapo et al., 
1974, 1980; Frank et al.,1989; Sjostrom et al., 1983).  
Using indicator dilution methods and mathematical modeling developed in our studies, we 
have demonstrated that the redox active quinone compound duroquinone (DQ) is reduced to 
durohydroquinone (DQH2) and DQH2 is oxidized to DQ on passage through the pulmonary 
circulation of the isolated perfused rat lung (Audi et al., 2003, 2005). Based on inhibitor studies, 
NAD(P)H:quinone oxidoreductase 1 (NQO1) was implicated as the dominant DQ reductase and 
mitochondrial complex III as the dominant DQH2 oxidase, and the capacities of the lung to reduce 
DQ to DQH2 and oxidize DQH2 to DQ were shown to be measures of lung NQO1 activity and 
complex III activity, respectively ( Audi et al., 2003, 2005).  
The results of chapter 4 show that rat exposure to 85% O2 for 7 days (hyper-85) increased 
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NQO1 activity by ~200% and complex III activity by ~180% estimated from changes in the 
capacity of NQO1-mediated DQ reduction and complex III mediated DQH2 oxidation, 
respectively, on passage through the pulmonary circulation. Furthermore, the results of chapter 4 
showed mitochondrial complex IV activity in lung homogenates was ~90% higher for hyper-85 
lungs compared to normoxic lungs. The objective of the current study was to evaluate the effects 
of a 7-day exposure of rats to 60% O2 (hyper-60) on NQO1 and mitochondrial complexes III in 
the intact lung using duroquinone (DQ) and its hydroquinone (DQH2), respectively, as indicator 
dilution probes. Demonstration that the activity of a particular redox enzyme is differentially 
altered by exposure to 60% O2 and 85% O2 would suggest its role in the development of the 
observed susceptibility or tolerance to 100% O2. 
6.2 Materials and Methods 
6.2.1 Hyperoxic Exposure 
 Rats were exposed to 60% O2 for 7 days (hyper-60) using the exposure chamber and 
protocol described in chapter 4.1.1. 
6.2.2 Lung Preparation 
The isolated perfused lung preparation and the lung ventilation-perfusion system are 
described in chapter 4.1.2. 
6.2.3 Pulse Infusion Experimental Protocols 
 To determine the DQ reducing capacity of the lung, four 135-second long sequential 
arterial pulse infusions at DQ concentrations of 50, 100, 200, and 400 µM were carried out as 
described in chapter 4.2.3. 
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 To determine the capacity of NQO1-mediated DQ reduction on passage through the 
pulmonary circulation, each lung was perfused for 5 min with perfusate containing antimycin A 
(10 µM). This was followed by four successive DQ pulse infusions, with the inhibitor present 
throughout the infusion protocol. 
 To evaluate the capacity of complex III mediated DQH2 oxidation on passage through the 
pulmonary circulation, each lung was perfused for 5 min with perfusate containing dicumarol (400 
µM) or dicumarol plus rotenone (20 µM). This was followed by four 135-second sequential DQH2 
infusions as described in chapter 4.2.3. 
 The perfused lung surface area was determined using the ACE substrate FAPGG as 
described in chapter 4.2.6. 
The concentrations of DQ and DQH2 in the venous effluent samples were determined as 
described in chapter 4.2.4. The steady state efflux rates of DQH2 or DQ from the lung during DQ 
or DQH2 arterial infusion were calculated as the product of the perfusate flow (10 ml/min) and the 
steady state venous effluent DQH2 or DQ concentrations, respectively. The log mean DQH2 or DQ 
concentration were determined as described in chapter 4.2.4.  
6.2.4 Tissue Assay 
i. Lung Homogenate NQO1 Activity & Immunoblot Analysis of NQO1 
 The measurements of lung homogenate NQO1 activity and lung mitochondrial complexes 
I and IV activities were carried out as previously described in chapter 4.2.6. 
 
ii. Total Glutathione Content 
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The lungs were washed free of blood with buffer containing 10 mM HEPES, 5 mM 
glucose, and 5% dextran (~67 kDa), pH 7.4. The lungs were then removed from the perfusion 
system, dissected free from connective tissue, and weighed. A portion of the lung was dried for 
determination of total lung dry weight and lung wet-to-dry wt ratio. The remaining tissue was 
placed into 10 volumes (per lung wet weight) of 4 
o
C sulfosalicylic acid (5%), minced and 
homogenized as above. The homogenate was centrifuged (10,000 × g) at 4 oC for 20 min, and the 
supernatant was used to determine total lung glutathione content as described by Owens and 
Belcher (Owens & Belcher, 1965) and later modified by Tietze (Tietze, 1969) and Griffith 
(Griffith, 1980). 
6.3 Results 
6.3.1 Rat Body Weight, Lung Wet/Dry Weight, Perfused Surface Area, and Arterial Blood 
Hematocrit 
Rats lost ~14% of their pre-exposure body weights (Figure 6.1) over the 7-day 85% O2 
exposure period (Crapo et al., 1980; Ramakrishna et al., 2010). Most of this weight loss occurred 
between days 2 and 6. On the other hand, rats exposed to 60% O2 gained body weight steadily 
over the 7-day exposure period at a rate that is virtually the same as age-matched normoxic rats 
(Coursin et al., 1987).  
 Rat exposure to 85% O2 for 7 days (hyper-85) increased lung wet weight by 87%, with no 
effect on wet/dry weight ratio as compared to normoxic lungs (Table 6.1). The lack of a difference 
in wet/dry weight ratios between normoxic and hyper-85 lungs (Table 6.1) is consistent with the 
finding of Crapo et al. that the increase in wet weight was due to increased tissue mass instead of 
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edema (Crapo et al., 1980).  Hyper-60 lung wet weights or wet/dry weight ratios were not different 
from normoxic lungs (Table 6.1) (Hayatdavoudi et al., 1981).   
 
Figure 6.1 Rat body weights normalized to pre-
exposure body weights at different time points during 
the 7-day exposure period to room air (normoxic), 
60% O2 (hyper-60), or 85% O2 (hyper-85). Values are 
mean ± SE (n = 6, 33 and 34 for normoxic, hyper-60, 
and hyper-85 rats, respectively). 
*,  #, &
Indicates 
normalized weights at a given time are significantly 
different from normalized weights at the previous 
time point for normoxic, hyper-60, or hyper-85 rats, 
respectively. 
   
 
Table 6.1 Rat information of normoxic rats, hyper-85 rats and hyper-60 rats. PS (permeability surface 
area product), measure of ACE mediated FAPGG hydrolysis and an index of perfused capillary surface 
area. For normoxic lungs, n = 38, 38, 31, 19, and 27 for body wt, lung wet wt, wet/dry ratio, PS, and 
Hct, respectively, where 38 is the total number of normoxic rats studied. For hyper-60 lungs, n =38, 38, 
29, 18, and 23 for pre-exposure body wt, lung wet wt, wet/dry ratio, PS, and Hct, respectively, where 
38 is the total number of hyper-60 rats studied. For hyper-85 lungs, n = 41, 41, 28, 20, and 27 for pre-
exposure body weight (B.W.), lung wet weight (W.W), lung wet/dry ratio (W/D ratio), PS 
(permeability-surface area product), and Hct (hematocrit), respectively, where 41 is the total number of 
hyper-85 rats studied. Values are mean ± SE. *: significantly different from normoxic values; *&: 
significantly different from normoxic and hyper-60 values, respectively. 
Exposure to 85% O2 for 7 days decreased PS (ml/min), an index of perfused capillary 
endothelial surface area, by 56% as compared to normoxic lungs (Table 6.1). This is consistent 
with the 50% decrease in capillary volume and endothelial surface area measured 
morphometrically (Crapo et al., 1980, Crapo 1974, Ramakrishna et al., 2010). The PS values for 
 B.W. (g) W. W. (g) W/D ratio PS (ml/min) Hct (%) 
Normoxic 316 ± 4 1.22 ± 0.03 5.56 ± 0.09 24.7 ± 1.7 43.5 ± 0.4 
Hyper-60 302 ± 2 1.31 ± 0.02 5.45 ± 0.05 25.1 ± 1.4 33.5 ± 0.6* 
Hyper-85 311 ± 2 2.29 ± 0.08* 
&
 5.72 ± 0.08 10.7 ± 0.8* 
&
 50.1 ± 0.8* 
&
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hyper-60 and normoxic lungs were not different. This observation supports presentation of 
morphometric measures of capillary volume and endothelial surface area in hyper-60 lungs 
(Hayatdavoudi et al., 1981). 
Rat exposure to 85% O2 and 60% O2 had a differential effect on aortic blood hematocrit 
(Table 6.1). Exposure to 85% O2 increased hematocrit by 16% while exposure to 60% O2 
decreased it by 12% as compared to normoxic lungs (Crapo et al., 1980). There was no significant 
difference in the isolated lung perfusion pressure at 10 ml/min among the three groups of lungs 
(Ramakrishna et al., 2010). 
6.3.2 Lung Infusion Experimental Results 
The capacities of hyper-60 and hyper-85 lungs to reduce DQ to DQH2 during DQ infusion 
were both higher than that of normoxic lungs (Figure 6.2). For both O2 levels, the steady state 
DQH2 efflux rates during the arterial infusion of DQ at the two highest concentrations were on 
average 37% higher than in normoxic lungs. For all three lung groups, lung treatment with 
dicumarol (NQO1 inhibitor) decreased the rate of DQH2 efflux by > 95% during the infusion of 
DQ at the highest concentration (data not shown). This is consistent with NQO1 being the 
dominant reductase of DQ on passage through the pulmonary circulation of normoxic, hyper-60, 
and hyper-85 lungs (Audi et al., 2004, 2005). 
To evaluate the capacity of the lung to oxidize DQH2, we measured the steady state rate 
of DQ efflux during DQH2 infusion in the presence of dicumarol to inhibit DQ reduction (Figure 
6.3). For hyper-60 and hyper-85 lungs, the steady state rates of DQ efflux during DQH2 infusion at 
the two highest concentrations were 40% higher than in normoxic lungs (Figure 6.3). For all three 
groups of lungs, treatment with antimycin A (complex III inhibitor) decreased the rate of DQ 
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efflux to nearly zero during DQH2 infusion at the highest concentration (data not shown). This is 
consistent with DQH2 oxidation on passage through normoxic and hyperoxic lungs occurring 
predominately via the hydroquinone oxidase-cytochrome c reductase activity of complex III (Audi 
et al., 2004, 2005; Merker, Audi & Bongard, 2006).  
 
Figure 6.2 The relationship between the steady 
state rate of DQH2 efflux and the log mean DQ 
concentrations , for normoxic lungs (n = 4), 
hyper-85 lungs (n = 5), and hyper-60 lungs (n = 
5). Values are mean ± SE. The solid lines are 
model fits to the mean values of the data. * 
Hyper-60 rates significantly different from the 
normoxic rates at the same log mean DQ 
concentrations. # Hyper-85 rates significantly 
different from the normoxic rates at the same log 
mean DQ concentrations. 
 
Figure 6.3 The relationship between the steady 
state rate of DQ efflux and the log mean  
DQH2 concentrations , which are the effective 
intravascular DQH2 concentrations during 
DQH2 arterial infusion in the presence of 
dicumarol (DIC, 400 µM), for normoxic lungs 
(n = 6), hyper-85 lungs (n = 6), and hyper-60 
lungs (n = 4). Values are mean ± SE. The solid 
lines are model fits to the mean values of the 
data. * Hyper-60 rates significantly different 
from the normoxic rates at the same log mean 
DQH2 concentrations. # Hyper-85 rates 
significantly different from the normoxic rates 
at the log mean DQH2 concentrations. 
 
To evaluate the effect of rat exposure to 60% O2 or 85% O2 on NQO1 mediated DQ 
reduction, the rate of DQH2 efflux during DQ infusion was measured in the presence of antimycin 
A to inhibit DQH2 oxidation (Figure 6.4). As expected, the rates of DQH2 efflux in the presence of 
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antimycin A were higher than those measured in the absence of antimycin A (Figure 6.2) over the 
range of infused DQ concentrations. Moreover, both O2 levels increased the rate of DQH2 efflux 
during DQ infusion at the two highest concentrations in the presence of antimycin A as compared 
to normoxic lungs, but the increase was larger for the hyper-85 lungs (52%) than for the hyper-60 
lungs (23%) (Figure 6.4).   
 
Figure 6.4 The relationship between the steady 
state rate of DQH2 efflux and the log mean  DQ 
concentrations, which are the effective 
intravascular DQ concentrations during DQ arterial 
infusion in the presence of antimycin A (AA, 10 
µM), for normoxic lungs (n = 5), hyper-85 lungs (n 
= 5), and hyper-60 lungs (n = 5). Values are mean ± 
SE. The solid lines are model fits to the mean 
values of the data.  
*
 Hyper-60 rates significantly 
different from the normoxic rates at the same log 
mean DQ concentrations. 
#
 Hyper-85 rates 
significantly different from the normoxic rates at 
the same log mean DQ concentrations. 
To evaluate the effect of rat exposure to 85% O2 or 60% O2 on mitochondrial complex III 
mediated DQH2 oxidation, the rate of DQ efflux during DQH2 infusion was measured in the 
presence of dicumarol and rotenone. Again, rotenone was added to minimize competition between 
DQH2 and reduced endogenous coenzyme Q9 hydroquinone (CoQ9H2) for oxidation via complex 
III. Figure 6.5 shows that for hyper-85 lungs, the steady state rates of DQ efflux during DQH2 
infusion at the two highest concentrations in the presence of dicumarol plus rotenone were about 
30% higher than those in normoxic lungs. For all three groups of lungs, the rate of DQ efflux 
during DQH2 infusion at the highest concentration in the presence of antimycin A along with 
dicumarol and rotenone was virtually zero. This further supports that complex III is the dominant 
site for DQH2 oxidation on passage through the pulmonary circulation of all three groups of lungs.  
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Figure 6.5 The relationship between the steady state 
rate of DQ efflux and the log mean  DQH2 
concentrations, which are the effective intravascular 
DQH2 concentrations during DQH2 arterial infusion 
in the presence of dicumarol (DIC, 400 µM) plus 
rotenone (ROT, 20 µM), for normoxic lungs (n = 4), 
hyper-85 lungs (n = 4), and hyper-60 lungs (n = 4). 
Values are mean±SE. The solid lines are model fits 
to the mean values of the data. & Hyper-85 rates 
significantly different from the normoxic rates at the 
same log mean DQH2 concentrations. 
 
 
6.3.3 Tissue Assay Results 
Table 6.2 shows that rat exposure to 85% O2 increased NOQ1 homogenate activity per 
lung by 72%, but had no effect on NQO1 activity per mg of protein. Exposure to 60% O2 on the 
other hand had no effect on NQO1 activity in homogenate per lung or per mg of protein.  
 
 
 
 
Table 6.2  Lung homogenate NQO1 activity of normoxic, hyper-85, hyper-60 rats. Values are mean ± 
SE. n = 7, 10, and 7 for normoxic, hyper-60, and hyper-85 lungs, respectively. *& indicate value 
significantly different from the corresponding normoxic and hyper-60 values, respectively. 
We also measured the activities of mitochondrial complexes I and IV in lung tissue 
homogenates. Table 6.3 shows that mitochondrial complex I activities normalized to protein were 
about 50% lower in P2 fractions derived from hyper-85 and hyper-60 lungs than normoxic lungs. 
Complex IV activity per mg of protein increased in only hyper-85 lung homogenates by 90% as 
compared to normoxic lungs (Table 6.3).  
 Homogenate NQO1 Activity 
(µmol/min/lung) 
Homogenate NQO1 Activity 
(nmol/min/mg protein) 
Normoxic 26.5 ± 1.7 670 ± 80 
Hyper-60 34.8 ± 2.0 737 ± 63 
Hyper-85     45.6 ± 4.7 
*,&
 538 ± 43 
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Table 6.3 Mitochondrial complexes I and IV activities measured in mitochondrial fractions. Values are 
mean ± SE. For complexes I and IV activities, n = 5, 5, and 7 for normoxic, hyper-60, and hyper-85 
lungs, respectively. * Indicates value significantly different from the corresponding normoxic value. 
Table 6.4 shows that total glutathione content (oxidized plus reduced glutathione) per 
lung and per gram of dry lung weight increased by 101% and 20%, respectively, in hyper-85 lungs 
only.  
 
 
 
 
 
 
Table 6.4 Total lung glutathione (GSH+GSSG) content. Reduced (GSH) and oxidized (GSSG) 
glutathione. Values are mean ± SE. n = 8, 5, and 7 for normoxic, hyper-60, and hyper-85 lungs, 
respectively. *& indicate value significantly different from the corresponding normoxic and hyper-60 
values, respectively. 
 Western blots were carried out to estimate the expression of NQO1 protein in normoxic or 
hyper-85 lungs. There was an ~200% increase in NQO1 protein density in hyper-85 lungs and 
~300% increase in hyper-60 lung (Figure 6.6). The quantitative results are listed in Table 6.5. 
 
Figure 6.6 Western blots of NQO1. 1
st
 column: normoxic rats, n=10; 2
nd
 column: rats exposed to 60% 
 Complex I activity 
(nmol/min/mg protein)  
Complex IV activity 
(nmol/min/mg protein) 
Normoxic 13.2 ± 2.3 232 ± 16 
Hyper-60      6.5 ± 0.8 
*
 202 ± 46 
Hyper-85      6.8 ± 1.2
*
    439 ± 51 
*
 
  (GSH + GSSG) 
(µmol/lung) 
(GSH + GSSG) 
(µmol/ g dry wt ) 
Normoxic 2.34 ±  0.17 10.23 ± 0.55 
Hyper-60 3.09 ± 0.14 11.96 ± 0.77 
Hyper-85     4.70 ± 0.39 
*&
   12.21 ± 0.47 
*
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O2 for 7 days, n=10; 3
rd
 column: rats exposed to 85% O2 for 7 days, n=12. 
 
 Normoxic Hyper-60 Hyper-85 
NQO1 Band Intensity (%) 100 394±91* 298±85 * 
Table 6.5 NQO1 band intensity of lung homogenate from normoxic rats (n=10), hyper-60 rats (n=10) 
and hyper-85 rats (n=12). *: significant different from the value of normoxic rats.  
6.4 Kinetic Analysis of DQ/DQH2 Pulse Infusion Data 
The data in Figures 6.2-6.5 are the net result of  a) DQ and DQH2 interactions with 
competing nonlinear tissue redox processes, b) DQ and DQH2 interactions with protein (i.e., BSA) 
in the vascular space, and c) capillary perfusion kinematics (i.e.,  a heterogeneous distribution, 
hc(t), of capillary transit times). Thus, for quantitative interpretation of the data in Figures 6.2-6.5 
we utilized a kinetic model that accounts for DQ and DQH2 tissue and vascular interactions as 
well as the distribution of capillary transit times (Audi et al., 2004, 2005, 2008). The model used 
to estimate parameters descriptive of the activities of NQO1 and complex III in the intact lung 
from the data in Figure 6.2-6.5 has been described in chapter 4.4.2. 
 The governing differential equations of the single capillary element model are the basis of 
the whole organ model which accounts for the distribution of pulmonary capillary transit times, 
hc(t). Previously, we determined hc(t) for normoxic rat lungs and hyper-85 lungs (Ramakrishna et 
al., 2010). These values were used in the kinetic analysis of the normoxic and hyper-85 lung data 
(Chapter 4). For hyper-60 lungs, hc(t) was assumed to be the same as that determined for 
normoxic lungs. This is based on results in Table 6.1 that show exposure to 60% O2 for 7 days had 
no effect on perfused capillary surface area (PS), and on previous results that showed rat exposure 
to 60% O2 for 7 days had no significant effect on morphometrically-measured lung capillary 
endothelial surface area and capillary volume (Hayatdavoudi et al., 1981).  
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Estimation of Model Parameters: 
 The unknown model parameters under steady-state conditions are Vmax1, Km1a, Vmax2, 
Km2a, and kox in Equation 4.7~4.10. The values of these parameters for each of the three groups of 
lungs were estimated using the following approach. First, the values of Vmax1 and Km1a, parameters 
descriptive of NQO1-mediated DQ reduction, were determined. This was done by fitting the 
steady-state solution of the organ model to the steady state rates of DQH2 efflux during DQ 
infusion in the presence of antimycin A (Figure 6.4), which corresponded to setting Vmax2 to zero 
in Equations (E4.3-4.4). The estimated values of these model parameters are given in Table 6.6. 
Rat exposure to 85% O2 for 7 days increased Vmax1 by ~200%. The estimated values of Vmax1 for 
hyper-60 lungs tended to be higher than those for normoxic lungs, but the mean difference was not 
significant (one way ANOVA). For all three groups of lungs, the estimated value of Km1a was 1 
µM, which was the lower bound set for this parameter in the least squares fitting procedure. Km1a 
is an intrinsic property of the enzyme and hence would be expected to be the same for all three 
groups of lungs.  
 Vmax1 
(µmol/min) 
Vmax1 
(µmol/min/g dry wt) 
Kma1 
(µM) 
Normoxic  1.38± 0.07              6.4 ± 0.3     1.0 
Hyper-60 1.84 ± 0.06              7.8 ± 0.5     1.0 
Hyper-85 4.11 ± 0.39
 *&
            10.8 ± 0.7 
*&
     1.0 
Table 6.6 Values of model parameters descriptive of NQO1-mediated DQ reduction in normoxic and 
hyperoxic lungs estimated from the steady-state DQH2 efflux rates during DQ infusion in the presence 
of antimycin A. Values are mean ± SE. n = 5 for all three groups. Vmax1 is the maximum DQ reduction 
rate; Kma1 is the apparent Michaelis-Menten constant. *& significantly different from normoxic and 
hyper-60 values, respectively. 
 For a given lung, parameters descriptive of complex III-mediated DQH2 oxidation (Vmax2 
and Km2a) were estimated by fitting the steady state solution of the organ model to the steady state 
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rates of DQ efflux during DQH2 infusion in the presence of dicumarol and rotenone (Figure 6.5), 
with Vmax1 was set to zero in Equations (E4.3-4.4) to account for the presence of dicumarol 
(NQO1 inhibitor). Results in Table 6.7 show that exposure to 85% O2 increased Vmax2 by ~180%, 
with no significant effect on Km2a, compared to normoxic lungs. The estimated values of Vmax2 and 
Km2a for hyper-60 lungs were not different from those estimated for normoxic lungs. 
 Vmax2 
(µmol/min) 
Vmax2 
(µmol/min/g dry wt) 
Kma2 
(µM) 
Normoxic  1.67 ± 0.10     8.7 ± 0.7     42  ± 2 
Hyper-60 2.07 ± 0.09     8.8 ± 0.5     38  ± 6 
Hyper-85 4.65 ± 0.36
 *&
   13.6 ± 1.8
 *&
     36  ± 11 
Table 6.7 Values of model parameters descriptive of complex III mediated DQH2 oxidation in 
normoxic and hyperoxic lungs estimated from the steady-state DQ efflux rates during DQH2 infusion in 
the presence of dicumarol plus rotenone. Values are mean ± SE. n = 4 for all three groups. Vmax2 is the 
maximum DQH2 oxidation rate; Kma2 is the apparent Michaelis-Menten constant. *& significantly 
different from normoxic and hyper-60 values, respectively. 
 The value of kox was estimated by fitting the solution of the steady state organ model, 
with Vmax1 set to zero in Equations (E4.5-4.6), to the steady state rates of DQH2 efflux during DQ 
infusion in the presence of dicumarol (Figure 6.3). Table 6.8 shows that rat exposure to 60% O2 or 
85% O2 for 7 days increased the estimated value of kox by ~70% and ~140%, respectively, as 
compared to normoxic lungs. 
 
 
 
 
 
 
Table 6.8 Parameters descriptive of DQH2 oxidation capacity. Values are mean ± SE. n = 6, 4 and 6 for 
normoxic hyper-60 and hyper-85 lungs, respectively. kox is rate of DQH2 oxidation on passage through 
the pulmonary circulation. *
&, #
 significantly different from normoxic, hyper-60, and hyper-85 values, 
 kox 
(ml/min) 
kox 
 (ml/min/g dry wt) 
Normoxic  6.38  ±  0.60 27.6  ± 2.9 
Hyper-60 10.84 ± 1.25 
*
    43.1 ± 4.0 
*#
 
Hyper-85 15.16 ± 1.58 
*&
 35.0 ±  8.4 
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respectively. 
 A second estimate of the values of Vmax1 and Km1a for normoxic and hyperoxic lungs was 
obtained by fitting the steady state organ model solution to the steady state rates of DOH2 efflux 
during DQ infusion in the absence of inhibitors (Figure 6.2), with kox in Equations (E4.5-4.6) set 
to the mean values in Table 6.8. The estimated values of Vmax1 for hyper-60 and hyper-85 lungs 
were ~80% and 140% higher than that estimated for normoxic lungs, respectively (Table 6.9).  
 
 
 
 
 
 
Table 6.9 Values of model parameters descriptive of NQO1-mediated DQ reduction in normoxic and 
hyperoxic lungs estimated from the steady-state DQH2 efflux rates during DQ infusion. Values are 
mean ± SE. n = 4, 5 and 5 for normoxic hyper-60 and hyper-85 lungs, respectively. Vmax1 is the 
maximum DQ reduction rate; Kma1 is the apparent Michaelis-Menten constant. The DQH2 oxidation 
rate, kox, was set to the mean value in Table 6.6. *
&, #
 significantly different from normoxic, hyper-60, 
and hyper-85 values, respectively. 
 For normoxic and hyper-85 lungs, the values of Vmax1 in Table 6.9 vs. Table 6.6, i.e. 
estimated from the steady state rates of DQH2 efflux during DQ infusion in the absence or 
presence, respectively, of antimycin A were not different. This is consistent with the hypothesis 
that the dominant effect of antimycin A is on complex III- mediated DQH2 oxidation. However, 
for hyper-60 lungs, the estimated values of Vmax1 were statistically different for the two 
approaches.  In the discussion below, we speculate on possible reasons for this difference. 
6.5 Discussion and Conclusions 
 The results of the present study demonstrate that rat exposure to 85% O2 or 60% O2 for 7 
days increases the capacity of the lung to reduce DQ to DQH2 by 37%. Inhibitor studies and 
 Vmax1 
(µmol/min) 
Vmax1 
(µmol/min/g dry wt) 
Kma1 
(µM) 
Normoxic  1.46 ± 0.10 7.2 ± 0.8 4.4 ± 1.4 
Hyper-60 2.64 ± 0.08
*
 11.8 ± 0.5
*
  12.5 ± 2.1
*#
 
Hyper-85     3.52 ± 0.12
*&
 10.1 ± 0.6
*
 6.4 ± 1.6 
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kinetic analysis revealed that for hyper-85 lungs this increase can be accounted for by a 140% 
increase in the capacity (Vmax1) of NOQ1 mediated DQ reduction and a 138% increase in the rate 
(kox) of DQH2 oxidation on passage through the pulmonary circulation. For hyper-60 lungs, the 
37% increase in the rate of DQH2 efflux during DQ infusion can be accounted for by an 80% and 
70% increase in Vmax1 and kox, respectively. Moreover, kinetic analysis revealed that the capacity 
(Vmax2) of complex III mediated DQH2 oxidation increased by ~180% in hyper-85 lungs, with no 
change in hyper-60 lungs.  
In addition to increasing Vmax1, Vmax2, and kox, rat exposure to 85% O2 for 7 days 
increased lung dry weight (Table 6.1), presumably due to a large increase in the number of 
interstitial cells (Crapo et al., 1974, 1980). This brought into question whether the estimated 
increase in these extensive kinetic parameters was simply the result of an increase in tissue mass 
(i.e., more cells). As shown in Tables 6.6 and 6.8, the increase in the dry weight of hyper-85 lungs 
cannot account for all of the increase in the values of Vmax1 and Vmax2 since the values of Vmax1 and 
Vmax2 per gram of dry lung are respectively 40% and 56% higher than corresponding values for 
normoxic lungs. However, for hyper-85 lungs the increase in kox may be accounted for by the 
increase in dry lung weight (Table 6.8). The above results suggest that rat exposure to 85% O2 for 
7 days induced an increase of 40% and 56% in the lung activities of NQO1 and complex III per 
gram of dry lung weight, respectively.  
 Normalizing the above extensive parameters to lung dry weight assumes that all lung 
cells are accessible to DQ and DQH2 on their passage through the pulmonary circulation. This 
assumption is based on the amphipathic nature of these redox active quinone compounds, which 
have high octanol:water partition coefficients along with significant water solubility (Audi et al., 
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2004, 2005, 2008; Merker 2004, 2006). As a result, these compounds rapidly equilibrate between 
blood and tissue during passage through the pulmonary capillary bed (Audi et al., 2004, 2005, 
2008).   
 As described above, for normoxic and hyper-85 lungs, the estimates of Vmax1 obtained 
using two independent data sets, i.e. DQH2 efflux rates during DQ infusion in the absence or 
presence of antimycin A, are not significantly different (Tables 6.6 and 6.9). However, for hyper-
60 lungs the difference in the estimated values of Vmax1 obtained from the two data sets is 42%. 
One possible reason for this difference might be that treatment of hyper-60 lungs with antimycin A 
not only inhibited complex III mediated DQH2 oxidation, but also partially inhibited NQO1 
mediated DQ reduction or other DQ reductase(s) (Von & Bohrer, 1975). In addition to inhibiting 
DQH2 oxidation, antimycin A would be expected to suppress ATP production via oxidative 
phosphorylation. This impairment to oxidative ATP production could stimulate anaerobic 
glycolysis (Ahmad, White & Chang, 2001; Allen, Guo & White, 1998; Allen & White, 1998a; 
Schoonen, Wanamarta & Moorsel, 1990). This in turn would divert glucose-6-phosphate from the 
pentose phosphate pathway, the main source of NADPH for NOQ1 (Bongard et al., 2009). 
Although isolated NQO1 can utilize either NADH or NADPH as a reducing cofactor (Ross, Kepa 
& Winski, 2000),  Bongard et al. (Bongard et al., 2009) demonstrated that NADPH is the 
endogenous NQO1 electron donor in cultured bovine pulmonary arterial endothelial cells. This 
suggests that for hyper-60 lungs the rate of NAPDH production in the presence of antimycin A 
may not be sufficient to maintain the maximum capacity of NQO1 for DQ reduction that is 
measurable in the absence of antimycin A (Figures 6.2 and 6.4). This explanation is consistent 
with previous studies which demonstrated that rat exposure to 85% O2 for 7 days, but not 60% O2 
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increased lung glucose-6-phosphate dehydrogenase and hexokinase activities as compared to 
normoxic lungs (Table 6.9) (Allen 1998, Hayatdavoudi et al., 1981). Glucose-6-phosphate is the 
substrate for the pentose phosphate pathway and hexokinase catalyzes the phosphorylation of 
intracellular glucose to glucose-6-phosphate, an important step for the cellular uptake of glucose. 
In addition, exposure to 85% O2, but not 60% O2 increased total glutathione content per lung and 
per gram of dry lung weight as compared to normoxic lungs (Table 6.4). 
 Figure 6.8 shows high correlation between NQO1 homogenate activity and the capacity 
(Vmax1) of NQO1 mediated DQ reduction in normoxic, hyper-60, and hyper-85 lungs. However, 
the increase in Vmax1 is larger than the increase in NQO1 homogenate activity in hyper-60 and 
hyper-85 lungs. One possible reason for this difference may be that hyperoxia-induced changes in 
key aspects of the intact lung environment that may regulate NQO1 activity (e.g., availability of 
electron donors and their accessibility to the enzyme) are not preserved in lung homogenates 
(Audi et al., 2005). Another reason may be that other dicumarol-inhibitable reductase(s) besides 
NQO1 contribute to DQ reduction during its passage through the pulmonary circulation (Von  & 
Bohrer, 1975; Gonzales-Aragon, Ariza & Villalba, 2007; Zhu & Beattie, 1988). This could be 
evaluated by using a different NQO1 inhibitor, e.g.5-methoxy-1,2-dimethyl-3-[(4-
nitrophenoxy)methyl]indol-4,7-dione (ES936), that inhibits NQO1 by an alternative mechanism 
(Bongard et al., 2009). Previously, we showed that both dicumarol and ES936 equally inhibited 
DQ reduction in cultured bovine pulmonary artery endothelial cells (Merker et al., 2006). 
Although NQO1 is predominantly a cytosolic enzyme (> 90%), non-cytosolic NQO1activity has 
been previously reported (Beattie, Japa & Howton, 1992; Gonzales-Aragon et al., 2007; Tan & 
Berridge, 2010). Thus, another reason for the above difference may be that these O2 levels induced 
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an increase in NQO1 activity in the non-cytosolic fraction of the lung tissue which was not 
preserved in the tissue homogenate used for the NQO1 assay. Several studies have evaluated the 
role of NQO1 in protection against pulmonary O2 toxicity (Cho et al. 2002; Whitney et al., 1993). 
Whitney et al. (1993) found that treatment with dicumarol (NQO1 inhibitor) did not diminish the 
survivability of adapted adult rats in 100% O2, and that the induction of NQO1 did not 
significantly improve the survivability of adult rats exposed to lethal O2 levels. The results with 
dicumarol treatment may be in part because dicumarol has such a high affinity for plasma proteins 
that only a small fraction would be taken up by the lung in vivo (Whitney 1993).  Cho et al. (2002)  
Figure 6.7 Relationship between total NQO1 
activity in lung tissue homogenates (Table 6.2) 
and the capacity (Vmax1) of NQO1 mediated 
duroquinone (DQ) reduction (Table 6.8) on 
passage through the pulmonary circulation of 
normoxic, hyper-60, or hyper-85 lungs. Values 
are mean ± SE. Solid line is linear model fit (r
2
 
=  0.975). 
 
 
 
 
 
showed that mice deficient in the transcription factor Nrf2, which is involved in the induction of 
phase II enzymes including NQO1, had significantly lower lung NQO1 mRNA expression and 
were significantly more sensitive to hyperoxia (> 95% O2 for 72 hours) than wild type mice. 
Furthermore, they showed that exposure of wild type mice to hyperoxia increased their lung 
homogenate NQO1 activity. Unlike rats, mice do not develop tolerance to 100% O2 following 
exposure to 85% O2 (Capellier, Maupoil & Boussat, 1999; Crapo et al., 1974). Previously we 
demonstrated that rat exposure to 85% O2 for 21 days, but not for 2 days, increased the capacity of 
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NQO1 mediated DQ reduction on passage through the lungs, and suggested a potential role for 
NQO1 in rat tolerance to 100% O2. One of the objectives of this study was to determine if rat 
exposure to 60% O2 for 7 days or 85% O2 for 7 days has a differential effect on the lung activity of 
NQO1. Demonstration that the activity of a redox enzyme is differentially altered by exposure to 
60% O2 versus 85% O2 would be suggestive of a role in conferring susceptibility or tolerance to 
100% O2. However, the results of this study reveal that both hyperoxic O2 levels appear to 
increase NQO1 activity in the intact lung.  
Previous studies have suggested complex I as a site of DQ reduction (Fato, Bergamini & 
Leoni, 2008; Zhu & Beattie, 1988). This raises the question of whether the increase in the DQ 
efflux rate during DQH2 infusion in the presence of rotenone plus dicumarol (Figure 6.5) versus 
dicumarol alone (Figure 6.3) is due to inhibition of complex I mediated DQ reduction or an 
increase in DQH2 oxidation. The latter has to do with the fact that inhibiting complex I results in 
more oxidized state of complex III. The results of the present study demonstrate that NQO1 is the 
dominant reductase of DQ on passage through the pulmonary circulation since lung treatment with 
dicumarol decreased the rate of DQH2 efflux during DQ infusion by > 95% for all three groups of 
lungs. Thus, complex I cannot be contributing significantly to the reduction of DQ on passage 
through the rat lung. Moreover, Table 6.3 shows that exposure to 60% O2 or 85% O2 resulted in a 
~50% decrease in complex I activity in lung tissue homogenate. Hence, complex I activity cannot 
account for the increase in DQ reduction capacity of hyper-60 and hyper-85 lungs. Furthermore, 
Audi et al. showed in a previous study that the rate of DQH2 efflux during DQ infusion in the 
presence of potassium cyanide (KCN) was the same as that in the presence of KCN plus rotenone 
(Audi et al., 2004). Again, inhibition of mitochondrial complex IV by KCN reduces complex III 
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and as a result inhibits complex III mediated DQH2 oxidation (Audi et al., 2004, 2005, 2008). 
These results suggest that the rotenone effect on the steady state rate of DQ efflux during DQH2 
infusion (Figures 6.3 and 6.5) is predominantly on DQH2 oxidation rate, rather than on DQ 
reduction rate. Again, the difference in the rate of DQ efflux during DQH2 infusion in the presence 
of dicumarol (Figure 6.3) as compared to that in the presence of dicumarol plus rotenone (Figure 
6.5) is consistent with competition between infused DQH2 and complex I generated coenzyme Q9 
hydroquinone (CoQ9H2) for complex III mediated oxidation. Hence, this difference is a measure 
of the capacity of complex I for generating reducing equivalent (CoQ9H2) and of lung tissue 
rotenone-sensitive O2 consumption. Previously, we estimated the rate of rotenone-sensitive O2 
consumption in normoxic lungs to be ~1.4 µmol/min/gram dry lung wt (Audi et al., 2003). This 
rate (which needs to be multiplied by two for comparison with the difference in DQ efflux rate in 
Figure 6.8) is comparable with the maximum difference in DQ efflux rate (~2.4 µmol/min/gram 
dry lung wt) in normoxic lungs (Figure 6.8).    
For hyper-85 lungs, the difference in DQ efflux rate (Figure 6.8) was comparable to that 
for normoxic lungs. However, for hyper-60 lungs the difference was ~ 50% smaller than that for 
normoxic lungs (Figure 6.8). This suggests a potential decrease in the capacity of complex I for 
generated CoQ9H2 in hyper-60 lungs as compared to normoxic and hyper-85 lungs. This could be 
due to a decrease in lung tissue complex I activity and/or decrease in the rate of the metabolic 
coenzyme NADH supplied to complex I. Table 6.3 shows that exposure to 85% O2 or 60% O2 for 
7 days decreased lung complex I activity (per mg of protein) by ~50% . This decrease appears to 
have no significant effect on the capacity of complex I for generating CoQ9H2 in hyper-85 lungs 
(Figure 6.8) suggesting a possible increase in the rate of NADH supplied to complex I to 
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compensate for the decrease in complex I activity. This would be consistent with an increase in 
tissue activities of glucose transporters and hexokinase in lungs of rats exposed to 85% O2 for 7 
days. For hyper-60 lungs, the decrease in complex I activity (Table 6.3) is proportional to the 
decrease in the rate of complex I generated CoQ9H2 (Figure 6.8).  
  
Figure 6.8 The relationship between the 
difference in steady state rates of DQ efflux 
during DQH2 infusion in the presence of 
dicumarol plus rotenone (Figure 6.5) and 
dicumarol alone (Figure 6.3) and the log mean 
DQH2 concentrations, for normoxic lungs, hyper-
85 lungs, and hyper-60 lungs respectively. 
Model-based interpolation was used to determine 
the rates of DQ efflux in the presence of 
dicumarol plus rotenone (Figure 6.5) at the same 
log mean DQH2 concentrations as in Figure 6.3. 
 
Rat exposure to 85% O2, but not to 
60% O2, for 7 days increased lung activities of complexes III and IV by 56% and 90%, 
respectively. This may be a compensatory mechanism to counter the potential effects of the 
decrease in lung complex I activity on mitochondrial ATP production (Desquiret, Gueguen & 
Malthiery, 2008). The increase in lung complexes III and IV activities could also be a means of 
decreasing ROS production at complex III, which involves the donation of electrons from 
ubisemiquinone to molecular O2 since the higher the respiration rate the less time the electrons are 
delayed at critical leakage sites such as complex III (Li et al., 2004). Additional studies would be 
needed to evaluate the effect of this increase in complexes III and IV on mitochondrial ATP and 
ROS production. 
Ratner et al. demonstrated that exposure of neonatal mice to hyperoxia (75% O2 for 72 
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hours) decreases complex I activity by ~70%, and that this decrease compromises mitochondrial 
oxidative phosphorylation and contributes to alveolar development arrest (Ratner et al., 2009). 
Based on these results, they concluded the decrease in complex I plays a key role in lung O2 
toxicity. In the present study, exposure to 60% O2 or 85% O2 for 7 days decreased complex I 
activity by ~ 50%. However, for hyper-85 lungs the effect of this decrease on oxidative 
phosphorylation may have been countered by an increase in the lung activities of glucose 
transporters and hexokinase upstream from complex I, and by increases in the activities of 
complexes III and IV downstream from complex I (Table 6.9).  
The results of the present study demonstrate an increase in lung tissue total glutathione 
(GSH) content per mg of protein in hyper-85 lungs as compared to normoxic lungs (Table 6.4). 
This is consistent with an increase in γ-glutamyltransferase activity in tissue homogenates of 
hyper-85 lungs, but not hyper-60 lungs, reported by Van Klaveren et al. (Table 6.9) (Van, Dinsdale 
& Pype, 1997). This enzyme is important for the uptake of substrates for intracellular GSH 
synthesis. However, in the same study Van Klaveren et al. reported no increase in GSH level in 
hyper-85 tissue homogenates per mg protein, which is different from the results in the present 
study (Van et al., 1997). This difference may be in part due to differences in rat strains (Wistar vs. 
Sprague-Dawley) and/or the methods used to measure tissue GSH content. The increase in GSH 
content in hyper-85 lung homogenates measured in the present study is potentially important since 
GSH is the major mechanism for scavenging H2O2 in endothelial cells, and since H2O2 is the most 
cytotoxic ROS in endothelial cells, which are a primary target of lung O2 toxicity (Suttorp, 
Toepfer & Roka, 1986).  
 Hyper-60 Hyper-85 Reference 
NQO1 (per g of dry wt) + 64% +40% Present study 
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Table 6.9 Summary of the effect of rat exposure to 60% or 85% O2 for 7 days compared with normoxic 
rats on cell surface, cytosolic, and mitochondrial enzymes. Kox (ml/min/g dry wt) is the rate of DQH2 
oxidation on passage through the pulmonary circulation. ACE, angiotensin converting enzyme; G-6-
PDH, glucose 6 phosphate dehydrogenase. NS and NA, not significant and not available, respectively. 
 In conclusion, the results demonstrate that NQO1 activity increased in both hyper-60 and 
hyper-85 lungs, whereas complexes III activity increased in hyper-85 lungs only. This increase 
along with the increase in complex IV activity in hyper-85 lungs could be to counter the effects 
the depression in complex I activity might have on cellular energy homeostasis and/or 
mitochondrial ROS production, and hence be potentially important to the tolerance to 100% O2 
observed in hyper-85 rats. These results demonstrate the utility of these two hyperoxic models and 
indicator dilution methods for furthering our understanding of the pathogenesis of lung O2 toxicity, 
and for providing insights into the underlying mechanisms of rat tolerance and susceptibility to 
100% O2. 
 
 
 
Complex III (per g dry wt) NS +56% Present study 
Complex I (per mg protein) -51% -49% Present study 
Complex IV (per mg protein) NS +90% Present study 
ACE  NS -57% Present study 
kox  (per g dry wt) +56% NS Present study 
Lung glutathione content  
(per g dry wt) 
NS +20 Present Study 
G-6-PDH (per g dry wt) NS +68% (Hayatdavoudi et al., 
1981) 
Hexokinase (per mg protein) NA 
 
+44% (Allen 2001) 
 
γ-glutamyltransferase (µU/mg) NS 220% (Van 1997) 
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CHAPTER 7. RHODAMINE DYES AS EXTRACELLULAR PROBES OF 
MITOCHONDRIAL AND PLASMA MEMBRANE POTENTIALS IN INTACT 
BOVINE PULMONARY ARTERIAL ENDOTHELIAL CELLS 
7.1 Introduction 
Pulmonary endothelial mitochondrial membrane potential (∆Ψm) and plasma membrane 
potentials (∆Ψp) are implicated in bioenergetic, metabolic and signaling processes which 
contribute to lung function under physiologic and pathophysiologic conditions (Chatterjee, 
Chapman & Fisher, 2008; Han, Moon & You, 2010; Madesh, Hawkins & Milovanova, 2005; 
Ruchko, Gorodnya & Ledoux, 2005; Wu, Jian & Xu, 2009; You & Park, 2010).  For instance, 
∆Ψm is the major component of the mitochondrial electrochemical transmembrane potential, and 
as such is involved in pulmonary endothelial mitochondrial ATP generation, regulation of calcium 
homeostasis, apoptosis, nitric oxide signaling and other functions (Dedkova & Blatter, 2005; 
Solaini, Sgarbi & Lenaz, 2007; Sud, Wells & Sharma, 2008; Terminella, Tollefson & Kroczynski, 
2002).  Dissipation of ∆Ψm is considered a hallmark of mitochondrial dysfunction in various cell 
types, including in pulmonary endothelial cells exposed to oxidative stresses (Han et al., 2010; 
Madesh et al., 2005;  Mungunsukh, Griffin & Lee, 2010; Ruchko et al., 2005; You & Park, 2010).  
On the other hand, pulmonary endothelial ∆Ψp is implicated in regulating channel mediated 
calcium entry as a key signaling response to mechanical stimuli, vasoactive substances, oxidative 
stress, ischemia and hypoxia (Cannell & Sage, 1989; Chatterjee et al., 2006; Koliwad, Kunze & 
Elliott, 1996; Paffett, Jo & Pak, 2007; Stevens et al., 1994; Wu  et al., 2009; Zhang, Chatterjee & 
Wei, 2008). Since the pulmonary capillary endothelium is a primary and early target of lung O2 
toxicity, the ability to quantify ∆Ψm and ∆Ψp is important for characterizing biochemical 
mechanisms underlying pulmonary endothelial responses to oxidative stress (e.g. hyperoxia), and 
                                                                                                                                                              124                                                             
  
to evaluate the utility of therapeutics directed at restoration of normal mitochondrial function.  
 While various techniques have been reported for evaluating ∆Ψm in different cell types, a 
typical approach has been to use cationic fluorescent dyes that accumulate in the mitochondrial 
matrix driven by the voltage gradient across the inner mitochondrial membrane (Ehrenberg, 
Montana & Wei, 1988; Huang, Camara & Stowe, 2007; Scaduto & Grotyohann, 1999; Solaini, 
Sgarbi & Lenaz, 2007; Ward 2010). Such studies generally have involved measurements of 
fluorescence intensity within cells or isolated mitochondria. Because such measurements are 
easily confounded by the propensity of the dyes to undergo self-aggregation and quenching, 
photobleaching and/or to exert phototoxic effects, the outcomes have been predominately confined 
to qualitative changes in ∆Ψm (Ehrenberg et al., 1988; Huang et al., 2007; Huser & Blatter, 1999; 
Scaduto et al., 1999; Solaini et al., 2007; Ward 2010).  In addition, the vast majority of studies 
have involved mitochondrial isolation, cell permeabilization or other conditions that have little 
relevance for intact cells, and yet, when intact cells have been studied, the contributions of 
processes other than ∆Ψm (e.g., the multi-drug transporter Pgp and/or ∆Ψp) to dye disposition have 
often been overlooked (Baracca, Sgarbi & Solaini, 2003; Duchen et al., 2003; Huang et al., 2007; 
Nicholls et al., 2006; Yeheskely, Regev & Katzir, 2009). 
 The goal of this study was to develop a means to quantify ∆Ψm and ∆Ψp in intact 
pulmonary endothelial cells using two common membrane potential sensitive cationic fluorescent 
dyes, rhodamine 123 (R123) and tetramethylrhodamine ethyl ester (TMRE).  The overall approach 
was to focus on the impact of the pulmonary arterial endothelial cells in culture on the 
extracellular concentrations of the dyes under a range of experimental conditions designed to 
separate the contributions of ∆Ψm, ∆Ψp and Pgp to the net effect of the cells on the dyes.  A kinetic 
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model was developed to interpret the data and to obtain parameter values for ∆Ψm, ∆Ψp and Pgp 
for both dyes.  R123 and TMRE were selected because whereas TMRE is more cell membrane 
permeable than R123, both have relatively strong fluorescence quantum yields, low sensitivity to 
changes in the cellular environment and undergo membrane potential-dependent changes in 
distribution across both the mitochondrial and plasma membranes (Duchen et al., 2003; Enrenberg 
et al., 1988; Loetchutinat, Saengkhae & Marbeuf, 2003; Solaini et al., 2007; Ward 2010).   Thus, 
one concept was that the utility of the proposed approach for quantifying ∆Ψm and ∆Ψp in 
pulmonary arterial endothelial cells would be revealed by the consistency of the parameter values 
obtained from the studies with two dyes that have both distinct (i.e. different membrane 
permeabilities) and common (i.e. mitochondrial and plasma membrane potentials) properties. 
7.2 Materials and Methods 
Materials 
 Fetal bovine serum was purchased from Hyclone Laboratories (Logan, UT, USA), RPMI 
1640 tissue culture medium and tetramethyrhodamine ethyl ester (TMRE) from Invitrogen 
(Carlsbad, CA), Biosilon microcarrier beads from Nunc (Roskilde, Denmark) and the protein 
assay reagent from Bio-Rad Laboratories (Hercules, CA).  The multi-drug efflux transporter P-
glycoprotein (Pgp) inhibitor N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl) ethyl]-
phenyl)- 9,10-dihydro-5-methoxy-9-oxo-4 acridine carboxamide (GF120918) was generously 
supplied by GlaxoSmithKline (Research Triangle Park, NC).   Rhodamine 123 (R123) and other 
chemicals unless specifically noted were purchased from Sigma Chemical (St. Louis, MO). 
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7.2.1 Endothelial Cell Culture 
 Bovine pulmonary arterial endothelial cells were isolated from segments of calf 
pulmonary artery obtained from a local slaughterhouse and cultured to confluence on gelatin 
coated (2% vol/wt) Biosilon (polystyrene) microcarrier beads (230 µm mean diameter; 160 
cm
2
/ml beads) in RPMI-1640 medium supplemented with 10% fetal calf serum, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 30 mg/ml L-glutamine as previously described (Merker, 
Bongard & Linehan, 1997). The control cells were grown in room air, and exposure of the cells to 
hyperoxia (95% O2, 5% CO2, 48 hours) was carried out as previously described (Merker et al., 
2006, 2007). 
7.2.2 Measurement of Rhodamine Dye Concentrations in Extracellular Medium 
 For experiments with R123 or TMRE, ~0.40 ml of settled confluent cell-coated beads 
(~59 cm
2
 cell surface area) or ~0.17 ml of confluent cell coated beads (~28 cm
2
 cell surface area), 
respectively (128,000 cells/cm
2
 surface area), were washed free of the culture medium by 
resuspension in Hanks balanced salt solution containing 5.5 mM glucose and 10 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4, warmed to 37
o
C 
(HBSS/HEPES), as previously described (Merker, Olson & Bongard, 1998). The cell-coated beads 
were allowed to settle (settling time ~ 15 sec), the supernatant was discarded, and the washing 
procedure repeated two more times. The washed cell-coated beads were then resuspended in 
10mm x 10mm x 48mm acrylic fluorometric cuvettes containing 2.5 or 3.0 ml HBSS/HEPES 
37
o
C (“control medium”) and R123 or TMRE (10, 30 and 100 nM). Immediately, the beads were 
allowed to settle to the bottom of the cuvette, and the fluorescence intensity in the medium above 
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the settled cell-coated beads was measured (R123, λex = 490 nm, λem = 525 nm; TMRE, λex = 530 
nm, λem = 573 nm) using a Perkin Elmer LS55 luminescence spectrometer.  The dye 
concentrations ([Re]) in the extracellular medium were calculated from a standard curve prepared 
on the same day in the same medium used in cell experiments.  After the initial measurements (t = 
0 min), the cell-coated bead suspension was then placed on a Nutator mixer at 37
o
C.  Periodically 
the mixing was stopped, the cell-coated beads were allowed to settle to the bottom of the cuvette 
and fluorescence intensity in the medium above the settled beads was measured. The same 
protocol was also carried out using the protonophore CCCP (0.1, 0.2, 0.3 and 5 µM), high K+ (138 
mM KCl/5 mM NaCl) and/or the Pgp inhibitor GF120918 (2.5 µM) and in the absence of cells, 
the latter to determine the contribution of nonspecific dye interactions with the plasticware. 
7.2.3 Additional Measurements 
To assess cellular viability, total cellular and medium lactate dehydrogenase (LDH) 
activity were measured at the end of each experiment, to determine % LDH release into the 
medium as previously described (Merker et al., 1998). Cell protein was measured using the Bio-
Rad protein assay, and cell bead weights were obtained by drying and weighing the beads at the 
end of each experiment (Merker et al., 1998).  
7.3 Results 
7.3.1 Cell Protein, Cell Surface Area 
Microcarrier bead surface area, cell protein, cell protein/cm
2
 cell culture area and % total 
cell LDH released into the medium at the end of the experiments, expressed as mean ± SE., for all 
R123 experiments combined were 59.00 ± 1.20 cm
2
, 1.54 ± 0.06 mg, 26.09 ± 1.04 µg/cm
2
 and 
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2.73 ± 0.24%, respectively (n = 55). For all TMRE experiments, the combined values were 28.31 
± 0.77 cm
2
, 0.74 ± 0.03 mg, 26.35 ± 0.85 µg/cm
2
 and 2.68 ± 0.20% (n = 68), respectively. There 
were no detectable differences between values for these parameters in control and inhibitor-treated 
experimental groups (p > 0.05).   
7.3.2 Time Course of Changes in the Extracellular Concentrations of R123 and TMRE in the 
Absence and Presence of Various Inhibitors 
 Figure 7.1 shows R123 (A) and TMRE (B) concentrations in the medium ([Re]) 
surrounding the pulmonary arterial endothelial cell-coated beads, normalized to the initial dye 
concentrations. In the presence of the cells, the normalized [Re] for both dyes decreased 
throughout their respective incubation periods in a manner that was independent of dye 
concentration.   For R123, the normalized [Re] fell continually throughout the 120 min incubation 
period (Figure 7.1 A).  For TMRE, it reached a steady-state within ~ 30 min that was maintained 
throughout the 60 min incubation period (Figure 7.1 B).  The decreases in the normalized [Re] 
over time were cell dependent since there was relatively very little change in the absence of cells 
(Figures 7.1 A and B). Thus, the decreases in dye concentration in the extracellular medium were 
interpreted as dye uptake by the cells.  
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Figure 7.1 Normalized concentrations of R123 and TMRE in the medium surrounding the pulmonary 
arterial endothelial cell-coated beads vs. time. (A) Medium containing R123 (10, 30 and 100 nM) or (B) 
TMRE (10, 30 and 100 nM) was added to the cell coated beads and the dye concentrations in the 
medium ([Re]) measured over time. The measured dye concentrations were normalized to the initial 
dye concentrations.  Also shown are the normalized (A) R123 or (B) TMRE concentrations in the 
medium over time in the absence of cells.  The symbols represent data without cells (n=3) and data 
with cells (n=4). The solid line is Equation (8) fit to the data and the dashed lines are model predictions 
using the parameter values in Table 7.1. 
TMRE uptake was more rapid than R123 because it is more highly cell membrane 
permeant (Duchen et al., 2003; Loetchutinat et al., 2003).  Accordingly, [Re] for TMRE reached 
the steady state more rapidly than the R123 data, thereby allowing the time course for TMRE 
studies to be comparatively shorter.  We also used fewer cells (i.e., a lower cell coated bead 
surface area) for TMRE than for R123 studies (28 vs. 59 cm
2
 confluent cell coated beads) because 
if we used the higher number for TMRE also, the cellular uptake of TMRE was so extensive that 
[Re] would rapidly approach zero, decreasing the sensitivity (i.e., dynamic range) of the 
measurement to experimental manipulation. On the other hand, if we used the lower surface area 
for the R123 studies, the time course required to obtain sufficient data to interpret would be too 
long to be consistent with high cell viability. The dye concentrations selected for further study 
were within the linear dye concentration vs. fluorescence intensity range, i.e., below the 
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aggregation threshold concentration for both dyes (10 nM for R123 and 20 nM for TMRE; data 
not shown) (Duchen et al., 2003; Huang et al., 2007). 
The next step was to separate the contributions of ∆Ψm, ∆Ψp and Pgp to the net effect of 
the cells on [Re].  The approach was to use the protonophore CCCP, high K
+
 or GF120918.  CCCP 
was primarily directed at dissipation of ∆Ψm and high K+ at ∆Ψp (Adams et al., 2004; Basuroy, 
Bhattachcharya & Leffler, 2009; Chatterjee et al., 2008; Carpo et al., 1980).  GF120918 was used 
as the Pgp inhibitor (Roerig, Audi & Ahlf, 2004; Ward, 2010). 
With regard to the concentrations of modulators used, 5 µM CCCP has been used to target 
the mitochondrial respiratory chain in cerebral microvascular endothelial cells (Basuroy et al., 
2009).  The high [K
+
] (143 mM; replacement of NaCl in the experimental buffer with KCl) was 
used to accomplish complete ∆Ψp depolarization, as specified by the Nernst equation, and as used 
for simultaneous determination of  cell membrane potentials using microscopic measurements of 
rhodamine dyes (Farkas, Wei & Febbroriello, 1989; He & Curry, 1995). 2.5 µM GF120918 was 
based on our previous studies demonstrating that the maximum effect of GF120918 on rhodamine 
6G accumulation in the perfused rabbit lung was attained at 2 mM (Roerig et al., 2004). 
 As can be seen in Figures 7.2A and B, the effects of the treatments on the [Re] vs. time 
progress curves for R123 and TMRE were qualitatively similar but quantitatively different.  In 
general, CCCP and high K
+
 attenuated the fall in [Re] for both dyes, whereas GF120918 had the 
opposite effect (Figures 7.2 A and B).  The overall implication was that dissipation of ∆Ψm or ∆Ψp 
with CCCP or high K
+
, respectively, decreased the extent of dye uptake by the cells. On the other 
hand, Pgp inhibition had the apparent effect of increasing dye uptake, but this was presumably via 
blockade of dye transport out of the cells (Katzir, Yeheskely & Regev, 2010; Yeheskely et al., 
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2009). 
 
 
Figure 7.2 Effects of CCCP, high K+ and GF120918 on the concentrations of R123 and TMRE in the 
medium surrounding the cell-coated beads. The symbols represent the medium concentrations, [Re], 
(mean ± SE) for the following number (n) of experiments: (A) control, 11; CCCP, 10; high K
+
, 4; 
GF120918, 5; (B) all conditions, 8.  The solid lines are the model fit to the data and the dashed lines are 
the model predictions using the Table 7.1 parameter values. 
 In Figures 7.3 A and C, [Re] vs. time for R123 or TMRE, respectively, was measured for 
control and CCCP treated cells.  As in Figure 7.2, the fall in [Re] for R123 and TMRE was 
attenuated in the presence of CCCP. At the time point indicated by the dotted vertical lines, CCCP 
was added to both control cells and to the cells that had been treated with CCCP from the 
beginning of the experiment. The latter was to control for any effect of experimental time course 
on the addition of CCCP.   
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Figure 7.3 Effects of CCCP on the concentrations of R123 and TMRE in the medium surrounding the 
cell-coated beads. A: [Re] for R123 in samples containing R123 only (closed circles, n = 11) or R123 + 
CCCP (open circles, n = 4). At the time represented by the dotted vertical line (150 min). B: CCCP was 
added to 4 of R123 samples (shaded triangles) and to all the R123 + CCCP samples (open circles).  C: 
[Re] for TMRE (closed circles, n = 4) or TMRE + CCCP (open circles, n = 4). At the time represented 
by the dotted vertical line (60 min). D: CCCP was added to all 4 TMRE samples (shaded triangles) and 
all 4 of the TMRE + CCCP samples (open circles).  The symbols are the data (means ± SE) and the 
solid lines are the model fit to the data.  The dashed lines are model predictions using the Table 7.1 
parameter values. 
For the control cells that had been allowed to accumulate the dyes in the absence of CCCP, 
[Re] increased when CCCP was added, approaching that for cells that had been treated with CCCP 
from the beginning of the experiment (Figures 7.3 B and D).  That is, CCCP not only blocked dye 
uptake by the cells if it was present from the beginning of the experiments, it also caused cell-
accumulated dye to be released into the medium. With regard to the differences between the two 
dyes, TMRE is taken up more rapidly and to a proportionately greater extent by control cells than 
is R123, as also seen in Figure 7.2. In addition, when CCCP was added to cells that had already 
accumulated dye, TMRE efflux into the medium from the cells was more rapid than for R123, as 
reflected in the more rapid increase in [Re] for TMRE than for R123 (Figures 7.3 D and B, 
respectively). 
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The data in Figures 7.2 and 7.3 implied that ∆Ψm, ∆Ψp and Pgp all contributed to the net 
effect of the cells on [Re] for R123 and TMRE. Since kinetic model parameters are not estimable 
from a single data set or experimental condition we designed an experimental data set to contain 
sufficiently discriminating data to distinquish between effects of ∆Ψm, ∆Ψp and Pgp on [Re].  
Figures 7.4 A and B show the effects of progressive, cumulative inhibition of Pgp, ∆Ψp and ∆Ψm 
on the [Re] vs. time progress curves for R123 and TMRE, respectively, using GF120918 only, 
GF120918  + high K
+
 or GF120918 + high K
+
 + CCCP. 
 
Figure 7.4 Cumulative inhibition of processes contributing to dye fate on the R123 and TMRE 
concentrations in the medium surrounding the cell- coated beads. The symbols are the data (means ± 
SE) for the following number (n) of experiments:  (A) cell medium R123 concentrations for control, 11; 
GF120918, 5; GF120918 + high K
+
,  4; GF120918 + high K
+
 + CCCP, 4; (B) all conditions, 8. The [Re] 
data for control and GF120918 are the same as those in Figures 7.2 and 7.3. The solid lines are the 
model fit to data. 
To take into account the possibility that CCCP might also depolarize ∆Ψp, an additional 
study was carried out.  Figure 7.5 A and B show the impact of CCCP on [Re] for R123 or TMRE, 
respectively, in the presence of GF120918 and absence of high K
+
.  Under these conditions, which 
include blocking any effect of Pgp, and without the high K
+
 that would depolarize ∆Ψp, any 
impact of CCCP on ∆Ψp should be unmasked. 
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Figure 7.5 The impact of CCCP on R123 and TMRE concentrations when the contribution of Pgp is 
minimized with GF120918. The experimental medium did not contain high K
+
.  The symbols are the 
data (means ± SE) for the following number (n) of experiments: A: GF120918, n=5; GF120918 + 
CCCP, n=5; B: all conditions, n=8. The symbols are the data (means ± SE), the solid lines are the 
model fits to the data, and the dashed line is a model prediction.   
7.4 Data Analysis 
7.4.1 Kinetic Model for the Disposition of Rhodamine Dyes in Endothelial Cells 
 A mathematical model was developed to quantify the contributions of ∆Ψm, ∆Ψp and Pgp 
to [Re] for R123 and TMRE. The model includes three regions, the extracellular medium, 
cytoplasm and mitochondrial matrix, with volumes Ve, Vc, and Vm, respectively (Figure 7.6).  The 
dye flux across plasma (J1) or inner mitochondrial membrane (J2) is represented by a modified 
one-dimensional Goldman–Hodgkin-Katz equation (Huang et al., 2007).  Because the fractional 
loss of dye from the extracellular medium in Figure 7.1 is dose-independent, Pgp-mediated dye 
efflux from Vc to Ve is hypothesized to follow first-order kinetics (Loetchutinat et al., 2003).  
Moreover, the model allows for slowly equilibrating nonspecific dye interactions with the cuvette 
(Be) within Ve, and rapidly equilibrating nonspecific dye interactions with binding sites Bc and Bm 
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Figure 7.6 A schematic representation of the kinetic model of the disposition of R123 or TMRE in 
pulmonary arterial endothelial cells and the extracellular medium. Ve, Vc, and Vm are volumes of 
medium, cytoplasm and mitochondrial matrix, respectively. Re, Rc and Rm are the free R123 or TMRE 
concentrations in the medium, cytoplasm and mitochondrial matrix, respectively. Within the medium, 
the dyes participate in nonspecific binding interactions with the fluorometric cuvette (Be). The dyes 
also participate in nonspecific rapidly equilibrating interactions with binding sites Bc and Bm within Vc 
and Vm, respectively. RcBc and RmBm are the concentrations of bound dye in the cytoplasm and 
mitochondrial matrix, respectively. J1 and J2 are dye fluxes across plasma cell membrane and inner 
mitochondrial membrane, respectively. ∆Ψm  and ∆Ψp are mitochondrial and plasma membrane 
potential, respectively; KPgp is the conductance of Pgp mediated dye release from the cells. 
within Vc and Vm, respectively.  Then, variations in dye concentrations in Ve, Vc and Vm with time 
are described by the ordinary differential equations 
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 [Re](t), [Rc](t) and [Rm](t) are dye concentrations in Ve, Vc, and Vm, respectively, at time t; 
[ReBe](t) is the dye concentration bound to cuvette at time t; α = ZF/RT = 0.0374 mV
−1
 at 37 
o
C is 
a constant dependent on the universal gas constant (R), Faraday constant (F), dye valence (Z), and 
absolute temperature (T) (Huang et al., 2007); KPgp (ml/min) is Pgp mediated dye release from the 
cells, and P1S1 (ml/min) and P2S2 (ml/min) are products of dye permeabilities (P) across plasma 
and mitochondrial membranes, respectively, and the surface areas (S) of these membranes V1 = 
1 +
k 2 [Bc]
k – 2
 Vc (ml) and V2 = 1 +
k 3 [Bm]
k – 3
 Vm (ml) are apparent cytoplasm and 
mitochondrial matrix volumes, respectively, where ki and k−i are dye association and dissociation 
rate constants, respectively, with Bc (i = 2) and Bm (i = 3), respectively; 1k = k1 [Be] (min
−1
) and 
k
−1 (min
−1
) are rate constants for dye-cuvette binding and unbinding, respectively, and [Be] is the 
concentration of cuvette dye binding sites.   
Although typically thought of as a mitochondrial uncoupler, the protonophore 
carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) depolarizes both bovine aortic 
endothelial and cultured neuronal cell ∆Ψp in a concentration dependent manner (Nicholls et al., 
2006; Park et al., 2002). Because CCCP is also an uncoupling protonophore, and the 5 µM CCCP 
concentration used in our study is in the range reported for the FCCP induced plasma membrane 
depolarization, we used model simulations to evaluate whether CCCP might have such an effect in 
the present study (not shown).  The result was that the effect of CCCP on [Re] for both dyes was 
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greater than what could be accounted for solely by dissipation of only ∆Ψm, as described by the 
empirical equation 
τδδ
t
ppp e
−
∆Ψ−+∆Ψ=Ψ∆ )1(              (E7.7) 
where (1-δ) is the ∆Ψp fraction dissipated by CCCP and τ the associated time constant (min) such 
that in the absence of CCCP, δ = 1 and pΨ∆  = ∆Ψp.   
 To break the high correlation between V2 and ∆Ψm in the model, the V2/V1 ratio was set 
to 0.02, consistent with a lower bound measured for this ratio in rat pulmonary endothelium 
(Oldendorf, Cornford & Brown, 1977).  Then, ∆Ψm ∆Ψp, V1, KPgp, P1S1, P2S2, δ , τ, 1k and k-1 are 
the unknown model parameters.  The model governing differential equations were solved 
numerically using the MATLAB (MathWords, Inc) function “ode45” which is based on an explicit 
Runge-Kutta formula. 
7.4.2 Estimation of Model Parameters  
 In the absence of cells, Equations (E7.1 – 7.4) become  
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where [Re]0 is the initial (t = 0) dye concentration and [Re](t) is the concentration at time t. Fitting 
E7.8 to the without cell data in Figure 7.1 gives 1k and k−1 as 4.3 x 10
−3
 min
−1 
and 8.9 x 10
−2
 
min
−1
, respectively, for R123 and 7.9 x 10
−3
 
 
min
−1 
and 5.4 x 10
−2
 min
−1
, respectively, for TMRE.  
The fitting procedure was implemented in MATLAB using function “lsqcurvefit” which solves a 
non-linear curve fitting problem in the least-squares sense using the Levenberg-Marquardt 
algorithm. 
 Estimation of the values of model parameters descriptive of the contributions of 
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membrane potentials and Pgp to changes in [Re] vs. time requires a collection of data sets that 
provides sufficiently discriminating information about these cellular processes. 
Thus for each dye, the values of ∆Ψm, ∆Ψp, V1, KPgp, P1S1 and P2S2 were obtained by 
fitting the solution of Equations (E7.1 – 7.4) simultaneously to the mean [Re] versus time data in 
Figure 7.4. The hypothesis was that ∆Ψm, ∆Ψp and KPgp could be set to zero in the presence of 
CCCP, high K
+
 or GF120918, respectively.  In addition, it was hypothesized that in the presence of 
CCCP + high K
+
, any effect of CCCP on ∆Ψp would be negligible, allowing to be set to one in 
Equation (E 7.7). The parameter values and the 95% confidence intervals (C.I.) are given in Table 
7.1 (Bates & Watts, 1983). The Figure 7.4 B data do not have sufficient temporal resolution to 
provide a value for P2S2 for TMRE other than an upper bound set in the non-linear regression 
algorithm.   
The means ± 95% C.I. for the parameters δ and τ were determined to be 0.25 ± 0.02 and 
2.3 ± 0.7 min, respectively, by fitting the solution of model Equations (E7.1-7.4) to the GF120918 
plus CCCP data for TMRE in Figure 7.5 B with KPgp and ∆Ψm set to zero, and with ∆Ψm and other 
parameters set to the values shown in Table 7.1. Model simulations revealed that the effect of 
CCCP on ∆Ψp is more apparent in the presence of GF120918 than under any other experimental 
condition studied.    
Model simulations based on Equations (E7.1-7.4) revealed that increasing or decreasing 
the V2/V1 ratio by 50% changed ∆Ψm by +10 mV and 18 mV, respectively, consistent with 
previous estimates of the sensitivity of ∆Ψm to the V2/V1 ratio (Nicholls 2005). Model simulations 
further demonstrated that values for ∆Ψp and KPgp are insensitive to changes in the V2/V1 ratio. 
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7.4.3  Model Predictions (Validation) 
The kinetic model was evaluated by testing its ability to predict [Re] under experimental 
conditions that were not used for estimating model parameters in Table 7.1. The Table 7.1 values 
were used to generate model predictions for data sets in Figures 7.2, 7.3 and 7.5 (dashed lines). 
The values for δ and τ, which quantify a time-dependent CCCP mediated ∆Ψp depolarization, 
obtained from the TMRE data in Figure 7.5B were used to predict the effect of CCCP on the R123 
[Re] vs. time curve in the presence of CCCP +  GF120918 (Figures 7.6 A).  That this prediction 
was a reasonable explanation of the R123 CCCP + GF120918 data provided support for the 
hypothesis of a depolarizing effect of CCCP on ∆Ψp under the study conditions. 
7.4.4 Steady State Analysis for Mitochondrial Membrane Potential 
 Following the addition of the dye along with GF120918 and CCCP to high K
+
 medium, 
the steady state dye concentrations in Ve, V1 and V2 should be equal to that in the medium, [Re]s1. 
[Re] = [Rc] = [Rm] = [Re]s1       (E7.9) 
Using mass balance,  
[Re]s0 Ve = [Re]s1 (Ve + V1 + V2)       (E7.10) 
where [Re]s0 is the steady state value of dye concentration in the medium following the addition of 
dye in the absence of cells (Figure 7.1). 
 Following the addition of dye along with GF120918 to high K
+
 medium, the steady state 
dye concentrations in Ve and V1 should be equal and different from that in V2. Thus, using mass 
balance 
[Re]s0 Ve =  [Re]s2 (Ve + V1) +  [Rm]s V2      (E7.11) 
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where [Re]s2 and [Rm]s are the respective steady state dye concentrations within Ve and V2, 
following the addition of dye + GF120918 to high K
+
 medium. [Re]s2 and [Rm]s can be related to 
∆Ψm using the Nernst equation. 
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 Using algebraic manipulations, Equations (E7.1-7.4) lead to the following equation: 
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where α is the ratio V2/V1, [Re]S0 is the steady-state [Re] in the absence of cells, [Re]s2 is the steady-
state [Re] for high K
+
 + GF120918, [Re]s1 is the steady-state [Re]  for high K
+
 + GF120918 + 
CCCP. 
 Since [Re] for TMRE reaches steady-state over the experimental time period (~30 min, 
Figures 7.1 – 5), we reasoned that steady-state analysis could be used to estimate ∆Ψm under just 
two experimental conditions, high K
+
 + GF120918 and high K
+
 + GF120918 + CCCP, using the 
above algebraic equation (E7.13), the ∆Ψm determined is −124 ± 6 mV (mean ± SE). 
Figures 7.7 and 7.8 exemplify the use of steady state TMRE data and steady state data 
analysis to evaluate the effect of a physiological stimulus on the ∆Ψm response to uncoupling with 
CCCP.  The studies included GF120918 and high K
+
 to eliminate the contributions of ∆Ψp and 
Pgp to TMRE fate, thereby isolating and emphasizing the impact of ∆Ψm.  Figure 7.7 shows [Re] 
vs. time data for control (room air) and hyperoxia-exposed cells in which the CCCP concentration 
varies from none (Figure 7.7 A) to 0.1, 0.2, 0.3 and 5.0 µM in Figures 7B-E, respectively.  Figures 
7.7 A and E show that the steady state [Re] is nearly the same for hyperoxia-exposed and control 
cells in the absence of CCCP and at the highest CCCP concentration (5 µM).  However, at 
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intermediate CCCP concentrations, the steady state [Re] appears higher for hyperoxia-exposed 
than control cells (Figures 7.7 B, C and D).  Figure 7.8 shows the ∆Ψm for control, room air and 
hyperoxia-exposed cells calculated from E7.13 and the Figure 7.7 [Re] vs. time data at each CCCP 
concentration.  As anticipated from Figure 7.7, the resting ∆Ψm and the ∆Ψm at 5 µM CCCP are 
not detectably different, but the hyperoxia-exposed cell ∆Ψm is more sensitive to the depolarizing 
effects of uncoupling with CCCP.    
 
Figure 7.7 The impact of varying concentrations of CCCP on TMRE concentrations in the medium 
surrounding control (room air) and hyperoxia-exposed pulmonary arterial endothelial cells. The 
experiments were carried out in the presence of GF120918 and high K
+
 without CCCP or with 0.1, 0.2, 
0.3 or 5.0 µM CCCP.  The symbols are the mean ± SE for n = 3 determinations at each CCCP 
concentration. 
 
 
Figure 7.8 Hyperoxia-exposed cell 
∆Ψm is more sensitive to CCCP 
induced depolarization than control 
(room-air) cells. The symbols 
represent the values for ∆Ψm obtained 
using the steady state TMRE data 
from Figure 7.7 and Equation.  
*Significantly different from control 
room air values at the same CCCP 
concentration, t-test, P < 0.05 
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Table 7.1 Kinetic model parameter values of  rhodamine model: Kinetic model parameter values ± 
asymptotic 95% confidence intervals (C.I.) ∆Ψm and ∆Ψp are mitochondrial and plasma membrane 
potentials, respectively; P1S1 and P2S2 are permeability-surface area products descriptive of R123 or 
TMRE conductance across plasma and mitochondrial membranes, respectively; KPgp is the constant 
rate of Pgp mediated release of R123 or TMRE from the cells; V1 is the apparent volume of cell 
cytoplasm. Parameter values were obtained by fitting the model solution to the mean values of the 
extracellular R123 or TMRE concentration ([Re]) versus time data in Figure 7.4.  * Significantly 
different than value for the same parameter obtained using R123 data; t-test, P < 0.05.  
7.5 Discussion and Conclusions 
The present study was based on the general hypothesis that changes in the concentrations 
of rhodamine dyes in the medium surrounding the intact pulmonary arterial endothelial cells ([Re]) 
would be sensitive to perturbations in ∆Ψm and ∆Ψp. The study reveals that the observed changes 
in extracellular dye disposition in response to the perturbations were highly predictable based on 
previous measurements of intracellular rhodamine dye disposition using the same or very similar 
kinds of perturbations, albeit in different cell types, e.g., in (Farkas et al., 1989).  Taken together 
with the knowledge that such intracellular dye measurements had been used to quantify ∆Ψm and 
∆Ψp, our reasoning was that the extracellular dye concentration vs. time kinetic data would also 
contain this quantitative information. 
A key challenge in unlocking this quantitative information was that the net effect of the 
cells on the rhodamine dye concentrations in the medium involved multiple interacting processes.  
A general strategy in this situation is to use inhibitors and treatment conditions to provide 
discriminating data relevant to these processes, and kinetic modeling to obtain values for kinetic 
parameters descriptive of the individual processes involved.  We used a variety of treatment 
conditions and inhibitors to target the processes hypothesized to be involved in dye disposition, 
 ∆Ψm (mV) ∆Ψp 
(mV) 
P1S1  
(µl/min/cm2) 
P2S2  
(µl/min/cm2) 
KPgp 
(µl/min/cm2) 
V1  
(µl/cm2) 
R123 -130 ± 7 -36 ± 4 0.17 ± 0.02   0.18 ± 0.20 0.41 ± 0.07   7.4 ± 0.8 
TMRE -133 ± 4 -49 ± 4* 5.20 ± 0.79* 37.67 ± 47.81 1.92 ± 0.41* 30.5 ± 3.8* 
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and a computational model to interpret the data. 
Computational modeling provides an integrated framework for quantifying the qualitative 
features of the data, as well as a means to evaluate mechanistic hypotheses regarding the processes 
that produce the data (Beard, Bassingthwaighte & Greene, 2005). Generally speaking, 
computational models make use of physical laws (e.g., mass balance) together with existing 
models of subsystems (e.g., Goldman-Katz equation) to describe the interactions among the 
components of a more complex system (e.g., intact cells) (Beard et al., 2005).  Our model 
incorporates mass balance, the Goldman-Katz equation, and linear kinetics to describe the cellular 
disposition of the rhodamine dyes within the cells and the medium.  The model is distinct from, 
and complementary to, certain already existing models for evaluating cell membrane potentials in 
that it allows for contributions of additional cellular processes to dye disposition (e.g., Pgp), 
utilizes extracellular dye concentration data (rather than microscopic measurements of 
intracellular dye) and takes advantage of an entire intact cell population (instead of individual cells 
or isolated mitochondria) (Ward 2010). 
In general, model parameters are not estimable from a single data set or experimental 
condition (Audi et al., 2003; Merker et al., 2004). Instead, a diverse set of experimental protocols 
are needed to provide sufficiently discriminating data to break correlations between the 
contributing processes.  In the present study, the data sets used to obtain the parameter values 
consist of concentration data for two different dyes under four experimental conditions, as a 
function of time (Figure 7.4). The model provided a good fit to the data for the two different dyes, 
and the values obtained for ∆Ψm and ∆Ψp were consistent for the two dyes. They were also 
consistent with values reported for pulmonary arterial endothelial cells in culture using an array of 
                                                                                                                                                              144                                                             
  
other approaches (discussed in more detail below).  Since the values representing Pgp activity 
(Kpgp) and dye permeability surface area product (PS) are determined by physical and chemical 
properties of the dyes rather than by intrinsic properties of the cells, they are not expected to be 
the same for R123 and TMRE. However, as anticipated from the reported higher cell membrane 
permeability of TMRE, the values of P1S1 and P2S2 (normalized to cell surface area) for TMRE 
are higher than those for R123 (Table 7.1) (Duchen et al., 2003;  Loetchutinat et al., 2003).    
To our knowledge, the values for ∆Ψm of 130 ± 7 mV and133 ± 4 mV (means ± 95% C.I.) 
using R123 and TMRE, respectively, obtained in the present study are the first quantification of 
∆Ψm for bovine pulmonary artery endothelial cells in culture.   Previous studies of bovine aortic 
endothelial cells using the potential sensitive triphenylphosphonium ion yielded a ∆Ψm of 220 mV 
(OMalley, Fink & Ross, 2006).  However, it is difficult to make a comparison because the latter 
studies involved isolated mitochondria under hyperpolarizing conditions (e.g., in the presence of 
oligomycin) (OMalley  et al., 2006). 
The study further showed that steady state analysis of TMRE data can be used to obtain 
values for ∆Ψm that were consistent with the values obtained from transient kinetic R123 and 
TMRE data. An application of the steady state approach to quantify the impact of hyperoxic 
exposure on pulmonary endothelial ∆Ψm was demonstrated, and to our knowledge, provides the 
first quantitative assessment of the impact of an oxidative stress on pulmonary endothelial cell 
∆Ψm. Hyperoxic exposure was selected as the stress because elevated O2 is the most common 
treatment for respiratory failure, yet is injurious to the lung, with endothelial cells being a primary 
and early target (Crapo, Barry & Foscue, 1980; Moody, Simon & Johns, 2001). 
For the hyperoxia-exposed cells, resting ∆Ψm was not different from control (room-air) 
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cells, but hyperoxia-exposed cell ∆Ψm was more sensitive to depolarization via uncoupling. It 
should be emphasized that the effect of hyperoxic exposure on pulmonary endothelial 
mitochondria would not have been revealed by measuring only the resting ∆Ψm or if we had used 
only a single commonly used CCCP concentration (5 µM) to depolarize the mitochondria.  
Previous studies have reported various indications of mitochondrial dysfunction in hyperoxia 
exposed rat lung, pulmonary endothelial cells in culture and other cell types (Ahmad et al., 2006; 
Audi et al., 2005, 2008; Bassett et al., 1986, 1989; Merker et al., 1996, 2007; Pruji, Schoonen & 
Joenje, 1992; Schoonen et al., 1990).  In this context, the present observations are consistent with 
a hyperoxia-induced mitochondrial deficiency. 
Previous methods for evaluating stimulation or stress induced alterations in pulmonary 
endothelial cell ∆Ψm using rhodamines or ratiometric probes have in general provided only indices 
of relative changes, estimated from changes in fluorescence intensity (Dedkova & Blatter, 2005; 
Han et al., 2010; Huser et al., 1999; Mungunsukh et al., 2010; You & Park, 2010).  A common 
pitfall in interpreting such data is that the logarithmic form of the Nernst equation specifies that 
changes in fluorescence intensity (and, for ratiometric dyes, ratios derived from such changes) are 
not linearly proportional to changes in ∆Ψm (Nicholls, 2000). In this context, the ratiometric dye, 
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanineiodide (JC-1), exists in a 
monomeric form, with an emission wavelength of 527 nm (green) when excited at 490 nm, but, 
when the dye accumulates in polarized mitochondria, it forms aggregates associated with a large 
shift in emission wavelength, to 590 nm (red) (Di, Blank & Colonna, 1995). Changes in green/red 
fluorescence ratio have been useful in giving a semi-quantitative picture of the impact of various 
stimuli on ∆Ψm. However, aside from the apparently few attempts that have been made to quantify 
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the association between these ratios and ∆Ψm in isolated mitochondria, the quantitative 
relationship between any given ratio change and the corresponding change in ∆Ψm in mV in intact 
cells is not generally considered (Di et al., 1995). Our approach could be viewed as 
complementary to that of JC-1 wherein it would provide a means for quantitative interpretation of 
changes in green/red fluorescence ratios. 
The values for ∆Ψp obtained in the present study were 36 ± 4 mV and 49 ± 4 mV (means 
± 95% C.I.) using R123 and TMRE, respectively (Table 7.1). The difference between the two may 
be attributable to the longer experimental time course needed to overcome the lower membrane 
permeability of R123 as compared to TMRE (as represented by PS products in Table 7.1).  
Previous estimates of cultured bovine pulmonary arterial endothelial ∆Ψp made using whole-cell 
patch clamp have yielded mean values of 26 mV to 67 mV (Adams et al., 2004; Campbell et al., 
1991; Johns et al., 1987; Koliwad et al., 1996; Voets et al., 1996).  The variation may be 
attributable to differences in culture conditions or from error arising from leakage currents (Adams 
et al., 2004; Campbell et al., 1991).  The issue of leakage currents has been addressed by rejecting 
cells displaying resting potentials below a set seal resistance, narrowing the range in values from 
56 mV to 67 mV (Adams et al., 2004; Campbell et al., 1991; Johns et al., 1987).  Issues to 
consider when comparing these values with those obtained in the present study include that the 
“whole cell” patch clamp studies were carried out at room temperature, used estimated values 
based on reversal potentials and involved rupturing the plasma membrane and cell dialysis with 
pipette solutions.   In contrast, we carried out our studies at 37
o
C using a non-destructive protocol.  
An additional point is that patch clamp focuses on relatively small numbers of individual cells, 
which reveals heterogeneity within the population, while our approach is directed at entire cell 
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populations (Campbell et al., 1991; Cannell et al., 1989; Duchen et al., 2003; Koliwad et al., 1996). 
Previous measurements of  ∆Ψm and ∆Ψp using rhodamine dyes have commonly not 
taken into account that they are also Pgp substrates (Mandala, Serck & Martino, 1999; Ward et al., 
2007, 2010; Yeheskely et al., 2009).  For cell types that have few or no multidrug transporters, this 
may be of minimal importance, but multidrug transporters perform a key function in the 
pulmonary endothelium, which is in direct contact with blood borne pharmacological, 
physiological and toxicological substances.  In the present study, the effect of increasing or 
decreasing KPgp by 50% on the dye concentration in the mitochondria [Rm] would be a ~45% 
increase or ~40% decrease for R123 and a 12% increase or 8% decrease for TMRE.  These effects 
could be misinterpreted to represent changes in ∆Ψm and/or ∆Ψp. This concept may be of 
particular importance in studying cell injury, which has been observed to affect Pgp protein levels 
in brain endothelial cells (Robertson, Kania & Hladky, 2009). 
Previous experimental and theoretical studies have been carried out for simultaneous 
assessment of ∆Ψm and ∆Ψp in a variety of non-endothelial mammalian cell types using 
rhodamine dyes and other probes (Farkas et al., 1989; Ward et al., 2000, 2007).  Among these, 
Nicholls used a proprietary ∆Ψp indicator, PMPI, along with tetramethylrhodamine methyl ester to 
monitor changes in both membrane potentials in cultured neurons (Nicholls et al., 2006; Park et al., 
2002).  The combination of probes allowed for a means to account for the impact of changes in 
∆Ψp on the rhodamine dye disposition (Nicholls et al., 2006; Park et al., 2002).  Ward et al. 
developed an elegant computational model to interpret intracellular rhodamine dye fluorescence 
measurements in terms of transmembrane potentials for cultured cerebellar neuronal and granular 
cells (Ward et al., 2000, 2007).  The Ward et al. and Nicholls studies accounted for the impact of 
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∆Ψm, ∆Ψp, membrane permeability and mitochondrial volume fraction, but not for effects of Pgp 
on dye disposition (Nicholls et al., 2006; Park et al., 2002; Ward 2000, 2007).  In contrast to our 
approach, the latter modeling approaches relied on input of initial values for ∆Ψm and ∆Ψp 
obtained in separate studies.  A MATLAB based public web service, TOXI-SIM, was developed as 
a tool for implementing the Ward et al. model, the output of which is information on changes in 
∆Ψm and ∆Ψp relative to fixed initial values (Huber et al., 2009). The approach described in the 
present study may be viewed as complementary in that it could provide initial values for the 
TOXI-SIM tool.  This would allow for quantitative assessment of changes in pulmonary 
endothelial plasma and mitochondrial membrane potentials, including under conditions in which 
changes are rapid relative to the time scale of the present studies. 
In summary, we took several approaches to optimize utility of rhodamine dyes for 
assessing ∆Ψm and ∆Ψp in intact pulmonary arterial endothelial cells.  Dye concentrations were 
maintained in the linear range of fluorescence intensity vs. concentration, overcoming many of the 
complexities associated with interpreting contributions of quenching and dequenching to the 
signals.  Solid microcarrier bead cell cultures optimized the cell surface to medium volume ratio, 
maximizing the impact of the cells on substances in the medium.  Additionally, since the cell 
coated beads rapidly (within ~15 sec) settle out of suspension, medium fluorescence 
measurements are made without exposing cells to light or requiring dissociation from the culture 
surface. 
 In conclusion, this study presents a unique approach for quantification of ∆Ψm and ∆Ψp in 
intact pulmonary endothelial cells, and for evaluating the impact of various stresses (e.g. 
hyperoxia) on the bioenergetic properties of the pulmonary endothelial cells. 
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CHAPTER 8. CONCLUSIONS, FUTURE DIRECTIONS AND CLINICAL 
IMPLICATIONS 
8.1 Conclusions and Future Directions 
 The long-term objectives of this study are to elucidate the underlying mechanisms of rat 
tolerance to 100% O2 and to further understand the mechanisms involved in lung O2 toxicity. A 
series of experiments were performed wherein rats were exposed to either 85% O2 or 60% O2, or 
cultured endothelial cells exposed to 95% O2. 
 The results of this study demonstrate that rat exposure to 85% O2 for 7 days (hyper-85) 
decreases the lung activity of complex I. This decrease is detectable following just 12 hours of 
exposure and persists for at least 7 days of exposure. The results also show that a comparable 
decrease in complex I activity occurs in lung homogenates of rats exposed to 60% O2 for 7 days 
(hyper-60). Previous studies demonstrate that the decrease in complex I activity can impair 
oxidative phosphorylation, decrease ATP production, and hence negatively impact ATP-dependent 
cellular functions (Paradies et al., 2004; Chen et al., 2003). Thus, the decrease in complex I 
activity appears to be an initial event in the sequential events in lung O2 toxicity and hence highly 
important pathologically. 
 The results of this study demonstrate that lung activities of complexes III and IV increase 
in lungs of rats exposed to 85% O2 for 7 days, but not for 2 days. This suggests that the increase in 
the activities of complexes III and IV, which are the downstream components in the electron 
transport chain, might be a result of the decreased complex I activity. The increase in the activities 
of complexes III and IV might serve to accelerate the electron transfer through complex III and 
hence reduce the electron leakage at complex III, the primary site of mitochondrial ROS formation. 
These increases are not detectable in hyper-60 lungs which are 100% O2 susceptible, suggesting 
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the role of complexes III and IV in rat tolerance of 100% O2. However, additional studies would 
be needed to ascertain their specific role in this tolerance. Previous studies on hypoxia indicate 
“Damage occurring in mitochondria during ischemia is associated with a loss of respiratory 
activity of complex I in the electron transport chain; the activity of complex III is also altered but 
this occurs at later time point” (Janssens, Delaive & Houbion, 2000, P1514), which is interestingly 
consistent with the results in this hyperoxic study. Thus, both an increase in O2 supply (hyperoxia) 
and a decrease in O2 supply (hypoxia), which are models of pulmonary oxidative stress, induce a 
loss of the activity of complex I and  a subsequent change in complex III. This suggests a potential 
common mechanism of adaptation to a change in O2 supply. Additional studies using hypoxic rats 
could help to determine this common mechanism. 
 Our experiments showed that exposure to 85% O2 for 7 days, but not 2 days, increases the 
activity of the cytosolic anti-oxidant enzyme NQO1. A comparable increase in NQO1 protein 
expression was measured in lungs of rats exposed to 85% O2 for 7 days, which suggests that the 
increase in NQO1 activity in these lungs might be due to an increase in NQO1 protein expression. 
However, since a similar increase was also measured in lungs of rats exposed to 60% O2 for 7 
days, this increase in NQO1 activity by itself is not sufficient to account for the tolerance of rats 
exposed to 85% O2 for 7 days to 100% O2. 
 An important outcome of this study is the development of a novel approach for 
quantitative estimation of the mitochondrial membrane potential (∆Ψm) in intact cells using 
cationic rhodamine dyes. In normoxic cultured bovine pulmonary arterial endothelial cells 
(BPAEC),  we estimated ∆Ψm to be ~-130 mV. This was done using two different dyes, R123 and 
TMRE, which yielded estimates without statistically difference, suggesting the reliability of our 
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newly-developed approach. Preliminary results using this approach indicate that endothelial cells 
exposed to 95% O2 for 48 hours were able to maintain normal ∆Ψm but with an increased 
sensitivity to a mitochondrial uncoupler, an indicator of endothelial mitochondrial dysfunction. 
Additional studies would be needed to evaluate the effect of prolonged exposure to hyperoxia on 
∆Ψm and the impact of a change in ∆Ψm on mitochondrial bioenergetics. 
8.2 Clinical Implications 
An important outcome from this study is the acquisition of data regarding the 
mechanisms of rat tolerance of 100% O2 toxicity that may translate rapidly into clinical 
therapeutic strategies. For instance, the results of this study highlight the critical role of 
mitochondria, especially the complexes of mitochondrial electron transport chain, in lung O2 
toxicity and O2 tolerance, and points to the mitochondrial electron transport chain as a target for 
protecting the lung from hyperoxia-induced injury. Thus drugs that can counter the hyperoxia-
induced depression in complex I on mitochondrial ATP production may provide protection against 
O2 toxicity. Aescine, a venotropic drug used in the treatment of chronic peripheral ischemia, has 
been shown to decrease endothelial cell death and to protect endothelial cells against the 
hyperoxia-induced decrease in ATP content and the injury caused by mitochondrial metabolic 
inhibitors (Janssens, Delaive & Houbiion, 2000). This suggests the potential utility of aescine for 
countering hyperoxia-induced mitochondrial dysfunction.  
Metformin, a mild complex I inhibitor and widely used Type II diabetes drug, has been 
shown to provide a protective role against endotoxin-induced acute lung injury (Zmijewski, Lorne 
& Zhao, 2008). Using bovine heart mitochondria, Nadanaciva et al. demonstrated that metformin 
not only decreased the activity of complex I but also slightly increased the activity of complex IV 
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(Nadanaciva, Bernal & Aggeler, 2007). The effect of metformin on the activities of complexes I 
and IV is consistent with the changes we observed in O2 tolerant hyper-85 rats. This might explain 
how metformin protects the lung against endotoxin-induced acute injury, and suggests that 
metformin might could be a potential drug to induce O2 tolerance. However, since metformin 
inhibits complex I and hence mitochondrial ATP production, this stimulates glycolysis and result 
in lactic acidosis,  which occurs in approximately 1% of cases (Price, 2003; Spiller & Quadrani, 
2004). Thus, additional studies are needed to validate the comprehensive effect of metformin on 
lung O2 toxicity.  
 Presently, there is no clinical means for detecting early lung O2 injury secondary to 
hyperoxia, i.e., before injury can be detected by CT scans. An important outcome of this study is 
that the depression in complex I activity could be a key and early event in lung O2 toxicity, i.e., 
occurring prior to significant structural, hemodynamic or morphometric changes. This suggests 
that new strategies for early identification of O2 injury ought to focus on methods for evaluating 
changes in complex I activity. I
123
-iodorotenone, a radioiodinated rotenone analog, is a lipophilic, 
neutral single-photon emission computed tomography (SPECT) imaging biomarker that binds to 
the ubiquinione site of complex I (VanBrocklin et al., 2007). This biomarker was developed to 
assess myocardial perfusion in vivo but also showed significant quantifiable uptake in the lung 
(VanBrocklin et al., 2007). Thus, I
123
-iodorotenone could be used to detect a hyperoxia-induced 
decrease in complex I activity as an early index of lung O2 injury. Since, I
123
-iodorotenone is an 
analog of rotenone, a potent inhibitor of complex I, a study on the potential toxic effect of I
123
-
iodorotenone is also needed. 
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The redox sensitive, SPECT imaging agent hexamethylpropyeneamine oxime (
99m
Tc–
HMPAO)  is an FDA-approved cerebral blood flow imaging agent (Inoue, Nakagawa & Goto, 2003), 
but there is evidence that it also serves as a marker of lung injury (Suga, Uchisako & Nishigauchi, 
1994; Hang, Shiau & Hsu, 2003). For instance, increased HMPAO uptake has been reported in 
subclinical lung injury due to chemotherapy, irradiation lung injury, diabetes and smoking injuries in 
the absence of significant perfusion impairment or x-ray abnormalities (Suga et al., 1994; Chang et 
al., 2004). Previous studies have shown that the cellular uptake of HMPAO is dependent on 
intracellular GSH content and other factors, including mitochondrial dysfunction (Jacquier, Polla & 
Slosman, 1996; Shimura, Musya & Hashimoto, 2000). The results of this study demonstrate an 
increase in GSH content in lungs of hyper-85 rats, but not hyper-60 rats.  Preliminary data by Drs. 
Clough and Audi suggest an increase in the lung uptake of HMPAO in lungs of hyper-85 rats, but 
not hyper-60 rats (Clough, Haworth & Audi, 2010). Based on these results, the ability of lung tissue 
to increase its capacity to generate GSH as measured by HMPAO uptake may be indicative of the 
ability of a critically ill patient to tolerate sustained exposure to O2 at high fractions (Chang, Liu 
and Lin, 2004). In contrast, a patient with the same O2 requirement and no increase in HMPAO 
uptake could be at a much higher risk for irreversible lung injury. In this case, the patient with 
evidence of enhanced susceptibility to hyperoxia would be a candidate for more invasive and 
expensive therapies (e.g., extracorporeal membrane oxygenation) or acceptance of lower arterial 
O2 tension. 
Exposure to >95% O2 causes lung O2 toxicity with a 4~22 hours latent period in which 
no overt clinical manifestations of toxicity can be detected (Bitterman, 2009). The duration of this 
latent period is inversely proportional to the level of inspired O2. Most clinicians believe that the 
                                                                                                                                                              154                                                             
  
treatment with 50%~60% O2 is relatively safe for humans (Clark & Lambertsen, 1971; Bitterman, 
2009). Though there is no substantial morphologic or structural change in lungs of rats exposed to 
60% O2 (Crapo et al., 1980, Hayatdavoudi et al., 1981), this study demonstrated a decrease in 
complex I activity and an increase in NQO1 activity in these lungs. These biochemical changes 
suggest the potential for toxicity caused by 60% O2 exposure, and hence 60% O2 therapy in the 
clinic might not be as safe as clinicians currently believe.  
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APPENDIX I  -  Recipes 
 
Krebs-ringer bicarbonate buffer (KRB) 
 
Stock solutions:  
KCl 0.07 g/ ml H2O 
CaCl2·2H2O 0.0737 g/ ml H2O 
MgSO4 ·7H2O 0.058 g/ ml H2O 
KH2PO4 0.032 g/ ml H2O 
 
Buffer composition 
0.5 ml of each stock / 100 buffer 
NaCl 0.69 g/100 ml buffer 
Dextrose 0.1 g/100 ml buffer 
NaHCO3 0.21 g/100 ml buffer 
 
 
5% Bovine Serum Albumin Perfusate (BSA) 
 
5 g BSA / 100 ml KRB 
PH 7.4 
 
5% Dextran Perfusate (KD) 
 
5 g dextran / 100 ml KRB  
PH 7.4 
 
 
Perfusate containing FAPGG 
 
Stock 
0.75 mg FAPGG/ ml ETOH 
2. 9 mg ZnSO4.7H2O / ml H2O 
 
Perfusate composition 
0.1 ml FAPGG stock / 12 ml perfusate 
132 µl ZnSO4 stock / 12 ml perfusate 
 
 
Perfusate containing Rotenone 
 
Stock  
Rotenone 3.944 mg/ ml DMSO 
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20 µM Perfusate 
20 µl rotenone stock / 10 ml perfusate 
 
 
Perfusate containing Dicumarol 
 
Stock 
Dicumarol 43.7 mg/ ml DMSO 
 
400 µM Perfusate 
310 µl dicumarol stock to 10 ml perfusate 
  
  
Perfusate containing Antimycin A 
 
Stock  
2.743 mg antimycin A/ ml DMSO 
 
10 µΜ Perfusate 
200 µl antimycin A stock/ 10 ml perfusate 
 
 
Perfusate containing KCN 
 
Stock  
130 mg KCN/ ml H2O 
 
2 mM Perfusate 
100 µl KCN stock/ 10 ml prepared perfusate 
 
 
Perfusate containing CoQ1 
 
Stock 
5 mg CoQ1 / ml DMSO 
 
400 µM Perfusate 
20.4 µl CoQ1 stock/ 10 ml perfusate 
 
Perfusate containing DQ 
 
stock 
3.284 mg DQ / ml DMSO 
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400 µM perfusate 
20.4 µl DQ stock/ 10 ml perfusate 
 
 
Perfusate containing CoQ1H2 
 
Stock 
5 mg CoQ1 / ml DMSO 
4 mg NaOH / ml H2O 
0.2 ml 1M HCl / ml H2O 
27 mg KBH4 / ml NaOH stock 
37 mg EDTA / ml H2O 
CoQ1H2 stock: 
 Take 375 µl CoQ1 stock into a 0.65 ml micro centrifuge tube 
 Add 15 µl KBH4 stock into the tube, keep reacting in darkness for 1 hour. 
 Add 75 µl HCl stock, mixes slowly 
 Add 5 µL EDTA stock, keep reacting in darkness for 30 min 
 
400 µM Perfusate 
25.56 µl CoQ1H2 stock/ 10 ml perfusate 
 
 
Perfusate containing DQH2 
 
Stock 
3.284 DQ / ml DMSO 
4 mg NaOH / ml H2O 
0.2 ml 1M HCl / ml H2O 
27 mg KBH4 / ml NaOH stock 
37 mg EDTA / ml H2O 
DQH2 stock: 
 Take 375 µl DQ stock into a 0.65 ml micro centrifuge tube 
 Add 15 µl KBH4 stock into the tube, keep reacting in darkness for 1 hour. 
 Add 75 µl HCl stock, mixes slowly 
 Add 5 µL EDTA stock, keep reacting in darkness for 30 min 
 
400 µM Perfusate 
25.56 µl DQH2 stock/ 10 ml perfusate 
 
Perfusate containing Amplex Red 
 
Stock 
5 mg amplex red / 1.943 ml DMSO 
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50 µM perfusate 
50 µl amplex red stock/10 ml perfusate 
 
 
Perfusate containing apocynin 
 
Stock 
apocynin 16.62 mg / ml ETOH 
 
1 mM perfusate 
100 µl apocynin stock / 10 ml perfusate 
 
 
Perfusate containing Diethylmaleate 
 
Stock 
0.1 ml 97% DEM / ml DMSO 
 
6 mM perfusate 
100 µl stock/10 ml perfusate 
 
 
Perfusate containing horseradish peroxidase 
 
Stock 
2 mg horseradish peroxidase / ml H2O 
 
5U perfusate 
100 µl stock/10 ml perfusate 
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APPENDIX II - Data Processing Codes 
 
A. Codes for estimation of tube-binding coefficient 
A.1 tube_model.m 
function tube_model 
% Function:  Find the optimized value for the parameters  
% Input:     experimental data 
% Output:    optimized value of parameters 
% Format of input data:  
%        1st column: sampling time 
%        2nd column: normalized [R]e at corresponding sampling time without cells 
% By Z Gan, updated on 04-17-2011 
   
clear global 
close all 
  
% open data file 
infile = 'tube.txt'; 
fid = fopen(infile, 'r');   
if fid < 1 
    input('invalid filename, press any key to end the program.', 's'); 
else   
    % get data  
    expdata = textscan(fid,'%f %f'); 
    fclose(fid); 
    mtime = (expdata{1})'; 
    tube = (expdata{2})'; 
     
    % set initial values  
    k1 = 0.0004382;  % Rate constant for dye-cuvette binding (min
-1
 nM
-1
) 
    k2 = 0.00079704; % Rate constant for dye-cuvette unbinding (min
-1
) 
     
    % define parameters which will be optimized 
    p0 = [k1 k2]; 
    % define lower and upper bound  
    lb = [0 0]; 
    ub = [1 1]; 
     
    % define time points used for optimization 
    tdata = mtime; 
     
    % define data used for optimization 
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    ydata = tube; 
   
    % define the optimization options 
    options=optimset('TolX',1e-8,'MaxFunEvals',3000); 
     
    % fitting model to input data and find out the optimized values for parameters 
    [p, ssd, residual,exitflag,output,lambda,nJa] = lsqcurvefit(@solve_tube, p0, tdata, ydata, lb, ub, 
options); 
  
    % calculate correlation matrix 
    [Q,R]=qr(nJa); 
    R1 = R(1:length(p), :); 
    h=inv(R1'*R1); 
    for i=1:length(p) 
        for j=1:length(p) 
            cc(i,j)=h(i,j)/(h(i,i)*h(j,j))^0.5; 
        end 
    end 
     
    % calculate confidence interval 
    s2=ssd/(length(ydata)-length(p)); 
    for i = 1:length(p) 
        seb(i)=(s2^0.5)*(h(i,i)^0.5); 
    end 
    ci=seb.*2.01 
     
    % display the estimated values and related results 
    fprintf('   k1 = %f ml/min\n', p(1)); 
    fprintf('   k2 = %f ml/min\n', p(2)); 
    fprintf('   ci = %f %f \n', ci); 
    fprintf('   ssd = %f \n', ssd);    
     
end 
 
A.2 slove_tube.m 
function yy = solve_tube (p,t) 
% Function: calculate [R]e according to given parameters 
% Input:    p: parameters  
%               t: sampling time 
% Output:   An array of [R]e 
% By Z Gan, updated on 04-17-2011 
  
k1 = p(1); 
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k2 = p(2);  
  
% calculate [R]e based on tubing-binding model 
for i=1:length(t) 
    Y11(i)= (k2+k1*exp(-(k1+k2)*t(i)))/(k1+k2); 
end 
  
% return [R]e 
yy = [Y11]; 
end 
 
 
B. Codes for rhodamine distribution model 
B.1 optimize_rhodamine.m 
function optimize_rhodamine 
% Function:  Find the optimized value for the parameters  
% Input:    experimental data 
% Output:  optimized value of parameters 
% By Z Gan, updated on 04-14-2011 
% Format of input data:  
%    1st column: sampling time 
%    2nd column: [R]e at corresponding sampling time with cells only 
%    3rd column: [R]e at corresponding sampling time with cells in the presence of CCCP 
%    4th column: [R]e at corresponding sampling time with cells in the presence of GF 
%    5th column: [R]e at corresponding sampling time with cells in the presence of HK 
%    6rd column: [R]e at corresponding sampling time with cells in the presence of CCCP and GF 
%    7th column: [R]e at corresponding sampling time with cells in the presence of CCCP and HK 
%    8th column: [R]e at corresponding sampling time with cells in the presence of GF and HK 
%    9th column: [R]e at corresponding sampling time with cells in the presence of CCCP, HK,GF 
  
clear global 
close all 
global params tt cccp150tt n data0 nCond nPara vmratio  
  
% index of optimization loop 
n = 0;   
v1 = 2.65;                     % volume of extracellular solution (ml) 
k1b = 0.0043;               % Rate constant for dye-cuvette unbinding (nM
-1
 min
-1
) 
km1 = 0.0897;              % Rate constant for dye-cuvette unbinding (min
-1
) 
zf_rt = 0.0374158;        % const of RT/ZF 
ps1 = 0.094;                  % PS product of rhodamine dye for plasma membrane (ml/min) 
ps2 = 0.0105;                % PS product of rhodamine dye for mitochondrial membrane (ml/min) 
v2  = 0.44;                   % volume of cytoplasma (ml) 
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v3  = 0.0088;               % volume of mitochondria (ml) 
vmaxkm = 0.025;        % Kpgp, P-glycoprotein mediated dye efflux rate (ml/min) 
delp = 35;                    % plasma membrane potential (mV) 
delm = 130;                 % mitochondrial membrane potential (mV) 
vmratio = 0.02;            % the ratio between cytosol volume and mitochondrial volume 
  
%open file, read experimental data to be fit 
infile = 'ndata9.dat'; 
fid = fopen(infile, 'r');   
if fid < 1 
    input('invalid filename, press any key to end the program.', 's'); 
else   
    %open data file  
    data150 = textscan(fid,'%f %f %f %f %f %f %f %f %f %f %f'); 
    fclose(fid); 
    %get data  
    tt = (data150{1})';     %  sampling time 
    cell=(data150{2})';   % data for cells + dye only 
    cccp=(data150{3})'; % data for cells+ dye + CCCP 
    gf = (data150{4})';   % data for cells+ dye + GF 
    hk = (data150{5})';  % data for cells+ dye + HK 
    cccpgf=(data150{6})'; % data for cells+ dye + CCCP+GF 
    cccphk = (data150{7})'; % data for cells+ dye + CCCP+HK 
    gfhk = (data150{8})'; % data for cells+ dye + GF+HIK 
    cccpgfhk = (data150{9})'; % data for cells+ dye + CCCP+GF+HK 
     
    % get the initial value of each array 
    data0=[cell(1) cccp(1) gf(1) hk(1) cccpgf(1) cccphk(1) gfhk(1) cccpgfhk(1)]; 
     
    % define all parameters for the model 
    params = [ps1, ps2, v2, v3, vmaxkm, delp, delm, k1b, km1, zf_rt, v1]; 
     
    % define the data which will be used to estimate parameters  
    indata = [cell gf  gfhk  cccpgfhk]; 
     
    % define the corresponding sampling time points 
    ttdata = [tt tt tt tt ]; 
       
    % define the parameters which will be estimated 
    p0 = [ps1, ps2, v2, vmaxkm, delp, delm]; 
     
    % define the lower bound of parameters 
    lb = [0.0001, 0.0001, 0.0001, 0.0001, 0.0001, 0.0001]; 
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    % define the upper bound of parameters 
    ub = [10 10 10 10 200 300]; 
       
    % define the optimization options 
    options = optimset('TolX',1e-8,'MaxFunEvals',3000); 
     
    % fitting model to input data and find out the optimized values for parameters 
    [p, ssd, residual,exitflag,output,lambda,nJa] = lsqcurvefit(@solve_rhodamine, p0, ttdata, indata, 
lb, ub, options); 
     
    % calculate correlation coefficient 
    [Q,R]=qr(nJa); 
    R1 = R(1:length(p), :); 
    h=inv(R1'*R1); 
    for i=1:length(p) 
        for j=1:length(p) 
            cc(i,j)=h(i,j)/(h(i,i)*h(j,j))^0.5; 
        end 
    end 
     
    % calculate confidence interval 
    s2=ssd/(length(indata)-length(p)); 
    for i = 1:length(p) 
        seb(i)=(s2^0.5)*(h(i,i)^0.5); 
    end 
    tt=2.01;  % constant for freedom 40-60 
    ci=seb.*tt; 
  
    % display the optimized values of parameters and related results 
    fprintf('result:\n   PS1 = %f ml/min\n', p(1)); 
    fprintf('   PS2 = %f ml/min\n', p(2)); 
    fprintf('   V2 = %f ml\n', p(3)); 
    fprintf('   V3 = %f ml\n', vmratio*p(3)); 
    fprintf('   VmaxKm = %f ml/min\n', p(4)); 
    fprintf('   PMP = %f mV\n', p(5)); 
    fprintf('   MMP = %f mV\n', p(6)); 
    fprintf('   SSD = %f\n', ssd);   
    ci 
      
end 
 
B.2 slove_rhodamine.m 
function Cmatch = solve_rhodamine(p, ttdata) 
% Function:  calculate [R]e with given parameters  
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% Input:    p: given parameters 
%            ttdata: sampling time 
% Output:  An array of [R]e 
% By Z.Gan, updated on 04-17-2011 
  
%declare global variables 
global  params tt cccp150tt n data0 nCond nPara vmratio 
  
% show the index of optimization loops 
n=n+1 
% show the values of parameters during optimization process 
p 
  
% set a small constant instead of zero, provent from dividing by zero 
nSmall = 0.001; 
  
% define an available to store updated parameters 
parameter_values1 = params; 
parameter_values1(1) = p(1);        % ps1 
parameter_values1(2) = p(2);        % ps2 
parameter_values1(3) = p(3);        % v2 
parameter_values1(4) = vmratio*p(3);% v3 
parameter_values1(5) = p(4);        % vmaxkm 
parameter_values1(6) = p(5);        % delp 
parameter_values1(7) = p(6);        % delm 
  
% define the optimization options 
options=odeset('RelTol', 1e-7); 
  
% calculate [R]e without inhibitors with given parameters 
temp = parameter_values1; 
y110  = [data0(1),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine, tt, y110, options, temp); 
CELL = Y11(:,1); 
  
% calculate [R]e in the presence of GF with given parameters 
temp = parameter_values1; 
% set Vmaxkm for Pgp to 0 
temp(5) = 0;                    
y110  = [data0(3),  0,  0, 0]';            
[T11,Y11] = ode45(@rhodamine, tt, y110, options, temp); 
GF=Y11(:,1); 
  
% calculate [R]e in the presence of GF and HK with given parameters 
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temp = parameter_values1; 
% set Vmaxkm for Pgp to 0; Set plasma membrane potential close to 0 
temp(5) = 0.0;                   
temp(6) = nSmall;  
y110  = [data0(7),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine, tt, y110, options, temp); 
GFHK=Y11(:,1); 
  
% calculate [R]e in the presence of GF,HK and CCCP with given parameters 
temp = parameter_values1; 
% set Vmaxkm for Pgp to 0; set plasma membrane potential close to 0 
% set mitochondrial membrane potential close to 0 
temp(5) = 0;                        % vamxkm=0 
temp(6) = nSmall;               % delp =0 
temp(7) = nSmall;               % delm =0 
y110  = [data0(8),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine, tt, y110, options, temp); 
CCCPGFHK=Y11(:,1); 
  
% return [R]e under above selected conditions 
Cmatch = [CELL' GF' GFHK' CCCPGFHK']; 
end 
 
B.3 rhodamine.m 
function dydt = rhodamine(time, y, parameters) 
% Function: calculated [R]e at a specific time with given parameters based on rhodamine 
distribution model  
% Input:   time: sampling time 
%          y: concentrations of rhodamine in extracellular medium, 
%              cytosol, mitochondria and bound to tubing 
%          parameters: an array of constants for rhodamine distribution 
%          model 
% Output: [R]e 
% By Z Gan, updated on 04-14-2011 
  
% rhodamine concentration in mediu (nM) 
C1    = y(1);             
% rhodamine concentration in cytoplasm (nM) 
C2    = y(2);             
% rhodamine concentration in mitochondrial matrix (nM) 
C3    = y(3);             
% bound rhodamine (nM) 
C1P   = y(4);             
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ps1        = parameters(1);   % PS product of rhodamine dye for plasma membrane (ml/min) 
ps2        = parameters(2);   % PS product of rhodamine dye for mitochondrial membrane (ml/min) 
v2          = parameters(3);  % volume of cytoplasma (ml) 
v3          = parameters(4);  % volume of mitochondrial (ml) 
vmaxkm      = parameters(5); % Kpgp, P-glycoprotein mediated dye efflux rate (ml/min) 
delp       = parameters(6);  % plasma membrane potential (mV) 
delm      = parameters(7);  % mitochondrial membrane potential (mV) 
k1b        = parameters(8);  % Rate constant for dye-cuvette unbinding (nM
-1
 min
-1
) 
km1       = parameters(9);  % Rate constant for dye-cuvette unbinding (min
-1
) 
alfa        = parameters(10); % const of RT/ZF 
v1          = parameters(11); % volume of extracellular solution (ml) 
 
% rhodamine distribution model 
constp0 = exp(alfa*delp); 
constp1 = ps1*alfa*delp*constp0/(constp0-1); 
constp2 = ps1*alfa*delp/(constp0-1); 
  
constm0 = exp(alfa*delm); 
constm1 = ps2*alfa*delm*constm0/(constm0-1); 
constm2 = ps2*alfa*delm/(constm0-1); 
  
a11 = -k1b - constp1/v1; 
a12 =  vmaxkm/v1 + constp2/v1; 
a13 =  0; 
a14 =  km1; 
  
a21 =  constp1/v2; 
a22 = -vmaxkm/v2 - constp2/v2 - constm1/v2; 
a23 =  constm2/v2; 
a24 =  0; 
  
a31 =  0; 
a32 =  constm1/v3; 
a33 = -constm2/v3; 
a34 =  0; 
  
a41 =  k1b; 
a42 =  0; 
a43 =  0; 
a44 = -km1; 
  
dC1dt   = a11*C1 + a12*C2 + a13*C3 + a14*C1P; 
dC2dt   = a21*C1 + a22*C2 + a23*C3 + a24*C1P; 
dC3dt   = a31*C1 + a32*C2 + a33*C3 + a34*C1P; 
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dC1Pdt  = a41*C1 + a42*C2 + a43*C3 + a44*C1P; 
  
% return resulting [R]e in extracellular medium, cytosol, mitochondria and 
% bound to tubing 
dydt = [dC1dt; dC2dt; dC3dt; dC1Pdt]; 
 
B.4 simulate_ rhodamine.m 
function simulate_rhodamine 
% Function:  simulate [R]e with given parameters  
% Input:     none 
% Output:    a datafile containing simulated data for 9 conditions 
% By Z Gan, updated on 04-17-2011 
  
clear global 
  
% define constant 
v1 = 2.65;                   % volume of extracellular solution (ml) 
k1b = 0.004286;         % Rate constant for dye-cuvette unbinding (nM
-1
 min
-1
) 
km1 = 0.089737;        % Rate constant for dye-cuvette unbinding (min
-1
) 
zf_rt = 0.0374158;     % const of ZF/RT 
ps1 = 0.005;               % PS product of rhodamine dye for plasma membrane (ml/min) 
ps2 = 0.005;               % PS product of rhodamine dye for mitochondrial membrane (ml/min) 
v2  = 0.2;                    % volume of cytoplasma (ml) 
v3  = 0.02;                  % volume of mitochondria (ml)a 
vmaxkm = 0.02;         % Kpgp, P-glycoprotein mediated dye efflux rate (ml/min) 
delp = 50;                   % plasma membrane potential (mV) 
delm = 160;                % mitochondrial membrane potential (mV) 
vmratio = 0.02;          % the ratio between cytosol volume and mitochondrial volume 
  
% define constants for rhodamine models 
params = [ps1, ps2, v2, v3, vmaxkm, delp, delm, k1b, km1, zf_rt, v1]; 
  
% define sampling time  
tt = [0 10 30 60 90 120 150]; 
  
% define given values for simulation parameters 
p = [0.009777  0.007747   0.443182  0.025156   35.772977   127.937142]; 
  
% define inital value of [R]e (when t=0) 
data0 =[9.0270    9.0378    9.0591    8.8482    9.0830    8.9201    8.9470    8.9872    9.0270]; 
  
params(1) = p(1);           % ps1 
params(2) = p(2);           % ps2 
params(3) = p(3);           % v2 
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params(4) = p(3)*vmratio;   % v3 
params(5) = p(4);           % vmaxkm 
params(6) = p(5);           % delp 
params(7) = p(6);           % delm 
  
% define a small number instead of zero 
nSmall = 0.001; 
  
% define sampling time points 
tt =0:1:300;  
% define a time avariable for adding CCCP after 150 minutes 
cccp150tt=150:1:300; 
  
% define the optimization options 
options = odeset ('RelTol', 1e-6); 
  
% calculate [R]e without inhibitors with given parameters 
temp = params; 
y110  = [data0(1),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine, tt, y110, options, temp); 
CELL = Y11(:,1); 
  
% calculate [R]e adding CCCP after 150 minutes  
temp = params; 
temp(7)=nSmall;                  
y110 = [Y11(151,1), Y11(151,2), Y11(151,3), Y11(151,4)]; 
[T11,Y11] = ode45(@rhodamine, cccp150tt, y110, options, temp); 
CELL150 = [CELL(1:151); Y11(2:151,1)]; 
  
% calculate [R]e in the presence of CCCP with given parameters 
% set mitochondrial membrane potential to 0 
temp = params; 
temp(7) = nSmall;           
y110  = [data0(2),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine,tt, y110, options, temp); 
CCCP = Y11(:,1); 
  
% calculate [R]e in the presence of GF with given parameters 
% set Kpgp to 0 
temp = params; 
temp(5) = 0;           
y110  = [data0(3),  0,  0, 0]';     
[T11,Y11] = ode45(@rhodamine,tt, y110, options, temp); 
GF=Y11(:,1); 
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% calculate [R]e in the presence of HK with given parameters 
% set plasma membrane potential to 0 
temp = params; 
temp(6) = nSmall; 
y110  = [data0(4),  0,  0, 0]';        
[T11,Y11] = ode45(@rhodamine,tt, y110, options, temp); 
HK=Y11(:,1); 
  
% calculate [R]e in the presence of CCCP and GF with given parameters 
% set mitochondrial membrane potential, Kpgp to 0 
temp = params; 
temp(5) = 0;              
temp(7) = nSmall;          
y110  = [data0(5),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine, tt, y110, options, temp); 
CCCPGF=Y11(:,1); 
  
% calculate [R]e in the presence of CCCP and HK with given parameters 
% set mitochondrial membrane potential, plasma membrane potential to 0 
temp = params; 
temp(7) = nSmall;       
temp(6) = nSmall;       
y110  = [data0(6),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine,tt, y110, options, temp); 
CCCPHK=Y11(:,1); 
  
% calculate [R]e in the presence of GF and HK with given parameters 
% set Kpgp, plasma membrane potential to 0 
temp = params; 
temp(5) = 0.0;              
temp(6) = nSmall; 
y110  = [data0(7),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine,tt, y110, options, temp); 
GFHK=Y11(:,1); 
  
% calculate [R]e in the presence of GF, CCCP and HK with given parameters 
% set Kpgp, plasma membrane potential and mitochondrial membrane potential to 0 
temp = params; 
temp(7)=nSmall;                   
temp(5)=0;                         
temp(6)=nSmall; 
y110  = [data0(8),  0,  0, 0]'; 
[T11,Y11] = ode45(@rhodamine,tt, y110, options, temp); 
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CCCPGFHK=Y11(:,1); 
  
% save simulated data 
str1 = input('Would you like to save these results, input the file name or input 0: ', 's'); 
if str1 == '0'; 
else 
    fid = fopen(str1,'w'); 
    for i = 1:length(tt) 
       fprintf(fid,'%f\t%f\t%f\t%f\t%f\t%f\t%f\t%f\t%f\t%f\n',tt(i),CELL(i),CCCP(i), GF(i), HK(i), 
CCCPGF(i), CCCPHK(i), GFHK(i), CCCPGFHK(i), CELL150(i)); 
   end 
    fclose(fid); 
end 
end 
 
C. Codes for rhodamine steady state model 
C.1 steady_delm_calculation.m 
function  steady_delm_calculation 
% Function:  calculate mitochondrial membrane potential according to steady_state model 
% Input:  [R]e 
% output:  mitochondrial membrane potential 
% Created by Z Gan, updated on 04-20-2011 
 
% steady_state concentration of medium R123 without cells ;   
% intial Re=9.0 nM, @150 minutes, it is about 0.9522*Re 
Res0=8.5698;                     
% steady_state concentration of medium R123 with cells in the presence of GF+HK+CCCP (nM) 
Res1=7.3991;                      
% steady_state concentration of medium R123 with cells in the presence of GF+HK (nM) 
Res2=5.1121;     
% The ratio between Vm and Vc 
beta=0.02;        
% const of ZF/RT,    
alfa=0.0374158;   
% extracelluar volume, ml 
Ve=2.65;          
% steady state model 
Vc = (Res0-Res1)*Ve/Res1/(1+beta) 
Rms = (Res0*Ve-Res2*Ve-Res2*Vc)/(Vc*beta) 
delm = log(Res2/Rms)/alfa 
% display the result 
fprintf('When beta= %f, MMP = %f mV\n', beta, delm); 
end 
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D. Codes for CoQ1/CoQ1H2 metabolism model 
D.1 gan_fitCoQ1.m 
% Function:  estimate Vmax and Km of complex I, complex III, NQO1 and other reductase %                   
%                        by fitting CoQ1 distribution model to experimental data  
% Input:  experimental data 
% Output:  estimated values of Vmax(s) and Km(s) 
% Created by Zhuohui Gan on 12-2010, updated on 04-20-2011                                                                     
 
clear variables 
global n 
  
%Parameter entry  
redo1 = 1; 
while(redo1) 
   % Enter parameters 
   par = gan_GetCoQ1Parameters(); 
   if par == -9999 
       disp('Error during parameter acquirement.'); 
       return; 
   else 
    homorg = par(17);  % 0: hetergenous  1: homogenous 
    % calculate peclet 
    for i = 1:(2-homorg)  % why pe calculated before adjustment of tibar, tcbar? 
      pe(i) = gan_Peclet(par(3*i-2),par(3*i-1)); 
      if (pe(i) <= 0) 
         disp(['    when tibar=' num2str(par(3*i-2)) '   vari must be <' num2str(par(3*i-1))]); 
      else 
         redo1 = 0;     
      end 
    end 
  end 
end 
  
% define all constants or parameters 
tibar   = par(1); % non-capillary mean transit time (sec) 
vari    = par(2); % variance of non-capillary  
avsi    = par(3); % shift for tibar 
tcbar   = par(4); % capillary mean transit time (sec) 
varc    = par(5); % variance of capillary  
avsc    = par(6); % shift for tcbar 
vmax1   = par(7); % m-m vmax for NQO1 mediated Q reduction (umol/min) 
akm1    = par(8); % m-m constant for NQO1 mediated Q reduction (uM) 
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vmax2   = par(9); % m-m vmax for complex III mediated QH oxidation (umol/min) 
akm2    = par(10); % m-m constant for complex III mediated QH oxidation (uM) 
qf1     = par(11); % virtual capillary volume (ml) 
qf2     = par(12); % virtual lung tissue volume (ml) 
alb1    = par(13); % apperant binding ratio between Q-Pc and Q-Pe for quinone (a1/a2) 
alb2    = par(14); % apperant binding ratio between QH-Pc and QH-Pe for hydroquione (a3/a4) 
qdot    = par(15); % flow (ml/s) 
dose    = par(16); % infused probe concentration  (uM) 
homog   = par(17); % homogenous or hetergenous 1=homogenous 
dt      = par(18); % time resolution (sec) 
tinj    = par(19); % total inject time (for input, sec) 
tsp     = par(20); % delay time (for input, sec) 
tfinal  = par(21); % time when the venous sample was collected (sec) 
alpha   = par(22); % constant for input function  
qflag   = par(23); % 1=Q, 0=QH 
vmax3   = par(24); % m-m vmax for complex I mediated Q reduction (umol/min) 
akm3    = par(25); % m-m constant for complex I mediated Q reduction (uM) 
vmax4   = par(26); % m-m vmax for other Q reduction (umol/min) 
akm4    = par(27); % m-m constant for other Q reduction (uM) 
  
% check the initial setting for the program 
if (tcbar <= 0) 
   disp('    tcbar <0, so program stopped.') 
   return; 
end 
if (tfinal <= 0) 
   disp('    tfinal<=0, Program stopped.') 
   return; 
end 
if qflag==1 
    disp('   Your infused probe is quione.'); 
elseif qflag==0 
    disp('   Your infused probe is hydroquione..'); 
else  
    disp('   Your infused probe flag is mistaken,quit program.'); 
    return; 
end 
 
%initialized variables 
ndim = round(tfinal/dt);  % # points of time axis 
npdes = 3;    % # of pdes for 1 model 
fcmin = 0.01;    % covered area 
dx      = dt/tcbar;   % normalized deltx , deltz  
qc      = qdot*tcbar;  % capillary volume (ml) 
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delx    = dx*tcbar;  % consider the delay into mean transit time 
tibar = tibar + avsi;  
tcbar = tcbar + avsc; 
  
% set up pe, tihat 
if homorg ==1 
    pei = pe(1); 
    pec = 0; 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
else 
    pei = pe(1); 
    pec = pe(2); 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
    tchat = tcbar/(1+2/pec); 
end 
  
hcpdf = zeros(1,ndim); % capillary transit time distribution   
hnpdf = zeros(1,ndim); % non-capillary transit time distribution 
if (homorg==1) 
   % if it is a homogeneous organ 
   iend = 1/dx + 0.001; % the last spacial point 
   test = 1.0/dx - iend; 
   if (test > 0.001) 
      disp(['    For a homogenous organ, 1/dx must be an integer, now 1/dx=' num2str(1/dx)]); 
      disp(['    With this dx, capillary mmt will be changed to ' num2str(iend*delx)]); 
      C_ok = input('Continue or Start over (C = continue)? ','s'); 
      if (C_ok == 'C' | C_ok == 'c') 
         tcbar = iend*delx; 
      else 
         return; 
      end 
   end 
   ibeg = iend; % since it is homogenous, so no scalar required 
else 
   % if it is not a hetergeneous organ 
   disp(['    dose=' num2str(dose)]); 
   % capillary distribution function 
   hcpdf = hcpdfunc(ndim,delx,avsc,tchat,pec);    
   % find the begin and the end, but for hetergenous organ, ibeg ==1  
   [ibeg,iend] = begendfunc(hcpdf,ndim,fcmin); 
   %Renormalize hc(t) to unit area 
   hcpdf = hcpdf(2:ndim); % get rid of the first point, because  
   % from first point to iend point, which is supposed to be 99.9% covered. 
   hcpdf = hcpdf(1:iend); 
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   % to get an interget for the area under the capillary function 
   ac = trapz(hcpdf)*dt; 
   % rescale ,so 100% area 
   hcpdf = hcpdf./(ac/delx); 
    
   %Noncapillary transport function 
   qd = qdot*tihat; % non-capillary volume 
   hnpdf = gan_hnpdfunc(ndim, par, qd); %non-capillary input function 
   hnpdf = hnpdf(2:ndim); 
   ibeg = 1; 
   disp(['    ibeg=' num2str(ibeg) '      iend=' num2str(iend)]); 
end 
  
captmin = ibeg*delx; 
captmax = iend*delx; 
disp(['    min/max capillary times are [ ' num2str(captmin) '  ' num2str(captmax)  ' ]']); 
if (iend == ndim) 
   disp('    iend=dimenssion..!'); 
end 
  
%set-up of nx  
nxy =round (3*captmax/dt); 
nfinala = round(tfinal/dt) + 1; 
nx = iend + 1; 
if (nx > nxy) 
   disp(['    dx is too small, required dx >= ' num2str(1/nxy)]); 
   return; 
else 
   disp(['    nx = ' num2str(nx)]);     
end 
  
%Initial conditions when t = 0 
par_var     = par; 
par_var(1)  = tibar; 
par_var(4)  = tcbar; 
par_var(23) = qflag; 
par_var(24) = nfinala; 
par_var(25) = nx; 
par_var(26) = nxy; 
par_var(27) = ndim; 
par_var(28) = ibeg; 
par_var(29) = iend; 
par_var(30) = pec; 
par_var(31) = pei; 
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par_var(32) = qc; 
par_var(33) = delx; 
par_var(34) = vmax3; 
par_var(35) = akm3; 
par_var(36) = vmax4; 
par_var(37) = akm4; 
par_var(38) = npdes; 
 
% sampling time series 
t = [0:dt:(tfinal-dt)]; 
  
% load experimental data 
redo2=1; 
in_con=[];      % infused dye concentration (uM) 
log_con = [];  % log mean concentration (uM) 
out_con = [];  % efflux metabolic product concentration (uM) 
cond = [];  % infused condition 
rate = [];    % the efflux rate of metabolic product (umol/min) 
while redo2==1 
   datafile = input ('Please enter the file which contains data:  ', 's'); 
   fid = fopen(datafile, 'r');   
   if (fid==-1) 
       temp = input('invalid file name, quit (0) or continue (1)?  '); 
       if (temp==1) 
       else 
           return; 
       end 
   else 
       fclose(fid); 
       % the required format of data file:   
       % Quinone infusion: [QH]v+[Q]v, log mean of [QH]v+[Q]v, [QH]v, QHv    
       % Hydroquinone infusion:    [QH]v, log mean of [QH]v, [Q]v, Qv    
       load(datafile); 
       data=eval(datafile(1:(length(datafile)-4))); 
       tempin = data(:,1);  % infused concentration 
       templog = data(:,2);  % log mean concenctration 
       tempout = data(:,3); ; % efflux product concentration, QHv or Qv 
       temprate = data(:,4);   % efflux product rate, umol/min 
       %  The infusion  condition 
       tempname = char(datafile(1:(length(datafile)-6))); 
    
       in_con= [in_con tempin']; 
       log_con = [log_con templog']; 
       out_con = [out_con tempout']; 
                                                                                                                                                              197                                                             
  
       rate = [rate temprate']; 
       tempcondi=[]; 
       for tempi= 1:length(tempin) 
           tempcondi{tempi}=upper(tempname); 
       end  
       cond = [cond tempcondi]; 
       % for multiple-condition fitting   
       temp = input (' Do you want to load more data? Yes (1) No (0)?  '); 
       if (temp==1) 
       else 
        redo2=0; 
       end  
   end 
end  
  
% define parameters that want to be evaluated; 
npara=input ('Please enter parameters you want to estimate, \n Vmax1 -> NQO1, Vmax2 -> 
complex III, Vmax3 -> complex I, Vmax4-> others\n1: Vmax4 Km4; \n2: Vmax1 Km1; \n3: 
Vmax2 Km2; \n4: Vmax1 Km1 Vmax3 Km3:\n5: Vmax2 Km2 Vmax4 Km4 \n6: Vmax1,2,3,4 
and their kms \n7: Vmax3 Km3 \n8: Vmax1,2,3 and their kms \n9: Vmax3\n your choice:  '); 
par_var(39) = npara; 
switch npara 
case 1 
    p0 = [vmax4 akm4]; 
    lb = [0.0001]; 
    ub = [2000 ];  
case 2 
    p0 = [vmax1 akm1]; 
    lb = [0.0001 0.0001]; 
    ub = [2000 2000];  
case 3 
    p0 = [vmax2 akm2]; 
    lb = [0.0001 0.0001]; 
    ub = [2000 2000];     
case 4 
    p0 = [vmax1 akm1 vmax3 akm3]; 
    lb = [0.0001, 0.0001, 0.0001, 0.0001]; 
    ub = [2000 2000 2000 2000];     
case 5 
    p0 = [vmax2 akm2 vmax4 akm4]; 
    lb = [0.0001 0.0001 0.0001 0.0001]; 
    ub = [2000 2000 2000 2000];   
case 6 
    p0 = [vmax1 akm1 vmax2 akm2 vmax3 akm3 vmax4 akm4]; 
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    lb = [0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001]; 
    ub = [2000 2000 2000 2000 2000 2000 2000 2000];   
case 7 
    p0 = [vmax3 akm3]; 
    lb = [0.0001]; 
    ub = [2000 ];      
case 8 
    p0 = [vmax1 akm1 vmax2 akm2 vmax3 akm3]; 
    lb = [0.0001 0.0001 0.0001 0.0001 0.0001 0.0001]; 
    ub = [2000 2000 2000 2000 2000 2000]; 
case 9 
    p0 = [vmax3]; 
    lb = [0.0001]; 
    ub = [2000]; 
otherwise 
    disp('The parameters you want to estimate is unclear. Quit Program...'); 
    return; 
end  
  
options=optimset('TolFun', 1e-8, 'TolX', 1e-8,'MaxFunEvals',1400); 
% Seeking for the optimized parameters by fitting the model to experimental data 
n=0; 
 [p, SSD, residual,exitflag,output,lambda,nJa] = lsqcurvefit(@gan_solveCoQ1, p0, in_con, rate, lb, 
ub, options,par_var,hcpdf, cond); 
 
% calculate correlation coefficient 
 [Q,R]=qr(nJa); 
R1 = R(1:length(p), :); 
h=inv(R1'*R1); 
for i=1:length(p) 
    for j=1:length(p) 
        cc(i,j)=h(i,j)/(h(i,i)*h(j,j))^0.5; 
    end 
end 
cc 
SSD 
  
% calculate confidence interval 
s2=SSD/(length(in_con)-length(p)); 
for i = 1:length(p) 
    seb(i)=(s2^0.5)*(h(i,i)^0.5); 
end 
  
switch npara 
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case 1 
    tt=2.07;  
    ci=seb.*tt 
    disp(['    vmax4= ' num2str(p(1))]); 
    disp(['    km4= ' num2str(p(2))]); 
    par_var(36) = p(1);  % update vmax4 
    par_var(37) = p(2);  % update vmax4 
case 2 
tt=2.07; 
ci=seb.*tt 
    disp(['    vmax1= ' num2str(p(1))]); 
    disp(['    km1= ' num2str(p(2))]); 
    par_var(7) = p(1);  % update vmax1 
    par_var(8) = p(2);  % update km1 
case 3 
    tt=2.07;  
    ci=seb.*tt 
    disp(['    vmax2= ' num2str(p(1))]); 
    disp(['    km2= ' num2str(p(2))]); 
    par_var(9) = p(1);  % update vmax2 
    par_var(10) = p(2);  % update km2 
case 4 
    tt=2.07;  
    ci=seb.*tt 
    disp(['    vmax1= ' num2str(p(1))]); 
    disp(['    km1= ' num2str(p(2))]); 
    disp(['    vmax3= ' num2str(p(3))]); 
    disp(['    km3= ' num2str(p(4))]); 
    par_var(7) = p(1);  % update vmax1 
    par_var(8) = p(2);  % update km1 
    par_var(34) = p(3);  % update vmax3 
    par_var(35) = p(4); % update km3 
case 5 
    tt=2.07;% 4 data points, 4 variable;     
    ci=seb.*tt 
    disp(['    vmax2= ' num2str(p(1))]); 
    disp(['    km2= ' num2str(p(2))]); 
    disp(['    vmax4= ' num2str(p(3))]); 
    disp(['    km4= ' num2str(p(4))]); 
    par_var(9) = p(1);  % update vmax2 
    par_var(10) = p(2);  % update km2 
    par_var(36) = p(3);  % update vmax4 
    par_var(37) = p(4); % update km4     
case 6 
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    tt=2.07;% 4 data points, 4 variable;     
    ci=seb.*tt 
    disp(['    vmax1= ' num2str(p(1))]); 
    disp(['    km1= ' num2str(p(2))]); 
    disp(['    vmax2= ' num2str(p(3))]); 
    disp(['    km2= ' num2str(p(4))]); 
    disp(['    vmax3= ' num2str(p(5))]); 
    disp(['    km3= ' num2str(p(6))]); 
    disp(['    vmax4= ' num2str(p(7))]); 
    disp(['    km4= ' num2str(p(8))]); 
    par_var(7) = p(1);  % update vmax1 
    par_var(8) = p(2);  % update km1 
    par_var(9) = p(3);  % update vmax2 
    par_var(10) = p(4); % update km2   
    par_var(34) = p(1);  % update vmax3 
    par_var(35) = p(2);  % update km3 
    par_var(36) = p(3);  % update vmax4 
    par_var(37) = p(4); % update km4  
case 7 
    tt=2.07; % 4 data points, 1 variable 
    ci=seb.*tt 
    disp(['    vmax3= ' num2str(p(1))]); 
    disp(['    km3= ' num2str(p(2))]); 
    par_var(34) = p(1);  % update vmax1 
    par_var(35) = p(2);  % update vmax1 
otherwise 
    tt=2.07;  % constant for freedom 40-60       
    ci=seb.*tt; 
    p 
end  
  
% ask whether a simulation is required. 
temp = input('Do you want to run a simulation? Yes(1) No(0)  '); 
if temp == 0 
    return; 
end 
  
% determine the time point of efflux (as tfinal for simulation) 
redo3=1; 
while redo3==1 
    temp = input('Input the time point you want to pick up the efflux concentration: '); 
    if temp>0 
        t = temp; 
    else  
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        disp('invalid time point.') 
        t = 99999; 
    end    
     
    if (t/dt)> ndim 
        temp = input ('Your time point is either too big or mistaken, Do you want to try again, Y(1), 
N(0)?  '); 
        if temp==0 
            return; 
        end 
    else 
        redo3=0; 
    end 
end  
  
% calculate the dose-dependent simulation based on new parameters. 
m = int16(t/dt); 
dose_interval =5; 
num_dose =80; 
for i=1:(num_dose+1); 
      % initialize yold, ynew 
      yold = zeros(npdes,nxy); % concentrations of probes (r, oxidized, reduced)at a given time t 
      ynew = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t+dt  
      par_var(16)=(i-1)*dose_interval; 
      [cr,cq,cqh,istop] = gan_CoQ1(ndim, par_var, yold, ynew, hcpdf); 
      mQ(i)=cq(m); 
      mQH(i)=cqh(m); 
end  
  
dose = 0:dose_interval:num_dose*dose_interval; 
plot(dose,mQ,dose,mQH); 
legend('Q', 'QH'); 
  
% save simulated results 
conc_save = [dose; mQ; mQH; mQ+mQH]; 
save_sims = input('Save simulated data? Yes [1] No[0] '); 
if save_sims == 1, 
   gan_SaveData(conc_save, dose_interval); 
elseif save_sims ~= 0, 
      disp(['Unexpected entry.  Program will complete without saving. ']); 
end  
disp(['Program completed']); 
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D.2 gan_getCoQ1Parameters.m 
function param = gan_GetCoQ1Parameters() 
% Function:  Acquire the initial setting for all parameters in the model 
% Input:  none 
% output:  an array containing initial values for all parameters 
% Created by Z Gan, updated on 04-20-2011 
  
stop_flag = 0; 
get_parms = 1; 
par =[]; 
% Vmax1, Km1: NQO1 mediated CoQ1 reduction  
% Vmax2, Km2: complex III mediated CoQ1H2 oxidation 
% Vmax3, Km3: complex I mediated CoQ1 reduction 
% Vmax4, Km4: other CoQ1 reduction 
while(get_parms), 
   T_or_F = input('Enter "t" for Term or "f" for file: ','s'); 
   if ((T_or_F == 't') | (T_or_F == 'T')), 
      % define input dlg 
      prompt1 = {'hn MTT (s):','hn VAR :','hn AVS (s):','hc MTT (s):','hc VAR:','hc AVS (s):',... 
          'Vmax1 (nmol/s): NQO1', 'Km1 (uM): NQO1', 'Vmax2(nmol/s): complex III', 'Km2(uM): 
complex III','QF1:','QF2:','alb1:','alb2:'}; 
      prompt2 = {'Qdot:','Dose:','homo? 1=Yes 0=No','dt','tinj:','tsp:','tfinal',... 
          'alpha', 'Q? 1=Q 0=QH','Vmax3(nmol/s): complex I', 'Km3 (uM): complex 
I','Vmax4(nmol/s): other reductase', 'Km4(uM): other reductase'}; 
      %         tibar  vari   avsi   tcbar  varc   avsc  vmax1 km1 vmax2 km2  qf1 qf2  alb1 alb2 
      defs1 = {'1.3333','0.4444','0.6667','0.8333','0.4444','0.00','19.5', 
'13.4','76.7','75.9','25.26','28.55','14.6','16.5'}; 
      %         qdot dose homog  dt   tinj   tsp   tfinal   alpha  Q/QH Vmax3   Km3   Vmax4  km4 
      defs2 = {'0.5','100','0','0.01','47','4.0490','47','0.5530','1','36.1','33.7','14.3','65.6'}; 
       
      %acquire parameters from inputdlg 
      temp = inputdlg(prompt1,'Enter Parameter Values (1/2)',1,defs1); 
      par1 = str2num(char(temp)); 
      temp = inputdlg(prompt2,'Enter Parameter Values (2/2)',1,defs2); 
      par2 = str2num(char(temp)); 
       
      % check whether all inputs are number. 
      non_number=0; 
      if(length(par1)<1) ||length(par2)<1 
           non_number=1; 
      end 
       
      % Inquiry if there is a non-number, what to do next step 
      if non_number>0 
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          msgbox('you have 1 or more non-number parameters,Please retry.','Warning','warn') 
      else 
        par = [par1; par2]; 
        % save paramters to a file if need 
        save_ck = input('Save parameter file? Yes [1] No [0]  '); 
        if save_ck == 1,       
        fcell = { 'hn MTT(s):      ', 'hn VAR(s):      ', 'hn AVS:         ','hc MTT(s):      ',... 
                  'hc VAR:         ', 'hc AVS:         ', 'Vmax1:          ','Km1:            ',... 
                  'Vmax2:          ', 'Km2:            ', 'QF1:            ','QF2:            ',... 
                  'alb1:           ', 'alb2:           ', 'Qdot:           ','Dose:           ',... 
                  'homo? 1=Yes 0=No', 'dt              ', 'tinj:           ','tsp:            ',... 
                  'tfinal          ', 'alpha           ', 'Q? 1=Q 0=QH     ','Vmax3:          ',... 
                  'Km3:            ', 'Vmax4:          ', 'Km4:            '}; 
        ffield = {'p1','p2','p3','p4','p5','p6','p7','p8','p9','p10','p11','p12','p13',... 
               'p14','p15','p16','p17','p18','p19','p20','p21','p22','p23','p24','p25','p26','p27'}; 
        fpar = cell2struct(fcell,ffield,2); 
        pno = length(par); 
        repeat = 1; 
        while(repeat), 
            s_fname = input('Enter filename to save parameters: ','s'); 
            fid_r = fopen(s_fname,'r'); 
            file_save = 0; 
            if fid_r ~= -1, 
                fclose(fid_r); 
                file_save = input('Filename already exists. Enter new name [1] or write over [0]? '); 
                if file_save == 0, 
                    fid_w = fopen(s_fname,'w'); 
                    fprintf(fid_w,' %i\n',pno); 
                    for i = 1:pno 
                        eval(['fprintf(fid_w,'' %s     %8.4f\n'',fpar.p' int2str(i) ... 
                        ', par(' int2str(i) '));']); 
                    end 
                    fclose(fid_w); 
                    repeat = 0; 
                end 
            else 
                fid_w = fopen(s_fname,'w'); 
                fprintf(fid_w,' %i\n',pno); 
                for i = 1:pno 
                    eval(['fprintf(fid_w,'' %s     %8.4f\n'',fpar.p' int2str(i) ... 
                    ', par(' int2str(i) '));']); 
                end 
                fclose(fid_w); 
                repeat = 0; 
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            end 
        end  % end of while 
      end  % end of if 
      % change the control for the loop 
      get_parms = 0  ; 
      param =  par; 
     end 
   elseif ((T_or_F == 'f') | (T_or_F == 'F')), 
      par=gan_ReadParameters; 
      if par==-9999 
        param =-9999; 
      else 
        param =par; 
        if length(par)<1 
            msgbox('You give up to set up parameters. This may cause sequential 
error.','Warning','warn') 
        else 
            for i = 1:length(par), 
                eval(['clear line_p' int2str(i) '; clear p' int2str(i) '; clear sp' int2str(i) ';' ]); 
            end 
        end 
      end 
      prompt1 = {'hn MTT (s):','hn VAR (s):','hn AVS:','hc MTT (s):','hc VAR (s):','hc AVS:',... 
          'Vmax1 (nmol/s, NQO1):', 'Km1 (uM):', 'Vmax2 (nmol/s, complexIII):', 'Km2 (uM):','QF1 
(ml):','QF2 (ml):','alb1:','alb2:'}; 
      prompt2 = {'Qdot (flow, ml/s):','Dose (uM):','homo? 1=Yes 0=No','dt(s):','tinj (s):','tsp 
(s):','tfinal (s):',... 
          'alpha', 'Q? 1=Q 0=QH','Vmax3 (nmol/s, complex I):', 'Km3 (uM):','Vmax4 (nmol/s, other):', 
'Km4 (uM):'}; 
      %         tibar  vari   avsi   tcbar  varc   avsc  vmax1 km1 vmax2 km2  qf1 qf2  alb1 alb2 
      defs1 = {num2str(par(1)),num2str(par(2)),num2str(par(3)),num2str(par(4)),num2str(par(5)),... 
               num2str(par(6)),num2str(par(7)),num2str(par(8)),num2str(par(9)),num2str(par(10)),... 
               num2str(par(11)),num2str(par(12)),num2str(par(13)),num2str(par(14))}; 
      %         qdot     dose homog  dt   tinj   tsp   tfinal    alpha  Q/QH Vmax3 Km3 Vmax4 km4 
defs2={num2str(par(15)),num2str(par(16)),num2str(par(17)),num2str(par(18)),num2str(par(19)),... 
             num2str(par(20)),num2str(par(21)),num2str(par(22)),num2str(par(23)),num2str(par(24)),... 
              num2str(par(25)),num2str(par(26)),num2str(par(27))}; 
      %acquire parameters from inputdlg 
      temp = inputdlg(prompt1,'Enter Parameter Values (1/2)',1,defs1); 
      par1 = str2num(char(temp)); 
      temp = inputdlg(prompt2,'Enter Parameter Values (2/2)',1,defs2); 
      par2 = str2num(char(temp)); 
      par = [par1; par2]; 
      param = par; 
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      get_parms = 0; 
   else 
      get_parms = input('Invalid entry.  Retry? [1] or Quit [0] '); 
      stop_flag = 1; 
      param = -9999; 
   end 
end 
  
D.3 gan_simCoQ1.m 
% Function:  simulate the efflux rate of CoQ1 or CoQ1H2 with a given set of  parameters 
% Input:  none 
% output:  simulated results 
% Created by Z Gan, updated on 04-20-2011 
 
clear all 
global tchat 
global pec 
  
%Parameter entry , update on 07-28-2010 by Gan 
redo1 = 1; 
while(redo1) 
   % Enter parameters 
   par = gan_GetCoQ1Parameters(); 
   if par == -9999 
       disp('Error during parameter acquirement.'); 
       return; 
   else 
    homorg = par(17); % 0: hetergenous  1: homogenous 
    % calculate peclet 
for i = 1:(2-homorg)   
  pe(i) = gan_Peclet(par(3*i-2),par(3*i-1)); 
      if (pe(i) <= 0) 
         disp(['    when tibar=' num2str(par(3*i-2)) '   vari must be <' num2str(par(3*i-1))]); 
      else 
         redo1 = 0;     
      end 
    end 
   end 
end 
  
% define all constants or parameters 
tibar   = par(1); % non-capillary mean transit time, sec 
vari    = par(2); % variance of non-capillary  
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avsi    = par(3); % shift for tibar 
tcbar   = par(4); % capillary mean transit time, sec 
varc    = par(5); % variance of capillary  
avsc    = par(6); % shift for tcbar 
vmax1   = par(7); % m-m vmax for NQO1 mediated Q reduction (umol/min) 
akm1    = par(8); % m-m constant for NQO1 mediated Q reduction (uM) 
vmax2   = par(9); % m-m vmax for complex III mediated QH oxidation (umol/min) 
akm2    = par(10); % m-m constant for complex III mediated QH oxidation (uM) 
vf1     = par(11); % virtual capillary volume (ml) 
vf2     = par(12); % virtual tissue volume (ml) 
alb1    = par(13); % apperant binding ratio between Q-Pc and Q-Pe for quinone (a1/a2) 
alb2    = par(14); % apperant binding ratio between QH-Pc and QH-Pe for hydroquione (a3/a4) 
qdot    = par(15); % flow (m/s) 
dose    = par(16); % infused probe concentration (uM) 
homog   = par(17); % homogenous or hetergenous 1=homogenous 
dt      = par(18); % time resolution (sec) 
tinj    = par(19); % total inject time (for input, sec) 
tsp     = par(20); % delay time (for input, sec) 
tfinal  = par(21); % total simulation time (sec) 
alpha   = par(22); % constant for input function 
qflag   = par(23); % 1=Q, 0=QH 
vmax3   = par(24); % m-m vmax for complex I mediated Q reduction (umol/min) 
akm3    = par(25); % m-m constant for complex I mediated Q reduction (uM) 
vmax4   = par(26); % m-m vmax for other Q reduction (umol/min) 
akm4    = par(27); % m-m constant for other Q reduction (uM) 
  
% basic check of the setting for the model initial value 
if (tcbar <= 0) 
   disp('    tcbar <0, so program stopped.') 
   return; 
end 
if (tfinal <= 0) 
   disp('    tfinal<=0, Program stopped.') 
   return; 
end 
  
 %initialized variables 
ndim = round(tfinal/dt); % # points of time axis 
npdes = 3;  % # of pdes for 1 model 
fcmin = 0.01;  % covered area 
dx      = dt/tcbar;  % normalized deltx , deltz 
qc      = qdot*tcbar; % capillary volume 
delx    = dx*tcbar; 
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% consider the delay into mean transit time 
tibar = tibar + avsi; 
tcbar = tcbar + avsc; 
  
% set up pe, tihat 
if homorg ==1 
    pei = pe(1); 
    pec = 0; 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
else 
    pei = pe(1); 
    pec = pe(2); 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
    tchat  = tcbar/(1+2/pec); 
end 
  
%set-up of cap trans. func. as vector, min and max cap trans. times 
hcpdf = zeros(1,ndim); % capillary transit time distribution   
hnpdf = zeros(1,ndim); % non-capillary transit time distribution 
if (homorg==1) 
   % if it is a homogeneous organ 
   iend = 1/dx + 0.001; % the last spacial point 
   test = 1.0/dx - iend; 
   if (test > 0.001) 
      disp(['    For a homogenous organ, 1/dx must be an integer, now 1/dx=' num2str(1/dx)]); 
      disp(['    With this dx, capillary mmt will be changed to ' num2str(iend*delx)]); 
      C_ok = input('Continue or Start over (C = continue)? ','s'); 
      if (C_ok == 'C' | C_ok == 'c') 
         tcbar = iend*delx; 
      else 
         return; 
      end 
   end 
   ibeg = iend; % since it is homogenous, so no scalar required 
else 
   % if it is not a hetergeneous organ 
   disp(['    dose=' num2str(dose)]); 
   % capillary distribution function 
   hcpdf = hcpdfunc(ndim,delx,avsc,tchat,pec);    
   % find the begin and the end, but for hetergenous organ, ibeg ==1  
   [ibeg,iend] = begendfunc(hcpdf,ndim,fcmin); 
   %Renormalize hc(t) to unit area 
   hcpdf = hcpdf(2:ndim); % get rid of the first point, because  
   % from first point to iend point, which is supposed to be 99.9% covered. 
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   hcpdf = hcpdf(1:iend); 
   % to get an interget for the area under the capillary function 
   ac = trapz(hcpdf)*dt; 
   % rescale ,so 100% area 
   hcpdf = hcpdf./(ac/delx); 
    
   %Noncapillary transport function 
   qd = qdot*tihat; % non-capillary volume 
   hnpdf = gan_hnpdfunc(ndim, par, qd); %non-capillary input function 
   hnpdf = hnpdf(2:ndim); 
   ibeg = 1; 
   disp(['    ibeg=' num2str(ibeg) '      iend=' num2str(iend)]); 
end 
 captmin = ibeg*delx; 
captmax = iend*delx; 
disp(['    min/max capillary times are [ ' num2str(captmin) '  ' num2str(captmax)  ' ]']); 
if (iend == ndim) 
   disp('    iend=dimenssion..!'); 
end 
  
%set-up of nx  
nxy =round (3*captmax/dt); 
nfinala = round(tfinal/dt) + 1; 
nx = iend + 1; 
if (nx > nxy) 
   disp(['    dx is too small, required dx >= ' num2str(1/nxy)]); 
   return; 
else 
   disp(['    nx = ' num2str(nx)]);     
end 
  
%Initial conditions when t = 0 
par_var     = par; 
par_var(1)  = tibar; 
par_var(4)  = tcbar; 
par_var(24) = nfinala; 
par_var(25) = nx; 
par_var(26) = nxy; 
par_var(27) = ndim; 
par_var(28) = ibeg; 
par_var(29) = iend; 
par_var(30) = pec; 
par_var(31) = pei; 
par_var(32) = qc; 
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par_var(33) = delx; 
par_var(34) = vmax3; 
par_var(35) = akm3; 
par_var(36) = vmax4; 
par_var(37) = akm4; 
par_var(38) = npdes; 
  
t = [0:dt:(tfinal-dt)]; 
myway = input('Input the way you to acquire doses: manual input(0), data file(1), auto input(2)? '); 
% determine the input approach of doses which need simulated 
switch myway  
  case 0 % input infusion dose one by one manually 
    num = input('How many doses for this simulation? '); 
    if num>=1  
        for i=1:num 
            disp(['please input your No.' num2str(i)  '  dose']); 
            temp = input('must be a number   ','s'); 
            if str2num(temp)>=0 
                temp=str2num(temp); 
            else  
                temp=0; 
            end 
            dose(i)=temp; 
        end  
    end 
  case 1  % load infusion doses from an experimental data file 
    redo2=1; 
    while redo2==1 
        datafile = input ('Please enter the file which contains data:', 's'); 
        fid = fopen(datafile, 'r');   
        if (fid==-1) 
            temp = input('invalid file name, quit (0) or continue (1)?'); 
            if (temp==1) 
            else 
                return; 
            end 
        else 
            fclose(fid); 
            redo2=0; 
        end 
    end  
    % the file name must be end with .txt or .dat. 
    load(datafile); 
    data=eval(datafile(1:(length(datafile)-4))); 
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    dose = data(:,1);  % infused concentration 
    num = length(dose); 
  case 2  % generate doses automatically based on start-end dose and dose interval 
    dose0 = input ('Please input the start dose:  ','s'); 
    dose1 = input ('Please input the end dose:  ', 's'); 
    interval = input('Please input dose interval:  ', 's'); 
    dose0 = str2num(dose0); 
    dose1 = str2num(dose1); 
    interval = str2num(interval); 
    if (dose0>dose1) 
        disp('The end dose can not be less than the start dose.'); 
    elseif (dose0<0) 
        disp('Dose can not be less than 0.'); 
    end 
    num = int16((dose1-dose0)/interval); 
    dose = dose0:interval:(dose0+num*interval); 
    num = length(dose); 
  otherwise 
    disp('You did not select a proper way. Quit the program..'); 
    return; 
end  
  
% Calculate efflux concentrations based on input concentrations. 
for i=1:num 
        par_var(16)=dose(i);  % set up dose 
        % initialize avaiable 
        cr = zeros(1,ndim); % concentration of reference probe 
        cq = zeros(1,ndim); % concentration of oxidized probe 
        cqh = zeros(1,ndim); % concentration of reduced probe 
        % initialize yold, ynew 
        yold = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t 
        ynew = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time 
t+dt 
        % calculate the result 
        [cr,cq,cqh,istop] = gan_CoQ1(ndim, par_var, yold, ynew, hcpdf); 
        mCr(i,1:ndim)=cr; 
        mCq(i,1:ndim)=cq; 
        mCqh(i,1:ndim)=cqh; 
end  
  
% display the results 
switch myway 
    case 2 
        redo3=1; 
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        while redo3 ==1 
            ptime = input('input the time point you want to collect sample. \n'); 
            if ptime>tfinal 
                disp('The time you selected is longer than tfinal. Try again'); 
                redo3=1; 
            elseif ptime<0 
                disp('Time can not be less than 0.'); 
                redo3=1; 
            elseif (0<ptime) && (ptime<=tfinal) 
                redo3=0; 
            else 
                disp('Your input may have some mistake. Quit program now.') 
                redo3=1; 
            end 
            if redo3==1 
                temp = input('Do you want to try again, Yes(1) No(0)?'); 
                if temp ==1 
                    redo3=1; 
                else 
                    redo3=0; 
                    return; 
                end 
            end 
        end 
        tpoint = int16(ptime/dt); 
        for i=1:num 
           mcr(i) = mCr(i,tpoint); 
           mcq(i) = mCq(i,tpoint); 
           mcqh(i)= mCqh(i,tpoint);  
        end 
        plot(dose,mcr,dose,mcq,dose,mcqh); 
        legend('Ref', 'Q', 'QH') ; 
        save_sims = input('Save simulated data? Yes [1] No[0] '); 
        if save_sims == 1, 
            conc_save = [double(dose); mcr; mcq; mcqh]; 
            gan_SaveData(conc_save, interval); 
        end 
    otherwise 
        for i=1:num 
            mcr = mCr(i,1:ndim); 
            mcq = mCq(i,1:ndim); 
            mcqh= mCqh(i,1:ndim); 
            subplot(1,num,i); 
            plot(t,mcr,t,mcq,t,mcqh); 
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            legend('Ref', 'Q', 'QH') ; 
            title(num2str(dose(i))); 
        end  
        % save the results 
        save_sims = input('Save simulated data? Yes [1] No[0] '); 
        if save_sims == 1, 
            for i=1:num 
                mcr = mCr(i,1:ndim); 
                mcq = mCq(i,1:ndim); 
                mcqh= mCqh(i,1:ndim); 
                conc_save = [double(t); mcr; mcq; mcqh]; 
                gan_SaveData(conc_save, dt); 
            end 
        elseif save_sims ~= 0, 
            disp(['Program will complete without saving. ']); 
        end 
end 
disp(['Program completed']); 
  
 D.4 gan_solveCoQ1.m 
function Cmatch = gan_solveCoQ1(p, in_con, par_var, hcpdf, cond) 
%this function is called by gan_fit.m, using to solve the pde set. 
% Function:  solve the PDE sets and return steady_state efflux value with a given set of  
%  parameters 
% Input:  p: variables for the model 
%  in_con: infused doses 
%  par_var: parameters for the model 
%  hcpdf: capillary distribution  
%  cond: infusion conditions 
% output:  an array of steady_state efflux values 
% Created by Z Gan, updated on 04-20-2011 
                       
%declare global variables 
global  n  
  
mparameters =  par_var; 
qflag = par_var(23); 
nxy = par_var(26); 
ndim = par_var(27); 
npdes = par_var(38); 
npara = par_var(39); 
flow = par_var(15); 
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switch npara 
    case 1         
        mparameters(36) = p(1);        % vmax4 
        mparameters(37) = p(2);        % km4 
    case 2        % 2 parameters 
        mparameters(7) = p(1);        % vmax1 
        mparameters(8) = p(2);        % km1 
    case 3        % 4 parameters 
        mparameters(9) = p(1);        % vmax2 
        mparameters(10) = p(2);       % km2 
    case 4        % 4 parameters 
        mparameters(7) = p(1);        % vmax1 
        mparameters(8) = p(2);        % km1 
        mparameters(34) = p(3);       % vmax3 
        mparameters(35) = p(4);       % km3 
    case 5        % 4 parameters 
        mparameters(9) = p(1);        % vmax2 
        mparameters(10) = p(2);       % km2     
        mparameters(36) = p(3);       % vmax4 
        mparameters(37) = p(4);       % km4 
    case 6        % 6 parameters 
        mparameters(7) = p(1);        % vmax1 
        mparameters(8) = p(2);        % km1 
        mparameters(9) = p(3);        % vmax2 
        mparameters(10) = p(4);       % km2     
        mparameters(34) = p(5);       % vmax3 
        mparameters(35) = p(6);       % km3 
        mparameters(36) = p(7);       % vmax4 
        mparameters(37) = p(8);       % km4  
    case 7         
        mparameters(34) = p(1);       % vmax3 
        mparameters(35) = p(2);       % km3 
    case 8        % 6 parameters 
        mparameters(7) = p(1);        % vmax1 
        mparameters(8) = p(2);        % km1 
        mparameters(9) = p(3);        % vmax2 
        mparameters(10) = p(4);       % km2     
        mparameters(34) = p(5);       % vmax3 
        mparameters(35) = p(6);       % km3 
    case 9 
        mparameters(34) = p(1);       % vmax3 
    otherwise 
end 
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% progress control...... 
n=n+1 
p 
% adjust the parameters based on infusion condition 
numDose = length(in_con); 
for i=1:numDose 
    temppara = mparameters; 
    temppara(16)=in_con(i); % dose 
    yold = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t 
    ynew = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t+dt 
    if (strcmp(cond{i},'COQ1DIC') ||strcmp(cond{i},'COQ1DIC21') || 
strcmp(cond{i},'COQ1DIC85') || strcmp(cond{i},'COQ1DIC60')) 
            temppara(7) = 0;        % vmax1=0, NQO1 inhibited 
            temppara(23)= 1;        % infused CoQ1 
    elseif (strcmp(cond{i},'COQ1ROT') ||strcmp(cond{i},'COQ1ROT21') 
||strcmp(cond{i},'COQ1ROT85') ||strcmp(cond{i},'COQ1ROT60')) 
            temppara(34) = 0;       % vmax3=0, COMPLEX I INHIBITED 
            temppara(23)= 1;        % infused CoQ1 
    elseif (strcmp(cond{i},'COQ1DICROT') ||strcmp(cond{i},'COQ1DICROT21') || 
strcmp(cond{i},'COQ1DICROT85') || strcmp(cond{i},'COQ1DICROT60')) 
            temppara(34) = 0;       % vmax3=0, COMPLEX I INHIBITED 
            temppara(7) = 0;        % vmax1=0, NQO1 inhibited 
            temppara(23)= 1;        % infused CoQ1    
elseif(strcmp(cond{i},'COQ1AA')||strcmp(cond{i},'COQ1AA21')||strcmp(cond{i},'COQ1AA85') 
||strcmp(cond{i},'COQ1AA60')) 
            temppara(9) = 0;        % vmax2=0, COMPLEX III inhibited 
            temppara(23)= 1;        % infused CoQ1 
    elseif(strcmp(cond{i},'COQ1KCN')||strcmp(cond{i},'COQ1KCN21')|| 
strcmp(cond{i},'COQ1KCN85') || strcmp(cond{i},'COQ1KCN60')) 
            temppara(9) = 0;        % vmax2=0, COMPLEX III inhibited 
            temppara(23)= 1;        % infused CoQ1 
    elseif(strcmp(cond{i},'COQ1H2DICROT')||strcmp(cond{i},'COQ1H2DICROT21')|| 
strcmp(cond{i},'COQ1H2DICROT85') || strcmp(cond{i},'COQ1H2DICROT60')) 
            temppara(34) = 0;       % vmax3=0, COMPLEX I INHIBITED 
            temppara(7) = 0;        % vmax1=0, NQO1 inhibited 
            temppara(23)= 0;        % infused CoQ1H2 
    else             
    end 
    % Calculate steady_state efflux values 
    [cr, cq, cqh, istop] = gan_CoQ1(ndim, temppara, yold, ynew, hcpdf); 
    mQ(i)=cq(ndim); 
    mQH(i)=cqh(ndim); 
    % pick up the right value corresponding to its infusion condition 
    if (temppara(23)==1) 
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        mResult(i)= mQH(i); 
    else 
        mResult(i)= mQ(i); 
    end  
end 
 
% adjust efflux rate from nmol/s to umol/min 
temp = flow*60/1000; 
Cmatch = mResult.*temp; 
 
D.5 gan_saveData.m 
function gan_SaveData(conc_save, dt) 
% Function:  save simulated data 
% Input:  conc_save: simulated data 
%  dt: sampling time interval 
% output:  a file containing simulated data 
%                    numbers should follow the format of 6.3 12.5 12.5 12.5 
%  1st column: time or dose  
%  2nd column: infused concentration 
%  3rd column: [Q]v  
%  4th column: [QH]v 
% Created by Z Gan 0n 07-2010, updated on 04-20-2011 
  
disp([' ']); 
disp(['Current stepsize is:']); 
disp([dt]); 
% inquiry whether adjust step size, if yes, adjust corresponding data 
change_dt = input('Change stepsize for output file? Yes [1] No[0]  ','s'); 
change_flag = 1; 
if change_dt == '1', 
   while(change_flag), 
      new_dt = input('Enter new step size: '); 
      if new_dt < dt, 
         disp(['New stepsieze cannot be smaller than original']); 
      elseif new_dt == dt, 
         n_conc_save = conc_save; 
         change_flag = 0;       
      else 
         index_dt = round(new_dt/dt); 
         n_dt = index_dt * dt; 
         disp(['New stepsize has been rounded to ' ]); 
         disp([n_dt]); 
         disp([' ']); 
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         for i = 1:index_dt:size(conc_save,2) 
            n_conc_save(:,(i-1)/index_dt + 1) = conc_save(:,i); 
         end 
         change_flag = 0; 
      end 
   end 
elseif change_dt ~= '0', 
   temp = input('Unexpected entry. Do you want to try again ? Yes [1] No[0]  '); 
   if temp ==1  
      new_dt = input('Enter new dt (Must be a positive number) : '); 
   end  
   n_conc_save = conc_save; 
else 
   n_conc_save = conc_save; 
end 
  
 % save data into a file 
repeat = 1; 
while(repeat), 
   save_dat = input('Enter filename to save data: ','s'); 
   fid_r = fopen(save_dat,'r');       
   file_save = 0; 
    
   if fid_r ~= -1, 
      fclose(fid_r); 
      file_save = input('Filename already exists. Enter new name [1] or write over [0]?  '); 
   else 
      fid_w = fopen(save_dat,'w'); 
      fprintf(fid_w,'%6.3f\t %12.5f\t %12.5f\t %12.5f\n',n_conc_save); 
      fclose(fid_w); 
      repeat = 0; 
   end 
    
   if file_save == 0, 
      fid_w = fopen(save_dat,'w'); 
      fprintf(fid_w,'%6.3f\t %12.5f\t %12.5f\t %12.5f\n',n_conc_save); 
      fclose(fid_w);          
      repeat = 0; 
   end 
end 
 
D.6 gan_getPeclet.m 
function [pe] = gan_Peclet(t,v) 
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% Function:  calculate peclet numbers 
% Input:  t: mean transit time 
%  v: variance of transit time 
% output:  peclet numbers 
% Created by Z Gan 0n 07-2010, updated on 04-20-2011 
% Use Rugani’s codes as reference 
d = v/(t^2); 
a = 1 - 2*d; 
b = 1 + 4*d; 
pe = (a + sqrt(b))/d; 
 
D.7 begendfunc.c 
// Function:  find out the begin and the end of capillary distribution 
// Input:  hcpdf: capillary distribution function 
//  ndim: total number of sampling points 
//  fcmin: uncovered area% under capillary distribution function 
// output:  ibeg: the index of begin of capillary distribution 
//                    iend: the index of end of capillary distribution 
// Created by Z Gan 0n 07-2010, updated on 04-20-2011 
 
#include <math.h> 
#include "mex.h" 
void begendfunc(double *ibeg, double *iend, double *hcpdf, int ndim, double fcmin) 
{ 
    double mmax(double *, int); 
    double hmx; 
    int i; 
    // find out the maximum 
    hmx = mmax(hcpdf, ndim); 
    // find out the begin  
    for (i=0;i<ndim;i++) 
    { 
        if(*(hcpdf + i) > hmx*fcmin) // fcmin =0.001, so 99.9% conserved 
        { 
            *ibeg = i; 
            break; 
        } 
} 
// find out the end 
    for (i=ndim-1;i>=0;i--) 
    { 
        if(*(hcpdf + i) > hmx*fcmin) 
        { 
            *iend = i; 
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            break; 
        }  
    } 
} 
 // sub-function used to figure out the maximum in a data series 
double mmax(double *hcpdf, int ndim) 
{ 
    int i; 
    double amax; 
  
    amax = -pow(10,30); 
    for (i=0;i<ndim;i++) 
    { 
        if(amax < *(hcpdf+i)) 
            amax = *(hcpdf+i); 
    } 
    return(amax); 
} 
// Gateway function to use C in matlab 
void mexFunction(int nlhs, mxArray *plhs[], int nrhs, mxArray *prhs[]) 
{ 
    double *hcpdf; 
    double fcmin; 
    int ndim; 
    double *ibeg, *iend; 
  
    if (nrhs != 3){ 
        mexErrMsgTxt("Three input arguments required."); 
    } 
    else if (nlhs != 2){ 
        mexErrMsgTxt("Two output argument requrired."); 
    } 
     
    plhs[0] = mxCreateDoubleMatrix(1, 1, mxREAL); 
    plhs[1] = mxCreateDoubleMatrix(1, 1, mxREAL); 
    hcpdf = mxGetPr(prhs[0]); 
    ndim = mxGetScalar(prhs[1]); 
    fcmin = mxGetScalar(prhs[2]); 
    ibeg = mxGetPr(plhs[0]); 
    iend = mxGetPr(plhs[1]); 
    begendfunc(ibeg, iend, hcpdf, ndim, fcmin); 
} 
 
D.8 gan_hnpdfunc.c 
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// Function:  construct non-capillary distribution function 
// Input:  par: parameters for the model 
//  fcmin: uncovered area% under capillary distribution function 
// output:  hnpdf: non-capillary distribution  
// Created by Z Gan 0n 07-2010, updated on 04-20-2011 
 
#include <math.h> 
#include "mex.h" 
void gan_hnpdfunc(double *hnpdf, int n, double *par, double qd) 
{ 
    double a, t, dose, dt, tsp, tinj, alpha, avsi; 
    int i; 
     
    dose    = *(par+15);  
    dt      = *(par+17); 
    tinj    = *(par+18); 
    tsp     = *(par+19); 
    alpha   = *(par+21); 
    avsi    = *(par+2); 
    a       = dose/qd; 
     
    for (i=0; i<n; i++){ 
        t=dt*i-avsi; 
        if (t<tsp) 
        { 
            *(hnpdf+i)=0; 
        }else if((t>=tsp) && (t<(tsp+tinj))) 
        { 
            *(hnpdf+i)=a *(1- exp(-alpha*(t-tsp)))/tinj; 
        }else 
        { 
            *(hnpdf+i)=a *(exp(-alpha*(t-tsp-tinj))-exp(-alpha*(t-tsp)))/tinj; 
        }       
    } 
} 
  
//  Gateway function                                                                                                 */ 
void mexFunction(int nlhs, mxArray *plhs[], int nrhs, mxArray *prhs[]) 
{ 
    double *hnpdf, *par; 
    double qd; 
    int ndim; 
    if (nrhs != 3){ 
        mexErrMsgTxt("Seven input arguments required."); 
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    } 
    else if (nlhs != 1){ 
        mexErrMsgTxt("One output argument requrired."); 
    } 
    ndim = mxGetScalar(prhs[0]); 
    plhs[0] = mxCreateDoubleMatrix(ndim, 1, mxREAL); 
    hnpdf = mxGetPr(plhs[0]); 
    par = mxGetPr(prhs[1]); 
    qd = mxGetScalar(prhs[2]); 
    gan_hnpdfunc(hnpdf, ndim, par, qd); 
} 
 
D.9 gan_hcpdfunc.c 
// Function:  construct capillary distribution function 
// Input:  delx: x interval 
//  capsft: shift of capillary transit time 
// output:  hcpdf: capillary distribution  
// Created by Z Gan 0n 07-2010, updated on 04-20-2011 
 
#include <math.h> 
#include "mex.h" 
void hcpdfunc(double *hcpdf, int n, double delx, double capsft, 
        double tchat, double pec) 
{ 
    double hc(double, double, double); 
    double hct1, hct2, xi; 
    int i; 
     
    for (i=0;i<n;i++) 
    { 
        xi = delx*i-capsft; 
        hct1 = hc(xi-delx/2, tchat, pec); 
        hct2 = hc(xi+delx/2, tchat, pec); 
        *(hcpdf+i) = (delx/2)*(hct1+hct2); 
    } 
} 
// calculate hct based on random-walk function 
double hc(double t, double tchat, double pec) 
{ 
    double rwf(double, double); 
    double hct, rwft; 
    rwft = rwf(t/tchat,pec); 
    hct = rwft/tchat; 
    return(hct); 
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} 
// random-walk function 
double rwf(double s, double p) 
{ 
    double rwft, sq, pi, ex; 
    pi = 3.1415926535897932; 
    if (s <= 0) 
    { 
        rwft = 0; 
    } 
    else  
    { 
        sq = sqrt(p/(4*pi*s)); 
        ex = exp((-p*(1-s)*(1-s))/(4*s)); 
        rwft = sq*ex; 
    } 
    return(rwft); 
} 
  
//  Gateway function                                                                                                 
void mexFunction(int nlhs, mxArray *plhs[], int nrhs, mxArray *prhs[]) 
{ 
    double *hcpdf; 
    double delx, capsft, tchat, pec; 
    int n; 
    if (nrhs != 5){ 
        mexErrMsgTxt("Five input arguments required."); 
    } 
    else if (nlhs != 1){ 
        mexErrMsgTxt("One output argument requrired."); 
    } 
     
    n = mxGetScalar(prhs[0]); 
    plhs[0] = mxCreateDoubleMatrix(n, 1, mxREAL); 
    hcpdf = mxGetPr(plhs[0]); 
    delx = mxGetScalar(prhs[1]); 
    capsft = mxGetScalar(prhs[2]); 
    tchat = mxGetScalar(prhs[3]); 
    pec = mxGetScalar(prhs[4]); 
    hcpdfunc(hcpdf, n, delx, capsft, tchat, pec); 
} 
 
D.10 gan_CoQ1.c 
// Function:  calculate efflux values based on mathematical model 
                                                                                                                                                              222                                                             
  
// Input:  yold: old efflux values 
//  ynew: new efflux values 
//  par_var: parameters for the model 
// output:  cr: concentration of Q+QHold efflux values 
//  cq: concentration of quinone 
//  cqh: concentration of hydroquinone 
//  istop: the sign of stop   
// Created by Z Gan 0n 07-2010, updated on 04-20-2011 
 
#include <math.h> 
#include "mex.h" 
int homorg, ibeg, iend, nx, nxy, ndim, qflag, nfinala; 
double tibar, vari, avsi, tcbar, varc, avsc, qdot, dose, dt, delx, qc, pei, pec; 
double qf1, qf2, vmax1, vmax2, akm1, akm2, vmax3, akm3, vmax4, akm4, alb1, alb2, f1,f2; 
double alpha, tfinal, tinj, tsp, tihat, qd; 
  
void gan_main(double *par_var, double *yold, double *ynew, double *hcpdf, double *cr, double 
*cq, double *cqh, double *istop) 
{ 
    int i, m; 
    double tout, crsum, cqsum, cqhsum, hcj, rbar, qbar, qhbar, rchem, qchem, qhchem, fchem1, 
fchem2, a1, a2; 
    double square(double, double); 
    // define all parameters 
    tibar       = *(par_var+0); 
    vari        = *(par_var+1); 
    avsi        = *(par_var+2); 
    tcbar       = *(par_var+3); 
    varc        = *(par_var+4); 
    avsc        = *(par_var+5); 
    vmax1       = *(par_var+6); 
    akm1        = *(par_var+7); 
    vmax2       = *(par_var+8); 
    akm2        = *(par_var+9); 
    qf1         = *(par_var+10); 
    qf2         = *(par_var+11); 
    alb1        = *(par_var+12); 
    alb2        = *(par_var+13); 
    qdot        = *(par_var+14); 
    dose        = *(par_var+15); 
    homorg      = *(par_var+16); 
    dt          = *(par_var+17); 
    tinj        = *(par_var+18); 
    tsp         = *(par_var+19); 
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    tfinal      = *(par_var+20); 
    alpha       = *(par_var+21); 
    qflag       = *(par_var+22); 
    nfinala     = *(par_var+23); 
    nx          = *(par_var+24); 
    nxy         = *(par_var+25); 
    ndim        = *(par_var+26); 
    ibeg        = *(par_var+27); 
    iend        = *(par_var+28); 
    pec         = *(par_var+29); 
    pei         = *(par_var+30); 
    qc          = *(par_var+31); 
    delx        = *(par_var+32); 
    vmax3       = *(par_var+33); 
    akm3        = *(par_var+34); 
    vmax4       = *(par_var+35); 
    akm4        = *(par_var+36); 
     
    // calculate public constant 
    tihat = tibar/(1+2/pei); 
    qd    = qdot*tihat; 
    // constants f1, 1-f1 
    f1 = qc/(qc+qf1/alb1); 
    f2 = qc/(qc+qf2/alb2); 
    // constants for chemical parts 
    fchem1 = dt/(qc+qf1/alb1); 
    fchem2 = dt/(qc+qf2/alb2); 
 
    *istop = ndim; 
    // loop at time axis 
    for (i=0;i<=ndim;i++) 
    { 
        tout = i*dt;  // actual time, second 
        if (tout >= tfinal)  // stop 
        { 
            *istop =i; 
            break; 
        } 
        // calculate boundary 
        if (qflag ==1)  // inject quinone 
        { 
            *yold=square((tout-avsi), dose*tinj); // normalization factor was removed '/areaa'; 
            *(yold+nxy)=square((tout-avsi), dose*tinj); 
            *(yold+2*nxy)=0; 
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        } 
        else    // inject hydroquinone 
        { 
            *yold=square((tout-avsi), dose*tinj); //  /areaa; 
            *(yold+nxy)=0; 
            *(yold+2*nxy)=square((tout-avsi), dose*tinj); 
        } 
         
        // calculate next time point, f1, f2, qchem, qhchem represent the model. 
        for (m=1; m<=nx;m++) 
        {   //average 
            rbar  = 0.5*(*(yold+m)+*(yold+m-1)); 
            qbar  = 0.5*(*(yold+nxy+m)+*(yold+nxy+m-1)); 
            qhbar = 0.5*(*(yold+2*nxy+m)+*(yold+2*nxy+m-1)); 
            // chemistry 
            rchem = 0;   
            // *****  The model key equations ***** 
            // vmax1: NQO1; vmax2: complex III; vmax3: complex I; vmax4: other reductase 
            a1 = vmax1/(akm1+qbar)+vmax3/(akm3+qbar)+vmax4/(akm4+qbar); 
            a2 = vmax2/(akm2+qhbar); 
            qchem = fchem1*(-qbar*a1+qhbar*a2); 
            qhchem= fchem2*(qbar*a1-qhbar*a2); 
            // ynew 
            *(ynew+m)= *(yold+m-1); 
            *(ynew+nxy+m)= (1-f1)**(yold+nxy+m)+f1**(yold+nxy+m-1)+qchem; 
            *(ynew+2*nxy+m)= (1-f2)**(yold+2*nxy+m)+f2**(yold+2*nxy+m-1)+qhchem; 
        } 
  
        // adjust the value according the type of flow distribution 
        if (homorg==1) // if homogenous distribution 
        { 
            *(cr+i)=*(ynew+nx-1); 
            *(cq+i)=*(ynew+nxy+nx-1); 
            *(cqh+i)=*(ynew+2*nxy+nx-1); 
        } 
        else // if heterogenous distribution 
        { 
            crsum=0;  
            cqsum=0;  
            cqhsum=0; 
            for (m=ibeg-1; m<nx-2; m++) 
            { 
                hcj = *(hcpdf+m); 
                crsum = crsum + hcj**(ynew+m+1); 
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                cqsum = cqsum + hcj**(ynew+nxy+m+1); 
                cqhsum = cqhsum + hcj**(ynew+2*nxy+m+1); 
            } 
            *(cr+i)=crsum; 
            *(cq+i)=cqsum; 
            *(cqh+i)=cqhsum; 
        } 
         
        // clean negative value and update yold 
        for (m=0; m<=nx; m++) 
        { 
            if(*(ynew+m)<0) // no negative value is allowed. 
                *(ynew+m)=0;                             
            if(*(ynew+nxy+m)<0) 
                *(ynew+nxy+m)=0; 
            if(*(ynew+2*nxy+m)<0) 
                *(ynew+2*nxy+m)=0; 
            *(yold+m)=*(ynew+m); 
            *(yold+nxy+m)=*(ynew+nxy+m); 
            *(yold+2*nxy+m)=*(ynew+2*nxy+m); 
        } 
    } 
} 
 
// sub-function which simulates a square function 
double square(double t, double a) 
{ 
    double hit; 
    if (t<tsp) 
    { 
        hit=0; 
    }else if((t>=tsp) && (t<(tsp+tinj))) 
    { 
        hit=a*(1- exp(-alpha*(t-tsp)))/tinj; 
    }else 
    { 
        hit=a*(exp(-alpha*(t-tsp-tinj))-exp(-alpha*(t-tsp)))/tinj; 
    } 
    return(hit); 
} 
  
  
  
// Gateway function                                           
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void mexFunction(int nlhs, mxArray *plhs[], int nrhs, const mxArray *prhs[]) 
{ 
    double *cr, *cq, *cqh, *par_var, *yold, *ynew, *hcpdf, *istop; 
    int n; 
  
    if (nrhs != 5){ 
        mexErrMsgTxt("5 input arguments required."); 
    } 
    else if (nlhs != 4){ 
        mexErrMsgTxt("4 output argument requrired."); 
    }    
    n = mxGetScalar(prhs[0]); 
    plhs[0] = mxCreateDoubleMatrix(n, 1, mxREAL); 
    plhs[1] = mxCreateDoubleMatrix(n, 1, mxREAL); 
    plhs[2] = mxCreateDoubleMatrix(n, 1, mxREAL); 
    plhs[3] = mxCreateDoubleMatrix(1, 1, mxREAL); 
    cr = mxGetPr(plhs[0]); 
    cq = mxGetPr(plhs[1]); 
    cqh = mxGetPr(plhs[2]); 
    istop = mxGetPr(plhs[3]); 
    par_var = mxGetPr(prhs[1]); 
    yold = mxGetPr(prhs[2]); 
    ynew = mxGetPr(prhs[3]); 
    hcpdf = mxGetPr(prhs[4]); 
    gan_main(par_var, yold, ynew, hcpdf, cr, cq, cqh,istop); 
} 
 
E. Codes for DQ/DQH2 metabolism model 
E.1 gan_fitDQ.m 
% Function:  estimate Vmax and Km of complex III, NQO1  
%                        by fitting DQ distribution model to experimental data  
% Input:  experimental data 
% Output:  estimated values of Vmax(s) and Km(s) 
% Created by Zhuohui Gan on 12-2010, updated on 04-20-2011                                                                    
% Using Rugani’s codes as a reference 
 
clear all  
close all 
global n  
 
% get initial values for all parameters 
redo1 = 1; 
while(redo1) 
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   % Enter parameters 
   par = gan_GetDQParameters(); 
   if par == -9999 
       disp('Error during parameter acquirement.'); 
       return; 
   else 
    homorg = par(17); % 0: hetergenous  1: homogenous 
    % calculate peclet 
    for i = 1:(2-homorg)  % why pe calculated before adjustment of tibar, tcbar? 
      pe(i) = gan_Peclet(par(3*i-2),par(3*i-1)); 
      if (pe(i) <= 0) 
         disp(['    when tibar=' num2str(par(3*i-2)) '   vari must be <' num2str(par(3*i-1))]); 
      else 
         redo1 = 0;     
      end 
    end 
   end 
end 
  
% define all constants  
tibar   = par(1); % non-capillary mean transit time, sec 
vari    = par(2); % variance of non-capillary  
avsi    = par(3); % shift for tibar 
tcbar   = par(4); % capillary mean transit time, sec 
varc    = par(5); % variance of capillary  
avsc    = par(6); % shift for tcbar 
vmax1   = par(7); % m-m vmax for NQO1 mediated Q reduction, nmol/min 
akm1    = par(8); % m-m constant for NQO1 mediated Q reduction, uM 
vmax2   = par(9); % m-m vmax for complex III mediated QH oxidation, nmol/min 
akm2    = par(10); % m-m constant for complex III mediated QH oxidation, uM 
qf1     = par(11); % virtual capillary volume, ml 
qf2     = par(12); % virtual tissue volume, ml 
alb1    = par(13); % apperant binding ratio between Q-Pc and Q-Pe for quinone (a1/a2) 
alb2    = par(14); % apperant binding ratio between QH-Pc and QH-Pe for hydroquione (a3/a4) 
qdot    = par(15); % flow cm/s 
dose    = par(16); % initial , uM 
homog   = par(17); % homogenous or hetergenous 1=homogenous 
dt      = par(18); % time resolution, sec 
tinj    = par(19); % total inject time (for input), sec 
tsp     = par(20); % delay time (for input), sec 
tfinal  = par(21); % time when the venous sample was collected, sec 
alpha   = par(22); % constant for input function 
qflag   = par(23); % 1=Q, 0=QH 
ratio   = 1; 
                                                                                                                                                              228                                                             
  
    
% check basic setting 
if (tcbar <= 0) 
   disp('    tcbar <0, so program stopped.') 
   return; 
end 
if (tfinal <= 0) 
   disp('    tfinal<=0, Program stopped.') 
   return; 
end 
if qflag==1 
    disp('   Your infused probe is quione.'); 
elseif qflag==0 
    disp('   Your infused probe is hydroquione..'); 
else  
    disp('   Your infused probe flag is mistaken,quit program.'); 
    return; 
end 
 
%initialized variables 
ndim = round(tfinal/dt); % # points of time axis 
npdes = 3;  % # of pdes for 1 model 
fcmin = 0.01;  % covered area 
dx      = dt/tcbar;  % normalized deltx , deltz 
qc      = qdot*tcbar; % capillary volume 
delx    = dx*tcbar; 
% consider the delay into mean transit time 
tibar = tibar + avsi; 
tcbar = tcbar + avsc; 
  
% set up pe, tihat 
if homorg ==1 
    pei = pe(1); 
    pec = 0; 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
else 
    pei = pe(1); 
    pec = pe(2); 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
    tchat = tcbar/(1+2/pec); 
end 
  
%set-up of cap trans. func. as vector, min and max cap trans. times 
hcpdf = zeros(1,ndim); % capillary transit time distribution   
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hnpdf = zeros(1,ndim); % non-capillary transit time distribution 
if (homorg==1) 
   % if it is a homogeneous organ 
   iend = 1/dx + 0.001; % the last spacial point 
   test = 1.0/dx - iend; 
   if (test > 0.001) 
      disp(['    For a homogenous organ, 1/dx must be an integer, now 1/dx=' num2str(1/dx)]); 
      disp(['    With this dx, capillary mmt will be changed to ' num2str(iend*delx)]); 
      C_ok = input('Continue or Start over (C = continue)? ','s'); 
      if (C_ok == 'C' | C_ok == 'c') 
         tcbar = iend*delx; 
      else 
         return; 
      end 
   end 
   ibeg = iend; % since it is homogenous, so no scalar required 
else 
   % if it is not a hetergeneous organ 
   disp(['    dose=' num2str(dose)]); 
   % capillary distribution function 
   hcpdf = hcpdfunc(ndim,delx,avsc,tchat,pec);    
   % find the begin and the end, but for hetergenous organ, ibeg ==1  
   [ibeg,iend] = begendfunc(hcpdf,ndim,fcmin); 
   %Renormalize hc(t) to unit area 
   hcpdf = hcpdf(2:ndim); % get rid of the first point, because  
   % from first point to iend point, which is supposed to be 99.9% covered. 
   hcpdf = hcpdf(1:iend); 
   % to get an interget for the area under the capillary function 
   ac = trapz(hcpdf)*dt; 
   % rescale ,so 100% area 
   hcpdf = hcpdf./(ac/delx); 
    
   %Noncapillary transport function 
   qd = qdot*tihat; % non-capillary volume 
   hnpdf = gan_hnpdfunc(ndim, par, qd); %non-capillary input function 
   hnpdf = hnpdf(2:ndim); 
   ibeg = 1; 
   disp(['    ibeg=' num2str(ibeg) '      iend=' num2str(iend)]); 
end 
captmin = ibeg*delx; 
captmax = iend*delx; 
disp(['    min/max capillary times are [ ' num2str(captmin) '  ' num2str(captmax)  ' ]']); 
if (iend == ndim) 
   disp('    iend=dimenssion..!'); 
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end 
  
%set-up of nx  
nxy =round (3*captmax/dt); 
nfinala = round(tfinal/dt) + 1; 
nx = iend + 1; 
if (nx > nxy) 
   disp(['    dx is too small, required dx >= ' num2str(1/nxy)]); 
   return; 
else 
   disp(['    nx = ' num2str(nx)]);     
end 
  
%Initial conditions when t = 0 
par_var     = par; 
par_var(1)  = tibar; 
par_var(4)  = tcbar; 
par_var(23) = qflag; 
par_var(24) = nfinala; 
par_var(25) = nx; 
par_var(26) = nxy; 
par_var(27) = ndim; 
par_var(28) = ibeg; 
par_var(29) = iend; 
par_var(30) = pec; 
par_var(31) = pei; 
par_var(32) = qc; 
par_var(33) = delx; 
par_var(34) = npdes; 
  
t = [0:dt:(tfinal-dt)]; 
  
% get all data 
redo2=1; 
in_con=[]; % infused dye concentration (uM) 
log_con = [];% log mean concentration of infused dye (uM) 
out_con = [];% efflux concentration of metabolic product (uM) 
cond = [];% infused condition 
rate = [];% efflux rate of metabolic product (umol/min) 
while redo2==1 
   datafile = input ('Please enter the file which contains data:  ', 's'); 
   fid = fopen(datafile, 'r');   
   if (fid==-1) 
       temp = input('invalid file name, quit (0) or continue (1)?  '); 
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       if (temp==1) 
       else 
           return; 
       end 
   else 
       fclose(fid); 
    
   end 
   load(datafile); 
   data=eval(datafile(1:(length(datafile)-4))); 
   tempin = data(:,1);  % infused concentration, in_con = Qv+QHv 
   templog = data(:,2);  % log mean concenctration, log_con=(in-Qv)/(log(in)-log(Qv)) 
   tempout = data(:,3); ; % efflux product concentration, QHv or Qv 
   temprate = data(:,4);   % efflux product rate, umol/min 
   tempname = char(datafile(1:(length(datafile)-4))); 
    
   in_con= [in_con tempin']; 
   log_con = [log_con templog']; 
   out_con = [out_con tempout']; 
   rate = [rate temprate']; 
   tempcondi=[]; 
   for tempi= 1:length(tempin) 
       tempcondi{tempi}=upper(tempname); 
   end  
   cond = [cond tempcondi]; 
    
   temp = input (' Do you want to load more data? Yes (1) No (0)?  '); 
   if (temp==1) 
   else 
        redo2=0; 
   end 
end  
  
% define parameters which wants to be evaluated; 
npara=input ('Please enter parameters you want to estimate, \n Vmax1 -> NQO1, Vmax2 -> 
complex III, Vmax3 -> complex I, Vmax4-> others\n0: ratio of vmax2\n1: Vmax1; \n2: Vmax1 
and km1; \n3: Vmax2 and km2; \n4: Vmax1, km1,Vmax2, km2:  '); 
par_var(35) = npara; 
switch npara 
case 0 
    p0=[ratio]; 
    lb=[0]; 
    ub=[1]; 
case 1 
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    p0 = [vmax1]; 
    lb = [0.0001]; 
    ub = [1000 ];  
case 2 
    p0 = [vmax1 akm1]; 
    lb = [0.0001 0.0001]; 
    ub = [1000 1000];  
case 3 
    p0 = [vmax2 akm2]; 
    lb = [0.0001 0.0001]; 
    ub = [1000 1000];     
case 4 
    p0 = [vmax1 akm1 vmax2 akm2]; 
    lb = [0.0001, 0.0001, 0.0001, 0.0001]; 
    ub = [2000 2000 2000 2000];     
otherwise 
    disp('The parameters you want to estimate is unclear. Quit.'); 
    return; 
end  
  
options=optimset('TolFun', 1e-8, 'TolX', 1e-8,'MaxFunEvals',1400); 
n=0; 
[p, SSD, residual,exitflag,output,lambda,nJa] = lsqcurvefit(@gan_solveDQ, p0, in_con, out_con, 
lb, ub, options,par_var,hcpdf, cond); 
result=p 
  
% calculate correlation coefficient 
[Q,R]=qr(nJa); 
R1 = R(1:length(p), :); 
h=inv(R1'*R1); 
for i=1:length(p) 
    for j=1:length(p) 
        cc(i,j)=h(i,j)/(h(i,i)*h(j,j))^0.5; 
    end 
end 
cc 
SSD 
  
% calculate confidence interval 
s2=SSD/(length(in_con)-length(p)); 
for i = 1:length(p) 
    seb(i)=(s2^0.5)*(h(i,i)^0.5); 
end 
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switch npara 
case 1 
    tt=3.182; % 4 data points, 1 variable 
    ci=seb.*tt 
    disp(['    vmax1= ' num2str(p(1))]); 
    par_var(7) = p(1);  % update vmax1 
case 2 
    tt=4.303; % 4 data points, 2 variable 
    ci=seb.*tt 
    disp(['    vmax1= ' num2str(p(1))]); 
    disp(['    km1= ' num2str(p(2))]); 
    par_var(7) = p(1);  % update vmax1 
    par_var(8) = p(2);  % update km1 
case 3 
    tt=4.303; % 4 data points, 2 variable 
    ci=seb.*tt 
    disp(['    vmax2= ' num2str(p(1))]); 
    disp(['    km2= ' num2str(p(2))]); 
    par_var(9) = p(1);  % update vmax1 
    par_var(10) = p(2);  % update km1 
case 4 
    tt=12.706;% 4 data points, 4 variable;     
    ci=seb.*tt 
    disp(['    vmax1= ' num2str(p(1))]); 
    disp(['    km1= ' num2str(p(2))]); 
    disp(['    vmax2= ' num2str(p(3))]); 
    disp(['    km2= ' num2str(p(4))]); 
    par_var(7) = p(1);  % update vmax1 
    par_var(8) = p(2);  % update km1 
    par_var(9) = p(3);  % update vmax2 
    par_var(10) = p(4); % update km2 
otherwise 
    tt=2.01;  % constant for freedom 40-60       
    ci=seb.*tt; 
    p 
end  
  
% ask whether a simulation is required. 
temp = input('Do you want to run a simulation? Yes(1) No(0)  '); 
if temp == 0 
    return; 
end 
  
% determine the time point of efflux  (as tfinal for simulation) 
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redo3=1; 
while redo3==1 
    temp = input('Input the time point you want to pick up the efflux concentration: '); 
    if temp>0 
        t = temp; 
    else  
        disp('invalid time point.') 
        t = 99999; 
    end    
     
    if (t/dt)> ndim 
        temp = input ('Your time point is either too big or mistaken, Do you want to try again, Y(1), 
N(0)?  '); 
        if temp==0 
            return; 
        end 
    else 
        redo3=0; 
    end 
end  
  
% calculate the dose-dependent simulation based on new parameters. 
m = int16(t/dt); 
dose_interval =10; 
num_dose =40; 
for i=1:(num_dose+1); 
        % initialize yold, ynew 
        yold = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t 
        ynew = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time 
t+dt  
        par_var(16)=(i-1)*dose_interval; 
        [cr,cq,cqh,istop] = gan_main2(ndim, par_var, yold, ynew, hcpdf); 
        mQ(i)=cq(m); 
        mQH(i)=cqh(m); 
end  
  
dose = 0:dose_interval:num_dose*dose_interval; 
plot(dose,mQ,dose,mQH); 
legend('Q', 'QH'); 
  
% save simulated results 
conc_save = [dose; mQ; mQH; mQ+mQH]; 
save_sims = input('Save simulated data? Yes [1] No[0] '); 
if save_sims == 1, 
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   gan_SaveData(conc_save, dose_interval); 
elseif save_sims ~= 0, 
      disp(['Unexpected entry.  Program will complete without saving. ']); 
end 
  
disp(['Program completed']); 
 
E.2 gan_getDQParameters.m 
function param = gan_GetDQParameters() 
% Function:  acquire all parameters  
% Input:  none 
% Output:  a list of parameter values 
% Created by Zhuohui Gan on 12-2010, updated on 04-20-2011                                                                     
 
stop_flag = 0; 
get_parms = 1; 
par =[]; 
  
% Vmax1, Km1: NQO1 mediated CoQ1 reduction  
% Vmax2, Km2: complex III mediated CoQ1H2 oxidation 
% Vmax3, Km3: complex I mediated CoQ1 reduction 
% Vmax4, Km4: other CoQ1 reduction 
while(get_parms), 
   T_or_F = input('Enter "t" for Term or "f" for file: ','s'); 
   if ((T_or_F == 't') | (T_or_F == 'T')), 
      % define input dlg 
      prompt1 = {'hn MTT (s):','hn VAR (s):','hn AVS:','hc MTT (s):','hc VAR (s):','hc AVS:',... 
          'Vmax1 (nmol/s, NQO1):', 'Km1 (uM):', 'Vmax2 (nmol/s, complexIII):', 'Km2 (uM):','QF1 
(ml):','QF2 (ml):','alb1:','alb2:'}; 
      prompt2 = {'Qdot (flow, ml/s):','Dose (uM):','homo? 1=Yes 0=No','dt(s):','tinj (s):','tsp 
(s):','tfinal (s):',... 
          'alpha', 'Q? 1=Q 0=QH','Vmax3:(not used for DQ)', 'Km3:(not used for DQ)','Vmax4:(not 
used for DQ)', 'Km4:(not used for DQ)'}; 
      %         tibar  vari   avsi   tcbar  varc   avsc  vmax1 km1 vmax2 km2  qf1 qf2  alb1 alb2 
      defs1 = {'4.00','4.00','2.00','2.50','4.00','0.00','45', '3','20','38','10','4','25','4.17'}; 
      %         qdot     dose homog  dt   tinj   tsp   tfinal    alpha  Q/QH Vmax3 Km3 Vmax4 km4 
      defs2 = {'0.1667','100','0','0.01','145','5.09706','140','0.20358','1','20','20','25','10'}; 
       
      %acquire parameters from inputdlg 
      temp = inputdlg(prompt1,'Enter Parameter Values (1/2)',1,defs1); 
      par1 = str2num(char(temp)); 
      temp = inputdlg(prompt2,'Enter Parameter Values (2/2)',1,defs2); 
      par2 = str2num(char(temp)); 
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      % check whether all inputs are number. 
      non_number=0; 
      if(length(par1)<1) ||length(par2)<1 
           non_number=1; 
      end 
       
      % Inquiry if there is a non-number, what to do next step 
      if non_number>0 
          msgbox('you have 1 or more non-number parameters,Please retry.','Warning','warn') 
      else 
        par = [par1; par2]; 
        % save paramters to a file if need 
        save_ck = input('Save parameter file? Yes [1] No [0]  '); 
        if save_ck == 1,       
        fcell = { 'hn MTT(s):      ', 'hn VAR(s):      ', 'hn AVS:         ','hc MTT(s):      ',... 
                  'hc VAR:         ', 'hc AVS:         ', 'Vmax1:          ','Km1:            ',... 
                  'Vmax2:          ', 'Km2:            ', 'QF1:            ','QF2:            ',... 
                  'alb1:           ', 'alb2:           ', 'Qdot:           ','Dose:           ',... 
                  'homo? 1=Yes 0=No', 'dt              ', 'tinj:           ','tsp:            ',... 
                  'tfinal          ', 'alpha           ', 'Q? 1=Q 0=QH     ','Vmax3:          ',... 
                  'Km3:            ', 'Vmax4:          ', 'Km4:            '}; 
        ffield = {'p1','p2','p3','p4','p5','p6','p7','p8','p9','p10','p11','p12','p13',... 
               'p14','p15','p16','p17','p18','p19','p20','p21','p22','p23','p24','p25','p26','p27'}; 
        fpar = cell2struct(fcell,ffield,2); 
        pno = length(par); 
        repeat = 1; 
        while(repeat), 
            s_fname = input('Enter filename to save parameters: ','s'); 
            fid_r = fopen(s_fname,'r'); 
            file_save = 0; 
            if fid_r ~= -1, 
                fclose(fid_r); 
                file_save = input('Filename already exists. Enter new name [1] or write over [0]? '); 
                if file_save == 0, 
                    fid_w = fopen(s_fname,'w'); 
                    fprintf(fid_w,' %i\n',pno); 
                    for i = 1:pno 
                        eval(['fprintf(fid_w,'' %s     %8.4f\n'',fpar.p' int2str(i) ... 
                        ', par(' int2str(i) '));']); 
                    end 
                    fclose(fid_w); 
                    repeat = 0; 
                end 
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            else 
                fid_w = fopen(s_fname,'w'); 
                fprintf(fid_w,' %i\n',pno); 
                for i = 1:pno 
                    eval(['fprintf(fid_w,'' %s     %8.4f\n'',fpar.p' int2str(i) ... 
                    ', par(' int2str(i) '));']); 
                end 
                fclose(fid_w); 
                repeat = 0; 
            end 
        end  % end of while 
      end  % end of if 
      % change the control for the loop 
      get_parms = 0  ; 
      param =  par; 
      end 
   elseif ((T_or_F == 'f') | (T_or_F == 'F')), 
      par=gan_ReadParameters; 
      if par==-9999 
        param =-9999; 
      else 
        param =par; 
        if length(par)<1 
            msgbox('You give up to set up parameters. This may cause sequential 
error.','Warning','warn') 
        else 
            for i = 1:length(par), 
                eval(['clear line_p' int2str(i) '; clear p' int2str(i) '; clear sp' int2str(i) ';' ]); 
            end 
        end 
      end 
      prompt1 = {'hn MTT (s):','hn VAR (s):','hn AVS:','hc MTT (s):','hc VAR (s):','hc AVS:',... 
          'Vmax1 (nmol/s, NQO1):', 'Km1 (uM):', 'Vmax2 (nmol/s, complexIII):', 'Km2 (uM):','QF1 
(ml):','QF2 (ml):','alb1:','alb2:'}; 
      prompt2 = {'Qdot (flow, ml/s):','Dose (uM):','homo? 1=Yes 0=No','dt(s):','tinj (s):','tsp 
(s):','tfinal (s):',... 
          'alpha', 'Q? 1=Q 0=QH','Vmax3:(not used for DQ)', 'Km3:(not used for DQ)','Vmax4:(not 
used for DQ)', 'Km4:(not used for DQ)'}; 
      %         tibar  vari   avsi   tcbar  varc   avsc  vmax1 km1 vmax2 km2  qf1 qf2  alb1 alb2 
      defs1 = {num2str(par(1)),num2str(par(2)),num2str(par(3)),num2str(par(4)),num2str(par(5)),... 
               num2str(par(6)),num2str(par(7)),num2str(par(8)),num2str(par(9)),num2str(par(10)),... 
               num2str(par(11)),num2str(par(12)),num2str(par(13)),num2str(par(14))}; 
      %         qdot     dose homog  dt   tinj   tsp   tfinal    alpha  Q/QH Vmax3 Km3 Vmax4 km4 
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      defs2 = 
{num2str(par(15)),num2str(par(16)),num2str(par(17)),num2str(par(18)),num2str(par(19)),... 
              
num2str(par(20)),num2str(par(21)),num2str(par(22)),num2str(par(23)),num2str(par(24)),... 
              num2str(par(25)),num2str(par(26)),num2str(par(27))}; 
       
      %acquire parameters from inputdlg 
      temp = inputdlg(prompt1,'Enter Parameter Values (1/2)',1,defs1); 
      par1 = str2num(char(temp)); 
      temp = inputdlg(prompt2,'Enter Parameter Values (2/2)',1,defs2); 
      par2 = str2num(char(temp)); 
      par = [par1; par2]; 
      param = par; 
      % get param, quit the loop 
      get_parms = 0; 
   else 
      get_parms = input('Invalid entry.  Retry? [1] or Quit [0] '); 
      stop_flag = 1; 
      param = -9999; 
   end 
    
end 
  
E.3 gan_simDQ.m 
 % Function:  simulate efflux value with a given set of parameters  
% Input:  none 
% Output:  a file containing simulated data 
% Created by Zhuohui Gan on 12-2010, updated on 04-20-2011                                                                     
 
clear all 
global tchat 
global pec 
  
%Parameter entry , update on 07-28-2010 by Gan 
redo1 = 1; 
while(redo1) 
   % Enter parameters 
   par = gan_GetDQParameters(); 
   if par == -9999 
       disp('Error during parameter acquirement.'); 
       return; 
   else 
    homorg = par(17); % 0: hetergenous  1: homogenous 
    % calculate peclet 
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for i = 1:(2-homorg)   
      pe(i) = gan_Peclet(par(3*i-2),par(3*i-1)); 
      if (pe(i) <= 0) 
         disp(['    when tibar=' num2str(par(3*i-2)) '   vari must be <' num2str(par(3*i-1))]); 
      else 
         redo1 = 0;     
      end 
    end 
   end 
end 
  
% define all constants or parameters 
tibar   = par(1); % non-capillary mean transit time, sec 
vari    = par(2); % variance of non-capillary  
avsi    = par(3); % shift for tibar 
tcbar   = par(4); % capillary mean transit time, sec 
varc    = par(5); % variance of capillary  
avsc    = par(6); % shift for tcbar 
vmax1   = par(7); % m-m vmax for NQO1 mediated Q reduction 
akm1    = par(8); % m-m constant for NQO1 mediated Q reduction 
vmax2   = par(9); % m-m vmax for complex III mediated QH oxidation 
akm2    = par(10); % m-m constant for complex III mediated QH oxidation 
qf1     = par(11); % virtual capillary volume 
qf2     = par(12); % virtual tissue volume 
alb1    = par(13); % apperant binding ratio between Q-Pc and Q-Pe for quinone (a1/a2) 
alb2    = par(14); % apperant binding ratio between QH-Pc and QH-Pe for hydroquione (a3/a4) 
qdot    = par(15); % flow m/s 
dose    = par(16); % infused concentration 
homog   = par(17); % homogenous or hetergenous 1=homogenous 
dt      = par(18); % time resolution 
tinj    = par(19); % total inject time (for input) 
tsp     = par(20); % delay time (for input) 
tfinal  = par(21); % total simulation time 
alpha   = par(22); % constant for input function 
qflag   = par(23); % 1=Q, 0=QH 
  
% if mean transit time for capillary is less than 0, something wrong, stop 
if (tcbar <= 0) 
   disp('    tcbar <0, so program stopped.') 
   return; 
end 
  
if (tfinal <= 0) 
   disp('    tfinal<=0, Program stopped.') 
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   return; 
end 
  
%initialized variables 
ndim = round(tfinal/dt);  % # points of time axis 
npdes = 3;  % # of pdes for 1 model 
fcmin = 0.01;  % covered area 
dx      = dt/tcbar;  % normalized deltx , deltz 
qc      = qdot*tcbar; % capillary volume 
delx    = dx*tcbar; 
  
% consider the delay into mean transit time 
tibar = tibar + avsi; 
tcbar = tcbar + avsc; 
  
% set up pe, tihat 
if homorg ==1 
    pei = pe(1); 
    pec = 0; 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
else 
    pei = pe(1); 
    pec = pe(2); 
    tihat   = tibar/(1+2/pei); % the parameter for the input function. 
    tchat = tcbar/(1+2/pec); 
end 
  
%set-up of cap trans. func. as vector, min and max cap trans. times 
hcpdf = zeros(1,ndim); % capillary transit time distribution   
hnpdf = zeros(1,ndim); % non-capillary transit time distribution 
if (homorg==1) 
   % if it is a homogeneous organ 
   iend = 1/dx + 0.001; % the last spacial point 
   test = 1.0/dx - iend; 
   if (test > 0.001) 
      disp(['    For a homogenous organ, 1/dx must be an integer, now 1/dx=' num2str(1/dx)]); 
      disp(['    With this dx, capillary mmt will be changed to ' num2str(iend*delx)]); 
      C_ok = input('Continue or Start over (C = continue)? ','s'); 
      if (C_ok == 'C' | C_ok == 'c') 
         tcbar = iend*delx; 
      else 
         return; 
      end 
   end 
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   ibeg = iend; % since it is homogenous, so no scalar required 
else 
   % if it is not a hetergeneous organ 
   disp(['    dose=' num2str(dose)]); 
   % capillary distribution function 
   hcpdf = hcpdfunc(ndim,delx,avsc,tchat,pec);    
   % find the begin and the end, but for hetergenous organ, ibeg ==1  
   [ibeg,iend] = begendfunc(hcpdf,ndim,fcmin); 
   %Renormalize hc(t) to unit area 
   hcpdf = hcpdf(2:ndim); % get rid of the first point, because  
   % from first point to iend point, which is supposed to be 99.9% covered. 
   hcpdf = hcpdf(1:iend); 
   % to get an interget for the area under the capillary function 
   ac = trapz(hcpdf)*dt; 
   % rescale ,so 100% area 
   hcpdf = hcpdf./(ac/delx); 
    
   %Noncapillary transport function 
   qd = qdot*tihat; % non-capillary volume 
   hnpdf = gan_hnpdfunc(ndim, par, qd); %non-capillary input function 
   hnpdf = hnpdf(2:ndim); 
   ibeg = 1; 
   disp(['    ibeg=' num2str(ibeg) '      iend=' num2str(iend)]); 
end 
 captmin = ibeg*delx; 
captmax = iend*delx; 
disp(['    min/max capillary times are [ ' num2str(captmin) '  ' num2str(captmax)  ' ]']); 
if (iend == ndim) 
   disp('    iend=dimenssion..!'); 
end 
  
%set-up of nx and the vector xbreak(i) of knots 
nxy =round (3*captmax/dt); 
nfinala = round(tfinal/dt) + 1; 
nx = iend + 1; 
if (nx > nxy) 
   disp(['    dx is too small, required dx >= ' num2str(1/nxy)]); 
   return; 
else 
   disp(['    nx = ' num2str(nx)]);     
end 
  
%Initial conditions when t = 0 
par_var     = par; 
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par_var(1)  = tibar; 
par_var(4)  = tcbar; 
par_var(24) = nfinala; 
par_var(25) = nx; 
par_var(26) = nxy; 
par_var(27) = ndim; 
par_var(28) = ibeg; 
par_var(29) = iend; 
par_var(30) = pec; 
par_var(31) = pei; 
par_var(32) = qc; 
par_var(33) = delx; 
par_var(34) = npdes; 
  
t = [0:dt:(tfinal-dt)]; 
myway = input('Input the way you to acquire doses: manual input(0), data file(1), auto input(2)? '); 
% set up the dose 
switch myway  
  case 0 
    num = input('How many doses for this simulation? '); 
    if num>=1  
        for i=1:num 
            disp(['please input your No.' num2str(i)  '  dose']); 
            temp = input('must be a number   ','s'); 
            if str2num(temp)>=0 
                temp=str2num(temp); 
            else  
                temp=0; 
            end 
            dose(i)=temp; 
        end  
    end 
  case 1 
    redo2=1; 
    while redo2==1 
        datafile = input ('Please enter the file which contains data:', 's'); 
        fid = fopen(datafile, 'r');   
        if (fid==-1) 
            temp = input('invalid file name, quit (0) or continue (1)?'); 
            if (temp==1) 
            else 
                return; 
            end 
        else 
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            fclose(fid); 
            redo2=0; 
        end 
    end  
    % the file name must be end with .txt or .dat. 
    load(datafile); 
    data=eval(datafile(1:(length(datafile)-4))); 
    dose = data(:,1);   
    num = length(dose); 
  case 2 
    dose0 = input ('Please input the start dose:  '); 
    dose1 = input ('Please input the end dose:  '); 
    interval = input('Please input dose interval:  '); 
    if (dose0>dose1) 
        disp('The end dose can not be less than the start dose.'); 
    elseif (dose0<0) 
        disp('Dose can not be less than 0.'); 
    end 
    num = int16((dose1-dose0)/interval); 
    dose = dose0:interval: (dose0+num*interval); 
    num = length(dose); 
  otherwise 
    disp('You did not select a proper way. Quit the program..'); 
    return; 
end  
  
% Calculate efflux concentrations based on input concentrations. 
for i=1:num 
        par_var(16)=dose(i);  % set up dose 
        % initialize avaiable 
        cr = zeros(1,ndim); % concentration of reference probe 
        cq = zeros(1,ndim); % concentration of oxidized probe 
        cqh = zeros(1,ndim); % concentration of reduced probe 
        % initialize yold, ynew 
        yold = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t 
        ynew = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time 
t+dt 
        % calculate the result 
        [cr,cq,cqh,istop] = gan_main2(ndim, par_var, yold, ynew, hcpdf); 
        mCr(i,1:ndim)=cr; 
        mCq(i,1:ndim)=cq; 
        mCqh(i,1:ndim)=cqh; 
end  
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% display the results 
switch myway 
    case 2 
        redo3=1; 
        while redo3 ==1 
            ptime = input('input the time point you want to collect sample.'); 
            if ptime>tfinal 
                disp('The time you selected is longer than tfinal. Try again'); 
                redo3=1; 
            elseif ptime<0 
                disp('Time can not be less than 0.'); 
                redo3=1; 
            elseif (0<ptime) && (ptime<=tfinal) 
                redo3=0; 
            else 
                disp('Your input may have some mistake. Quit program now.') 
                redo3=1; 
            end 
            if redo3==1 
                temp = input('Do you want to try again, Yes(1) No(0)?'); 
                if temp ==1 
                    redo3=1; 
                else 
                    redo3=0; 
                    return; 
                end 
            end 
        end 
        tpoint = int16(ptime/dt); 
        for i=1:num 
           mcr(i) = mCr(i,tpoint); 
           mcq(i) = mCq(i,tpoint); 
           mcqh(i)= mCqh(i,tpoint);  
        end 
        plot(dose,mcr,dose,mcq,dose,mcqh); 
        legend('Ref', 'Q', 'QH') ; 
        save_sims = input('Save simulated data? Yes [1] No[0] '); 
        if save_sims == 1, 
            conc_save = [dose; mcr; mcq; mcqh]; 
            gan_SaveData(conc_save, interval); 
        end 
    otherwise 
        for i=1:num 
            mcr = mCr(i,1:ndim); 
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            mcq = mCq(i,1:ndim); 
            mcqh= mCqh(i,1:ndim); 
            subplot(1,num,i); 
            plot(t,mcr,t,mcq,t,mcqh); 
            legend('Ref', 'Q', 'QH') ; 
            title(num2str(dose(i))); 
        end  
        % save the results 
        save_sims = input('Save simulated data? Yes [1] No[0] '); 
        if save_sims == 1, 
            for i=1:num 
                mcr = mCr(i,1:ndim); 
                mcq = mCq(i,1:ndim); 
                mcqh= mCqh(i,1:ndim); 
                conc_save = [t; mcr; mcq; mcqh]; 
                gan_SaveData(conc_save, dt); 
            end 
        elseif save_sims ~= 0, 
            disp(['Program will complete without saving. ']); 
        end 
end 
disp(['Program completed']); 
  
E.4 gan_solveDQ.m 
function Cmatch = gan_solvepdes(p, in_con, par_var, hcpdf, cond) 
% Function:  solve PDE sets with a given set of parameters  
% Input:  in_con: infused concentration 
%  par_var: parameters 
%  hcpdf: capillary distribution 
%  cond: infusion conditions 
% Output:  a list of steady_state efflux values 
% Created by Zhuohui Gan on 12-2010, updated on 04-20-2011                                                                     
                       
global  n 
  
mparameters =  par_var; 
qflag = par_var(23); 
nxy = par_var(26); 
ndim = par_var(27); 
npdes = par_var(34); 
npara = par_var(35); 
  
switch npara 
    case 0 
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        mparameters(9) = mparameters(9)*p(1); %vmax2 for the probe 
    case 1        % 1 parameters 
        mparameters(7) = p(1);        % vmax1 
    case 2        % 2 parameters 
        mparameters(7) = p(1);        % vmax1 
        mparameters(8) = p(2);        % km1 
    case 3        % 4 parameters 
        mparameters(9) = p(1);        % vmax2 
        mparameters(10) = p(2);       % km2 
    case 4        % 4 parameters 
        mparameters(7) = p(1);        % vmax1 
        mparameters(8) = p(2);        % km1 
        mparameters(9) = p(3);        % vmax2 
        mparameters(10) = p(4);       % km2 
    otherwise 
end 
  
% progress control...... 
n=n+1 
p 
% adjust parameter based on the infusion condition 
numDose = length(in_con); 
for i=1:numDose 
    temppara = mparameters; 
    temppara(16)=in_con(i); % dose 
    yold = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t 
    ynew = zeros(npdes,nxy); % concentrations of probes(r, oxidized, reduced)at a given time t+dt 
    if (strcmp(cond{i},'DQH2DIC') ||strcmp(cond{i},'DQH2DIC21')|| 
strcmp(cond{i},'DQH2DIC85') || strcmp(cond{i},'DQH2DIC60')) 
            temppara(7) = 0;        % vmax1=0, NQO1 inhibited 
            temppara(23) = 0;       % infused DQH2 
    elseif (strcmp(cond{i},'DQDICROT')||strcmp(cond{i},'DQDICROT21') || 
strcmp(cond{i},'DQDICROT85') || strcmp(cond{i},'DQDICROT60')) 
            temppara(7) = 0;        % vmax1=0, NQO1 inhibited 
            temppara(23) = 1;       % infused DQ 
    elseif(strcmp(cond{i},'DQAA') ||strcmp(cond{i},'DQAA21') || strcmp(cond{i},'DQAA85') || 
strcmp(cond{i},'DQAA60')) 
            temppara(9) = 0;        % vmax2=0, COMPLEX III inhibited 
            temppara(23) = 1;       % infused DQ 
    elseif(strcmp(cond{i},'DQKCN') ||strcmp(cond{i},'DQKCN21') || strcmp(cond{i},'DQKCN85') 
|| strcmp(cond{i},'DQKCN60')) 
            temppara(9) = 0;        % vmax2=0, COMPLEX III inhibited 
            temppara(23) = 1;       % infused DQ 
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    elseif(strcmp(cond{i},'DQH2DICROT')||strcmp(cond{i},'DQH2DICROT21')|| 
strcmp(cond{i},'DQH2DICROT85') || strcmp(cond{i},'DQH2DICROT60')) 
            temppara(7) = 0;        % vmax1=0, NQO1 inhibited 
            temppara(23) = 0;       % infused DQH2 
    elseif(strcmp(cond{i},'DQ')||strcmp(cond{i},'DQ21')|| strcmp(cond{i},'DQ85') || 
strcmp(cond{i},'DQ60')) 
            temppara(23) = 1;       % infused DQ 
    else             
    end 
     
    [cr, cq, cqh, istop] = gan_main2(ndim, temppara, yold, ynew, hcpdf); 
    mQ(i)=cq(ndim); 
    mQH(i)=cqh(ndim); 
    % pick up the right value  
    if (temppara(23)==1) 
        mResult(i)= mQH(i); 
    else 
        mResult(i)= mQ(i); 
    end  
     
end 
Cmatch = mResult; 
 
E.5 Gan_main2.c 
// Function:  calculate efflux values based on mathematical model for DQ/DQH2 
// Input:  yold: old efflux values 
//  ynew: new efflux values 
//  par_var: parameters for the model 
// output:  cr: concentration of Q+QHold efflux values 
//  cq: concentration of quinone 
//  cqh: concentration of hydroquinone 
//  istop: the sign of stop   
// Created by Z Gan 0n 07-2010, updated on 04-20-2011 
 
#include <math.h> 
#include "mex.h" 
  
int homorg, ibeg, iend, nx, nxy, ndim, qflag, nfinala; 
double tibar, vari, avsi, tcbar, varc, avsc, qdot, dose, dt, delx, qc, pei, pec; 
double qf1, qf2, vmax1, vmax2, akm1, akm2, alb1, alb2, f1,f2; 
double alpha, tfinal, tinj, tsp, tihat, qd; 
  
void gan_main(double *par_var, double *yold, double *ynew, double *hcpdf, double *cr, double 
*cq, double *cqh, double *istop) 
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{ 
    int i, m; 
    double tout, crsum, cqsum, cqhsum, hcj, rbar, qbar, qhbar, rchem, qchem, qhchem, fchem1, 
fchem2; 
    double rwfhi(double); 
    double square(double, double); 
   
    // define all parameters 
    tibar       = *(par_var+0); 
    vari        = *(par_var+1); 
    avsi        = *(par_var+2); 
    tcbar       = *(par_var+3); 
    varc        = *(par_var+4); 
    avsc        = *(par_var+5); 
    vmax1       = *(par_var+6); 
    akm1        = *(par_var+7); 
    vmax2       = *(par_var+8); 
    akm2        = *(par_var+9); 
    qf1         = *(par_var+10); 
    qf2         = *(par_var+11); 
    alb1        = *(par_var+12); 
    alb2        = *(par_var+13); 
    qdot        = *(par_var+14); 
    dose        = *(par_var+15); 
    homorg      = *(par_var+16); 
    dt          = *(par_var+17); 
    tinj        = *(par_var+18); 
    tsp         = *(par_var+19); 
    tfinal      = *(par_var+20); 
    alpha       = *(par_var+21); 
    qflag       = *(par_var+22); 
    nfinala     = *(par_var+23); 
    nx          = *(par_var+24); 
    nxy         = *(par_var+25); 
    ndim        = *(par_var+26); 
    ibeg        = *(par_var+27); 
    iend        = *(par_var+28); 
    pec         = *(par_var+29); 
    pei         = *(par_var+30); 
    qc          = *(par_var+31); 
    delx        = *(par_var+32); 
     
    // calculate public constant 
    tihat = tibar/(1+2/pei); 
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    qd    = qdot*tihat; 
    // constants f1, 1-f1 
    f1 = qc/(qc+qf1/alb1); 
    f2 = qc/(qc+qf2/alb2); 
    // constants for chemical parts 
    fchem1 = dt/(qc+qf1/alb1); 
    fchem2 = dt/(qc+qf2/alb2); 
  
  
    *istop = ndim; 
    // loop at time axis 
    for (i=0;i<=ndim;i++) 
    { 
        tout = i*dt;  // actual time, second 
        if (tout >= tfinal)  // stop 
        { 
            *istop =i; 
            break; 
        } 
        // calculate boundary 
        if (qflag ==1)  // inject quinone 
        { 
            *yold=square((tout-avsi), dose*tinj); // normalization factor was removed '/areaa'; 
            *(yold+nxy)=square((tout-avsi), dose*tinj); 
            *(yold+2*nxy)=0; 
        } 
        else    // inject hydroquinone 
        { 
            *yold=square((tout-avsi), dose*tinj); //  /areaa; 
            *(yold+nxy)=0; 
            *(yold+2*nxy)=square((tout-avsi), dose*tinj); 
        } 
         
        // calculate next time point, f1, f2, qchem, qhchem represent the model. 
        for (m=1; m<=nx;m++) 
        {   //average 
            rbar  = 0.5*(*(yold+m)+*(yold+m-1)); 
            qbar  = 0.5*(*(yold+nxy+m)+*(yold+nxy+m-1)); 
            qhbar = 0.5*(*(yold+2*nxy+m)+*(yold+2*nxy+m-1)); 
            // chemistry 
            rchem = 0;   
            // vmax1: NQO1; vmax2: complex III 
            qchem = -fchem1*vmax1*qbar/(akm1+qbar)+fchem1*vmax2*qhbar/(akm2+qhbar); 
            qhchem= fchem2*vmax1*qbar/(akm1+qbar)-fchem2*vmax2*qhbar/(akm2+qhbar); 
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            // ynew 
            *(ynew+m)= *(yold+m-1); 
            *(ynew+nxy+m)= (1-f1)**(yold+nxy+m)+f1**(yold+nxy+m-1)+qchem; 
            *(ynew+2*nxy+m)= (1-f2)**(yold+2*nxy+m)+f2**(yold+2*nxy+m-1)+qhchem; 
        } 
  
        // adjust the value according the type of flow distribution 
        if (homorg==1) // if homogenous distribution 
        { 
            *(cr+i)=*(ynew+nx-1); 
            *(cq+i)=*(ynew+nxy+nx-1); 
            *(cqh+i)=*(ynew+2*nxy+nx-1); 
        } 
        else // if heterogenous distribution 
        { 
            crsum=0;  
            cqsum=0;  
            cqhsum=0; 
            for (m=ibeg-1; m<nx-2; m++) 
            { 
                hcj = *(hcpdf+m); 
                crsum = crsum + hcj**(ynew+m+1); 
                cqsum = cqsum + hcj**(ynew+nxy+m+1); 
                cqhsum = cqhsum + hcj**(ynew+2*nxy+m+1); 
            } 
            *(cr+i)=crsum; 
            *(cq+i)=cqsum; 
            *(cqh+i)=cqhsum; 
        } 
         
        // clean negative value and update yold 
        for (m=0; m<=nx; m++) 
        { 
            if(*(ynew+m)<0) // no negative value is allowed. 
                *(ynew+m)=0;                             
            if(*(ynew+nxy+m)<0) 
                *(ynew+nxy+m)=0; 
            if(*(ynew+2*nxy+m)<0) 
                *(ynew+2*nxy+m)=0; 
            *(yold+m)=*(ynew+m); 
            *(yold+nxy+m)=*(ynew+nxy+m); 
            *(yold+2*nxy+m)=*(ynew+2*nxy+m); 
        } 
    } 
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} 
   
// sub-function used to simulate a square input 
double square(double t, double a) 
{ 
    double hit; 
    if (t<tsp) 
    { 
        hit=0; 
    }else if((t>=tsp) && (t<(tsp+tinj))) 
    { 
        hit=a*(1- exp(-alpha*(t-tsp)))/tinj; 
    }else 
    { 
        hit=a*(exp(-alpha*(t-tsp-tinj))-exp(-alpha*(t-tsp)))/tinj; 
    } 
    return(hit); 
} 
  
// for random-walk input 
double rwfhi(double t) 
{ 
    double rwf(double); 
    double hit; 
     
    double rwft, sq, pi, ex,s; 
    pi = 3.1415926535897932; 
    s=t/tihat; 
    if (s <= 0) 
    { 
        rwft = 0; 
    } 
    else  
    { 
        sq = sqrt(pei / (4 * pi * s)); 
        ex = exp((-pei * (1-s) * (1-s)) / (4 * s)); 
        rwft = sq * ex; 
    } 
     
    hit = (dose/qd) * rwft; 
    return(hit); 
} 
  
/*  Gateway function        */                                           
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void mexFunction(int nlhs, mxArray *plhs[], int nrhs, const mxArray *prhs[]) 
{ 
    double *cr, *cq, *cqh, *par_var, *yold, *ynew, *hcpdf, *istop; 
    int n; 
  
    if (nrhs != 5){ 
        mexErrMsgTxt("5 input arguments required."); 
    } 
    else if (nlhs != 4){ 
        mexErrMsgTxt("4 output argument requrired."); 
    }     
    n = mxGetScalar(prhs[0]); 
    plhs[0] = mxCreateDoubleMatrix(n, 1, mxREAL); 
    plhs[1] = mxCreateDoubleMatrix(n, 1, mxREAL); 
    plhs[2] = mxCreateDoubleMatrix(n, 1, mxREAL); 
    plhs[3] = mxCreateDoubleMatrix(1, 1, mxREAL); 
    cr = mxGetPr(plhs[0]); 
    cq = mxGetPr(plhs[1]); 
    cqh = mxGetPr(plhs[2]); 
    istop = mxGetPr(plhs[3]); 
    par_var = mxGetPr(prhs[1]); 
    yold = mxGetPr(prhs[2]); 
    ynew = mxGetPr(prhs[3]); 
    hcpdf = mxGetPr(prhs[4]); 
    gan_main(par_var, yold, ynew, hcpdf, cr, cq, cqh,istop); 
} 
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APPENDIX III – Glossary 
 
AA = Antimycin A 
ACE = Angiotensin converting enzyme 
ALI = Acute lung injury 
AR = Amplex red 
ARDS = Acute respiratory distress syndrome 
Bc = Dye binding sites within the cytoplasm 
Be = Dye cuvette bonding sites 
Bm = Dye binding sites within mitochondrial matrix 
BPAEC = Bovine pulmonary arterial endothelial cells 
BSA = Bovine serum albumin 
CCCP = Carbonyl cyanide 3-chlorophenylhydrazone 
CoQ9H2 = endogenous coenzyme Q9 hydroquinone 
DCF = 2,7-dichlorofluorescein 
DCPIP = 2,6-dichlorophenolindophenol 
DQH2 = Durohydroquinone 
[DQ] (x,t), and [DQH2] (x,t) = Vascular concentrations of free DQ and DQH2, respectively, at 
distance x from the capillary inlet and time t (µM).  
[DQ] = Total (free + BSA bound) vascular concentration of DQ (µM) 
[DQH2] = Total (free + BSA bound) vascular concentration of DQH2 (µM) 
ES936 = 5-methoxy-1,2-dimethyl-3-[(4-nitrophenol)methyl]-indole-4,7-dione 
F = Faraday constant (coluomb/mol) 
FCCP = Carbonylcyanide p-trifluoromethoxyphenylhydrazone 
hc(t) = Capillary transit time distribution  
FAPGG = N-[3-(2-Furyl) acryloyl]-Phe-Gly-Gly 
GF120918 = N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl) ethyl]-phenyl)-9,10-
dihydro-5-methoxy-9-oxo-4 acridine carboxamide 
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GSH = Glutathione 
H2O2 = Hydrogen peroxide 
HBSS = Hank’s buffered salt solution 
HEPES = 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRP = Horseradish peroxidase 
J1 = Dye flux across plasma membrane (pmol/cm
2
) 
J2 = Dye flux across inner mitochondrial membrane (pmol/cm
2
) 
k1 = Rate constant for dye-cuvette binding (min
-1
 nM
-1
) 
k-1 = Rate constant for dye-cuvette unbinding (min
-1
) 
k 1 = k1 [Be] = Rate for dye-cuvette binding (min
-1
) 
k2 = Association rate constant of dye binding with Bc (min
-1
 nM
-1
) 
k-2 = Dissociation rate constant of dye binding with Bc (min
-1
) 
k3 = Association rate constant of dye binding with Bm (min
-1
 nM
-1
) 
k-3 = Dissociation rate constant of dye binding with Bm (min
-1
) 
Km1a  =  Apparent Michaelis-Menten constant for NQO1 mediated DQ reduction, (µM) 
Km2a  = Apparent Michaelis-Menten constant for DQH2 oxidation via complex III, (µM) 
KPgp = Pgp mediated dye efflux rate (ml/min) 
kox = NQO1  =  NAD(P)H:quinone oxidoreductase 1 
KCN = Potassium cyanide 
KRB = Kreb’s ringer bicarbonate buffer 
KRB-Dex = Kreb’s ringer bicarbonate buffer containg dextran 
KRB-GO = Krebs’ ringer bicarbonate buffer containing glucose and glucose oxidase 
LDH = Lactate dehydrogenase 
NADH = Nicotinamide adenine dinucleotide 
o-PD = Ortho-phenylenediamine dihydrochloride 
P1 = Dye permeability across plasma membrane (cm/min) 
P2 = Dye permeability across mitochondrial membrane (cm/min) 
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P1S1 = Dye permeability-surface area product across plasma membrane (ml/min) 
P2S2 = Dye permeability-surface area product across mitochondrial membrane (ml/min) 
Pa = Pulmonary arterial pressure, (Torr) 
Pgp = Multi-drug efflux pump p-glycoprotein 
PS = Permeability-surface area product, (ml/min), which is a measure of rate of ACE mediated 
FAPGG hydrolysis, and an index of perfused capillary surface area 
Qi  = quinone-reducing center 
Qo = quinol-oxidizing center 
R = Universal gas constant (Joule K
-1
 mol
-1
) 
R123 = Rhodamine 123 
[Rc](t) = Dye concentration in cytoplasm at time t (nM) 
[Re](t) = Dye concentration in extracellular medium at time t (nM)  
[Re]s0 = Dye steady-state concentration in extracellular medium in absence of BPAEC (nM) 
[Re]s1 = Dye steady-state concentration in extracellular medium in presence of BPAEC, GF120918 
and high potassium(nM) 
[Re]s2 = Dye steady-state concentration in extracellular medium in presence of BPAEC, GF120918, 
high potassium, and CCCP (nM) 
[Rm](t) = Dye concentration in mitochondrial matrix at time t (nM) 
[Rm]s = Dye steady-state concentration in mitochondrial matrix (nM) 
ROS = Reactive oxygen species 
Rot = Rotenone 
S1 = Surface area of plasma membrane (cm
2
) 
S2 = Surface area of mitochondrial membrane (cm
2
) 
T = Absolute temperature (Kelvin) 
TBST = Tris buffered saline with tween-20 
TMRE = Tetramethyrhodamine ethyl ester 
V1 = Apparent cytoplasm volume (ml) 
V2 = Apparent mitochondrial matrix volume (ml) 
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Vc = Volume of the vascular region of the single capillary element model (ml)  
Vc = Physical cytoplasm volume (ml) [For rhodamine distribution model] 
Ve = Volume of the tissue region of the single capillary element model (ml) 
Ve = Extracellular medium volume (ml) Ve = Extracellular medium volume (ml) 
Vm = Physical mitochondrial matrix volume (ml) 
Vmax1 = Maximum rate for DQ reduction via NQO1, (µmol/min) 
Vmax2 = Maximum rate for DQH2 oxidation via complex III, (µmol/min)   
VF1 /α1  = Virtual volume of distribution for DQ, (ml)   
VF2 /α2  = Virtual volume of distribution for DQH2, (ml)   
W = Convective transport velocity, (cm/min) 
Z = Dye valence  
 
Greek symbols 
 
α = ZF/RT (mV
-1
) 
 
β = V2/V1 
 
δ = Fraction of ∆ψp not dissipated by CCCP 
 
τ = Time constant of ∆ψp decay in presence of CCCP (min) 
 
∆Ψp = Plasma membrane potential (mV) 
 
∆Ψm = Mitochondrial membrane potential (mV)  
 
α1 and α2 =  Constants which account for the rapidly equilibrating interactions of DQ and DQH2 
with the 5% BSA (i.e., Pc) perfusate 
 
α3 and α 4  = Constants which account for the rapidly equilibrating interactions of DQ and DQH2 
with lung tissue sites of association, respectively 
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